





Structural and Functional Studies of 


















Structural and Functional Studies of 














NUS Graduate School for Integrative Sciences 
and Engineering 






I hereby declare that the thesis is my original work and it has been written by me 
entirely. I have duly acknowledged all the sources of information which have been 
used in the thesis. 










I would like to take this opportunity to express my sincere thanks to those who helped 
me in one way or another during my PhD studies. 
First, I would like to thank my advisors, Prof Subhash Vasudevan and Prof 
Kunchithapadam Swaminathan, for providing me the opportunity to pursue my PhD 
studies at Duke-NUS Graduate Medical School and NUS Graduate School for 
Integrative Sciences and Engineering during the past four years. I especially want to 
thank Prof. Subhash Vasudevan, for supervising my thesis work on the spot.  
I would also like to extend my special appreciation to our collaborators, Prof Dahai 
Luo from Lee Kong Chian School of Medicine, and Prof Julien Lescar from School of 
Biological Sciences, Nanyang Technological University, for their patience, 
motivation, enthusiasm and immense knowledge in X-ray crystallography. 
I am grateful to the thesis advisory committee members, Prof Mary Ng, Prof Julien 
Lescar for serving as my committee members. They gave me brilliant comments and 
suggestions during every TAC meeting to keep my research on track. 
I also thank members of Subhash’s lab: Dr Moon Tay for always giving me critical 
suggestion and help me on my project, Dr Nikki Moreland for performing phage 
display, and other colleagues Miss Kitti Chan, Miss Chin Chin Lee for providing 
technical assistance and support.  
I also want to thank members of Dahai’s lab and Julien’s lab: Dr Ming Wei Chen and 
Dr Chong Wai Liew for synchrotron trip and suggestions on structure determination 
and refinement, Dr Jie Zheng for his help in the HDX-MS experiment and other 
colleagues Miss Wint Wint Phoo and Miss Kuohan Li for general support. 
ii 
 
My gratitude also goes to our collaborator Prof Pei-Yong Shi’s lab in Novartis for 
performing in vitro enzymatic assays to characterize NS5 mutants, and collaborator 
Jade Forwood from Charles Sturt University in Australia for solution study of NS5 by 
SAXS. 
I would also like to thank NGS for financial support and the opportunity to attend 
international conferences every year. 
Finally, I want to give thousands of roses to my parents and my husband Dr Zhihai Ke 
for all the understanding and support during these years.  
iii 
 
Table of Contents 
Acknowledgements ...…………………………………………………………………i 
Table of contents ……………………………………………………………………iii 
List of figures ………………………………………………………………………..ix 
List of tables ………………………………………………………………………....xi 
List of publications ………………………………………………………………....xii 
List of conference posters/presentation ………………………………………….xiii 
List of abbreviation ………………………………………………………………..xiv 
Abstract ……………………………………………………………………………xvii 
Chapter 1: Introduction ...……………………………………….………………..…1 
1.1 Dengue epidemiology ...…………………………………………………………..1 
1.2 Dengue pathogenesis ...………………………………………………………..…..3 
1.3 Phylogeny of dengue virus ……….…..………………………………………..….7 
1.3.1 Flaviviridae .…………………..……………………………………………....7 
1.3.2 Flavivirus ...………………………………………………………………...…7 
1.3.3 Dengue virus ...………………………………………………………………..8 
1.4 Structural biology of dengue virus ...…………………………………….………10 
1.4.1 Virus particle ...…………………………………………………………..…..10 
1.4.2 Replication cycle ...……………………………………………………..……11 
1.4.2.1 Virus entry ...……………………………………………………………..…..11 
1.4.2.2 Fusion and uncoating ...……………………………………………………...11 
1.4.2.3 Translation and polyprotein processing ……………………………………..13 
iv 
 
1.4.2.4 Genome replication ………………………………….…………………..…..14 
1.4.2.5 Progeny viruses assembly, maturation and release ………………….………15 
1.4.3 Structure of flaviviral genome RNA ……………………….………………..16 
1.4.4 Structure and functions of dengue proteins ………………………………….19 
1.4.4.1 Structural proteins ……………………………………….…………………..22 
a) Capsid protein …………………………………...………………………22 
b) Membrane protein ………………….……..……………………………..22 
c) Envelop …………………………………………………………………..23 
1.4.4.2 Nonstructural proteins ……………………………………………………….25 
a) NS1 …………………………………..…………………………………..25 
b) NS2A ……………………………………………...……………………..26 
c) NS2B …………………………………………………………………….27 
d) NS3 …………………………………..…………………………………..27 
e) NS4A …………………………………………………………………….32 
f) NS4B …………………………………………………………………….32 
g) NS5 …………………………………………..…………………………..33 
1.5 Replication complex ……………………………………………………………..34 
1.5.1 Advantages of membrane platform ………………………………………….34 
1.5.2 Interactions between non-structural proteins within RC …………………….35 
1.6 Nonstructural protein 5 (NS5) …………………………………...………………38 
1.6.1 N-terminal MTase domain and its activities …………………...……………40 
1.6.2 C-terminal RdRp domain and its activities ………………………………….44 
1.6.3 Other structures of RdRp-RNA complex for RNA replication ……...………50 
1.6.4 Full length structure of NS5 …………..……………………………………..56 
1.6.5 Non-enzymatic roles of NS5 …………………….…………………………..58 
v 
 
1.7 Dengue prevention and control ……………………………………….…………59 
1.8 Scope of the thesis ……………………………………...………………………..62 
Chapter 2: Materials and Methods ………………………………………………..64 
2.1 Molecular cloning ……………………………………………………….………64 
2.2 NS5 Protein expression and purification ……………………………..………….65 
2.3 2.3 NS5 antibody screening by phage display- (Initiated by Dr Moreland Nicole, 
former Research Fellow in Subhash’s lab) ………………………………………72 
2.4 Antibody (Fab-fusion protein) expression and purification ……..………………73 
2.5 Characterisation of antibodies …………………………….……………………..74 
2.5.1 ELISA …………………………………….………………………………….74 
2.5.2 Western blot ………………………………………………..………………..75 
2.5.3 SPR …………………………………..………………………………………75 
2.5.4 Peptide competition ELISA …………………………...…………………….76 
2.5.5 Peptide phage display …………………………..……………………………76 
2.6 Protein-Fab complex screening by size-exclusion chromatography (SEC) ….….76 
2.7 Studies of Protein-Fab complex by Small Angle X rays Scattering (SAXS) 
(conducted in collaboration with Jade Forwood from Sturt Charls University) ...77 
2.8 Structural studies of NS5 ……………………………...…………………………77 
2.8.1 Protein crystallisation ………………………………………………………..77 
2.8.2 Soaking experiment and co-crystallization …………………….……………78 
2.8.3 Data collection ……………………………………………………………….79 
2.8.4 Structure solution, refinement and analysis ………………...……………….79 
2.9 Studies of NS5 by HDX (conducted in collaboration with Dr Jie Zheng from 
NTU) …………………………………...………………………………………..80 
2.9.1 Hydrogen-Deuterium exchange (HDX) …………………….……….………80 
vi 
 
2.9.2 LC-MS/MS under quenched condition …………………….………………..81 
2.10 Functional studies of NS5 mutants in DENV2 full-length cDNA 
clone ………………………………………………………………….………….82 
2.10.1 Generation of mutant viral cDNA clones ………………….……….………..82 
2.10.2 Linearization and in vitro transcription ………………..…………………….85 
2.10.3 Electroporation of DENV RNAs into mammalian cells ……...……………..86 
2.10.4 Quantitative real time PCR (RT-PCR), immunofluorescence assay (IFA) and 
plaque assay ………………...………………………………………………..87 
2.11 Functional studies of NS5 mutants in NS5 protein (conducted in collaboration 
with Sherryl Soh from NTU and NITD) …………….…………………………..89 
2.11.1 NS5 methyltransferase in vitro assays …………………...…………………..89 
2.11.2 NS5 polymerase in vitro assays ……………………..………………………89 
2.12 Functional studies of NS5 mutants in replicon (conducted in collaboration 
with Sherryl Soh from NTU and NITD)………………...……………………….90 
2.12.1 Generation of DENV4 NS5 mutant replicons ……………………………….90 
2.12.2 In vitro transcription, RNA transfection, and renilla luciferase (RenLUC) 
measurements ………………………………………..………………………91 
Chapter 3: Results and Discussion ……………………….…………………...…..93 
3.1 Identification and characterisation of NS5 specific monoclonal antibodies …….93 
3.1.1 Expression and purification of NS5 proteins ……………………..…………93 
3.1.2 Fab phage display screening …………………….…………………………..94 
3.1.3  Characterization of NS5-specific monoclonal antibody …………..………..97 
3.1.3.1 Characterization of 5M1 Fab …………...……………………………………97 
3.1.3.2 Characterization of 5R3 Fab ………………………………………………..100 
3.1.3.3 Characterization of 5M3 Fab ……………………………………………….102 
vii 
 
3.1.4 Summary ………………………………….………………………………..103 
3.2 Crystal structure of full length NS5 from DENV3 ……………….…………….106 
3.2.1 Purification of NS5FL-Fab complex for crystallization …………...……….106 
3.2.1.1 Complex formation …………………………………….…………………..107 
3.2.1.2 Solution study of NS5FL-5M3 complex by small angle X-ray scattering 
(SAXS) ……………………………………………………………………..109 
3.2.2 Purification of NS56-895 for crystallisation ……………...………………….111 
3.2.3 Overall structure of NS56-895 from DENV3 ………………………………..113 
3.2.3.1 N-terminal MTase domain ……………………..…………………………..116 
3.2.3.2 C-terminal RdRp domain …………………………………………………..117 
3.2.3.3 GTP stabilization effect of DENV3 NS5 …………………………………..120 
3.2.4 Cross-talking between MTase and RdRp domains ………….……………..122 
3.2.4.1 Effect of the interface mutants on in vitro enzymatic activities of NS5 ...…123 
3.2.4.2 Effect of the interface mutants on virus replication ……..…………………127 
3.2.5 Physical linker between MTase and RdRp domains …………...…………..131 
3.2.5.1 Effect of the linker mutants on in vitro enzymatic activities of NS5 …..…..134 
3.2.5.2 Effect of the linker mutants on virus replication …………….……………..136 
3.2.6 Solution structure of NS5 probed by HDX-LCMS …………..…………….139 
3.2.7 Comparison with crystal structure for NS5 from JEV ……….…………….147 
3.2.7.1 Overall structures ………………...……………………………….………..147 
3.2.7.2 Two unique but conserved interfaces ………………………………………147 
3.2.8 Summary ………………...…………………………………………………153 
3.3 Crystal structure of NS5 complex with RNA ………………………………….154 
3.3.1 Structure determination …………………………………………………….154 
3.3.2  Overall structure of NS5-RNA-SAH ternary complex ……...…………….156 
viii 
 
3.3.3 Specific recognition of flaviviral RNA by NS5 …….……………………..157 
3.3.4 Enzymatic mechanism of 2’OMethylation …………….…………………..162 
3.3.5 Comparison with other 2’OMTase proteins ………………………………..166 
3.3.6 Functional significance of the ternary complex structure …...……………..171 
3.3.7 Summary ……………………………….…………………………………..173 
Chapter 4: Discussion and Future Directions ………………...…………………175 
4.1 Preface ………………………………...………………………………………..175 
4.2 NS5 specific monoclonal antibodies as a toolbox for dengue research .……….176 
4.3 First 3D structure of full length NS5 from dengue virus revealed domain crosstalk 
and conformational flexibility is regulated by a polar interface and physical linker, 
which are important for flavivirus replication. ...…...…………………………..176 
4.4 A ternary complex for NS5 with authentic cap 0 viral RNA reveals the 
mechanistic for 2’OMTase activity and molecular basis for sequence conservation 
at 5’end of flaviviral genome. ...……………….……………………………….180 
4.5 Coupling of RNA capping with RNA replication. .…………………………….181 
4.6 Outlook ………………………………..………………………………………..183 
Reference …………………………………………………………………………..185 





List of Figures 
Figure 1.1 Countries and areas at risk of dengue transmission in 2014. …………...…2 
Figure 1.2 Average number of total dengue cases reported to WHO during year 1955-
2010. …………………………………………………………………………..………3 
Figure 1.3 Criteria for classification of dengue and severe dengue. ……….…………4 
Figure 1.4 Model for antibody-dependent enhancement (ADE) during dengue virus 
infection. ………………………………………………………………………………6 
Figure 1.5 Genomic organization of members of the Flaviviridae. …………………..8 
Figure 1.6 Phylogenetic tree of Flavivirius genus. ………………………………...…9 
Figure 1.7 Arrangement of the E protein dimer on surface of mature 
virus. …………………………………………………………………………………11 
Figure 1.8 Schematic depiction of the DENV replication cycle. ……………………12 
Figure 1.9 Conformational changes of dengue sE monomer during membrane fusion 
and class II membrane fusion. ……………………………………………………….13 
Figure 1.10 Predicted membrane topology of DENV polyprotein on ER membrane 
and its cleavage sites. ………………………………………………………………..15 
Figure 1.11 Schematic representation of predicted secondary structure of 5’ terminal 
region (Left) and RNA elements within 3’UTR (right) of DENV genome. ………..18 
Figure 1.12 Schematic representations of dengue genome organization, polyprotein 
processing and structures of dengue viral proteins. ………………………………...20 
Figure 1.13 Structures of NS2BNS3protease in apo conformation (left, DENV) and 
inhibitor-bound conformation (right, WNV). …………………………………….…30 
Figure 1.14 Structures of NS3 helicase domain from DENV2. ……………………..31 
Figure 1.15 Side by side view of two conformations of scNS2B18NS3. …………...31 
Figure 1.16 Schematic model of ER-membrane associated replication complex for 
flaviviruses. ………………………………………………………………………….37 
Figure 1.17 Type I capped structure at 5’end of flaviviral genome and the enzymatic 
activities required for its formation. ………………………………………………....39 
Figure 1.18 Schematic representation of flaviviral NS5 protein. ……………………40 
Figure 1.19 Crystal structure of flaviviral NS5 MTase domain. …………………….42 
Figure 1.20 Structure based sequence alignment of Flavivirus RdRp domain based on 
DENV3 RdRp structure (PDB: 2J7U). ……………………………………………...47 
Figure 1.21 Structure of DENV3 RdRp (PDB: 2J7U). ……………………………...48 
Figure 1.22 Proposed schematic models for polymerase activities of RdRp 
domain. ………………………………………………………………………………50 
Figure 1.23 Proposed model with sequential stages for bacteriophage ϕ6 RdRp-RNA 
polymerization. …………………………………………………………………...….53 
Figure 1.24 Proposed model of RNA replication by HCV NS5B. ……………….…53 
Figure 1.25 Proposed a six-state elongation catalytic cycle. ………………………...55 
Figure 1.26 Structure representation of full length flaviviral NS5. ………………….58 
Figure 2.1 Schematic representation of full-length DENV2 cDNA clone. ………….83 
Figure 3.1.1 Recombinant DENV NS5 proteins constructed and purified. …….…...94 
Figure 3.1.2 Monoclonal antibody discovery workflow by phage display and unique 
Fab-phage clones specific to NS5 identified. ………………………………………..96 
Figure 3.1.3 Characterization of 5M1 Fab. ……………………….…………………99 
Figure 3.1.4 Characterization of 5R3 Fab. ……………………………….………...101 
Figure 3.1.5 Characterization of 5M3 Fab. …………………………….…………..103 
Figure 3.1.6 NS5 from DENV1-4 exhibits differential subcellular localization. …..105 
x 
 
Figure 3.2.1 Screening and purification of NS5-Fab protein complex by size exclusion 
chromatography. ……………………………………………………………….…..108 
Figure 3.2.2 Solution structure of NS5. ………………………………………....…111 
Figure 3.2.3 Typical crystals obtained during initial crystal screening. ……..….….112 
Figure 3.2.4 Global view of DENV3 NS5 structure in cartoon representation. …....114 
Figure 3.2.5 Structure of MTase domain in NS5. .…………………………………117 
Figure 3.2.6 Structure of RdRp domain in NS5. ………….………………………..118 
Figure 3.2.7: Melting temperature of NS5 proteins upon ligand binding from 
Thermoshift assay. …………………………………………………………………121 
Figure 3.2.8 Close-up views of the interface between the MTase domain and RdR 
domain as indicated in Figure 3.2.4B.………………………………………………123 
Figure 3.2.9 In vitro enzymatic activities of DENV4 NS5 and its mutants. ….……125 
Figure 3.2.10 Renilla luciferase activities of DENV4 WT and mutant replicons. ....129 
Figure 3.2.11 Growth kinetics of BHK-21 cells that were transfected with DENV2 
WT and NS5 interface mutants were monitored over the course of 5-day. …….….130 
Figure 3.2.12 Linker between MTase and RdRp domain. ……………….………...133 
Figure 3.2.13 In vitro enzymatic activities of DENV3 NS5 and its mutants. ……...136 
Figure 3.2.14 Replication profiles of NS5 interface mutants. ………….…………..138 
Figure 3.2.15 Amide hydrogens for HDX-MS. ………………………….………...140 
Figure 3.2.16 HDX-MS results. ……………………………………….…………...146 
Figure 3.2.17 Comparison of NS5 structure between DENV3 and JEV. ……….…151 
Figure 3.3.1 Crystal structure for ternary complex of NS56-896-RNA-SAH. ……....156 
Figure 3.3.2 Stereo views of the electron density maps of the RNA and SAH. ...…158 
Figure 3.3.3 RNA binding within ternary complex. …………………………….…159 
Figure 3.3.4 Local environment selects adenine as the first base and guanine as the 
second base. ………………………………………………………………………..161 
Figure 3.3.5 The catalytic site and the proposed enzymatic mechanism for 2’-O 
methylation. ………………………………………………………………………...165 
Figure 3.3.6 Structural based alignment of NS5 with non-flaviviral MTase using Dali 
server. ………………………………………………………………………………168 
Figure 3.3.7 Comparison of DENV3 NS5 MTase with human and other viral 2’O 
MTase. ……………………………………………………………………………...171 
Figure 4.1 A schematic model for the divergent evolution of flaviviral NS5 
proteins. …………………………………………………………………………….179 
Figure 4.2 Schematic model of possible conformations of NS5FL. ……………….180 

















List of Tables 
Table 1.1 RNA structure elements at 5’- and 3’-UTRs and their functions in flavivirus 
life cycle. …………………………………………………………………………….19 
Table 1.2 Summary of flaviviral proteins. ……………………………………..……21 
Table 1.3 Mapped interactions within replication complex for flaviviruses. ……..…37 
Table 1.4 Dengue virus NS5 methyltransferase and RdRp inhibitors. ……………...61 
 Table 2.1.Detail of NS5 constructs. ……………………………………………...…67 
Table 2.2 Primers used for generate mutant DENV3 NS5 proteins. …………….…..69 
Table 2.3 Protein expression conditions and purification buffers. ………………..…72 
Table 2.4 Primers used for site-directed mutagenesis (SDM) to construct mutant 
DENV2 infectious clone. ………………………………………………..…………..84 
Table 2.5 Primers used for site-directed mutagenesis (SDM) of DENV4-F 
plasmid. .……………………………………………………………………………..92 
Table 3.1.1 Sequence analysis and variable gene usage of anti-NS5 Fab. …….…….96 
Table 3.1.2 Summary of resultant kinetic constants and binding affinities for 
interactions between NS5FL and 5M1 determined by surface plasmon 
resonance. …………………………………………………………………………...99 
Table 3.1.3 Summary of resultant kinetic constants and binding affinities for 
interactions between NS5FL and 5R3 determined by surface plasmon 
resonance. …………………………………………………………………………..101 
Table 3.2.2 Data collection statistics for NS5 and NS5-GTP. ……………….…….115 
Table 3.2.3 Refinement statistics for NS5 and NS5-GTP. ……….……………...…115 
Table 3.2.4 List of structures of flaviviral NS5 up to date. ………..…………….…119 
Table 3.2.5 Pairs of residues from MTase and RdRp that are involved in inter-domain 
interactions. ………………………………………………………………………...123 
Table 3.2.6. Enzymatic activities and thermo-stabilities of DENV4 WT and mutant 
NS5 proteins. ……………………………………………………………………….126 
Table 3.2.7 Enzymatic activities and thermo-stabilities of DENV3 WT and mutant 
NS5 proteins. ……………………………………………………………………….135 
Table 3.2.8 Summary of the MTase-RdRP interdomain interface analysis of NS5 from 
DENV3 and JEV. ……………………………………………………………..……152 
Table 3.3.1 Data collection and Refinement statistics for NS5-RNA-SAH. ……....155 
Table 3.3.2 non-flaviviral NS5 MTase hits in PDB. ………………….………..…..170 
Table 3.3.3 Residues involved in RNA binding and effect of alanine mutants on 





List of publications 
1. Zhao Y, Soh S, Lim SP, Chung KY, Swaminathan K,  Vasudevan SG, Shi PY, 
Lescar J, , Luo D. Molecular basis for specific viral RNA recognition and 2’-O 
ribose methylation by the dengue virus NS5 protein. Under review in PNAS. 
 
2. Zhao Y, Soh S, Chan KW, Fung S, Swaminathan K, Lim SP, Shi PY, Huber 
T, Lescar J, Luo D, Vasudevan SG. Flexibility of NS5 Methyltransferase-
Polymerase Linker Region is Essential for Dengue virus Replication. Journal 
of Virology, 2015 Aug, doi:10.1128/JVI.01239-15. 
 
3. Zhao Y, Soh S, Zheng J, Chan KW, Phoo WW, Lee CC, Tay MY, 
Swaminathan K, Cornvik TC, Lim SP, Shi PY; Lescar J, Vasudevan SG, Luo 
D. A crystal structure of the dengue virus NS5 protein reveals a novel inter-
domain interface essential for protein flexibility and virus replication. PLoS 
Pathog, 2015 Mar 16;11(3):e1004682. 
 
4. Tay MY, Saw WG, Zhao Y, Chan KW, Singh D, Chong Y, Forwood JK, Ooi 
EE, Grüber G, Lescar J, Luo D, Vasudevan SG. The C-terminal 50 amino acid 
residues of Dengue NS3 protein are important for NS3-NS5 interaction and 
viral replication. J Biol Chem. 2014 Dec 8. pii: jbc.M114.607341 
 
5. Zhao Y, Moreland NJ, Tay MY, Lee CC, Swaminathan K, Vasudevan SG. 
Identification and molecular characterization of human antibody fragments 
specific for dengue NS5 protein. Virus Res, 2014 Jan 22;179:225-30. 
xiii 
 
List of conferences attended 
1. Singapore International Conference on Dengue and Emerging Infections  
21-23 November, 2012； Grand Copthorne Waterfront, Singapore 
Poster presentation: Structure, Function and Interactions of DENV 
Multifunctional NS5 Protein. 
 
2. Duke/Duke-NUS Symposium 
20-24 April, 2013. Durham, Duke University 
Poster presentation: Novel phage-display antibodies provide new tools to 
study dengue NS5 protein and reveal functional interaction between 
methyltransferase and RNA-dependent RNA polymerase domains. 
 
3. Positive Strand RNA Viruses  
28 April – 3 May, 2013. Boston Park Plaza & Tower, Boston, Massachusetts, 
USA 
Poster presentation: Novel phage-display antibodies provide new tools to 
study dengue NS5 protein and reveal functional interaction between 
methyltransferase and RNA-dependent RNA polymerase domains. 
 
4. The 40th Lorne Conference on Protein Structure and Function 
8-12 February, 2015. Mantra Lorne, Lorne Victoria 
Poster presentation: Cross-talk between methyltrasferase and polymerase 








aa: amino acid 
ADE Antibody dependent enhancement  
ADP: adenosine diphosphate 
ATP: adenosine triphosphate 
ATPase: adenosine triphosphatase 
β-ME: β-mercaptoethanol 
BVDV: bovine viral diarrhea virus 
CCP4: The Collaborative Computational Project Number 4 
CM: convoluted membrane 
CryoEM: Cryo-electron microscopy 
CS: complementary sequence 
BCA Bicinchoninic acid  
BHK-21 Baby hamster kidney  
BSA Bovine serum albumin  
C Capsid  
cDNA Complementary DNA  
DENV Dengue virus  
DF Dengue fever  
DHF Dengue hemorrhagic fever  
DNA Deoxyribonucleic acid  
dsRNA Double-stranded RNA  
DSS Dengue shock syndrome 
DTT: dithiothreitol 
E Envelope  
xv 
 
E. coli Escherichia coli  
EDTA Ethylenediaminetetraacetic acid 
ELISA Enzyme-linked immunosorbent assay  
ER Endoplasmic reticulum 
Fab Fragment antigen-binding  
FBS Fetal bovine serum  
FL: full length 
FMDV: Foot Mouth Disease Virus 
FP Forward primer  
GFP Green fluorescent protein  
GPI glycosylphosphatidylinositol  
GTase Guanylyltransferase 
h: hour 
HBV: hepatitis B virus 
HCV: hepatitis C virus 
HDX-LCMS: Hydrogen Deuterium exchange with liquid chromatography mass 
spectrometry 
IFA Immunofluorescence assay  
IgG Immunoglobulin G  
IP Immunoprecipitation 
IPTG: Isopropyl-ß-D-thiogalactopyranoside 
IRES Internal ribosome entry site  
JEV Japanese encephalitis virus  
HIV Human immunodeficiency virus  
HRP Horseradish peroxidise 
Kd: binding affinity 
KUNV: Kunjin virus 
LB Luria Broth  
LC-MS/MS Liquid chromatography tandem mass spectrometry  
M Membrane  
xvi 
 




MW: molecular weight 
NEB New England Biolabs  
NGC: New Guinea C 
NITD: Novartis Institute for Tropical Diseases (Singapore) 
NLS: nuclear localization signal  
NS Nonstructural  
PAGE Polyacrylamide gel electrophoresis  
PBS Phosphate buffered saline pH 7.2  
PBST PBS with 0.1% Tween 20  
PBST-M PBST with 5% (w/v) skim milk powder  
PCR Polymerase chain reaction 
PDB: protein data bank 
pfu Plaque forming units 
PEG: polyethylene glycol 
PPi: pyrophosphate 
prM Pre-membrane 
RC: replication complex 
RdRP RNA-dependent RNA-polymerase 
RF: replication form 
RI: replicative intermediate 
r.m.s. deviation: root mean square deviation 
RNA Ribonucleic acid  
RP Reverse primer  
rpm Rounds per minute  
RT Reverse transcription  
xvii 
 
RT Room temperature  
RTPase RNA 5’-triphosphatase 
SAH: S-Adenosyl-L-homocysteine 
SAM S-adenosyl-L-methionine  
SAXS Small angle X-ray scattering  
SD Standard deviation  
SDM Site-directed mutagenesis  
SDS Sodium dodecyl sulphate 
SL: stem loop 
SLA: stem loop A 
SPR Surface plasma resonance 
ss: single stranded 
TBEV: tick-borne encephalitis virus 
TGN Trans-Golgi network 
Tm: melting temperature 
TM Transmembrane 
TMB 3,3′,5,5′-tetramethylbenzidine 
UTR Untranslated region 
VP: vesicle packets 
WHO World Health Organization  
w/v Weight/volume  
WNV West Nile virus  
WT Wildtype  
v/v Volume/volume  
YFV Yellow fever  






Dengue, an emerging infectious disease that threatens almost half of the world’s 
population, is caused by mosquito-transmission of any of the four serotypes of dengue 
virus (DENV). Currently, no effective vaccine or effective antiviral is available for 
prevention or treatment of dengue infection. NS5 protein is the largest and the most 
conserved dengue protein. It plays vital roles in the capping of viral genomic RNA 
(methyl transferase activity; MTase) and replication of the viral genome (RNA-
dependent RNA-polymerase activities; RdRp). Additionally NS5 interacts with 
several viral and host proteins to modulate viral RNA replication and the host’s innate 
immune response, thus making NS5 a good target for designing anti-viral compounds. 
We successfully isolated NS5 specific antibodies that are cross-reactive to four 
serotypes of DENV, and determined 3D structures for full length NS5 and its ternary 
complex with viral RNA. These epitope-mapped NS5 specific monoclonal antibodies 
could provide significant insight into the replication complex and help elucidate the 
mechanisms of dengue replication. The full length NS5 structure provides molecular 
basis for inter-domain crosstalk and its conformational flexibility for accommodating 
its various enzymatic activities, as well as its dynamic properties within the 
replication complex for viral replication. The ternary complex of NS5 with RNA and 
cofactor SAH reveals the specificity of RNA recognition and the molecular 
mechanism of methyl transfer reaction and suggests strategies for the design of 





Chapter 1: Introduction 
1.1 Dengue epidemiology 
Dengue virus (DENV) causes the most prevalent and important vector-borne 
viral disease in humans globally. It threats an estimated 3.6 billion people (more than 
half the world population) and has become a major public health problem in more 
than 100 countries in the tropical and subtropical regions, with the main dengue 
endemic countries of South and South-East Asia, the Caribbean, Central and South 
America, and Africa (Figure 1.1). The incidence of dengue cases has increased thirty-
fold in the last 50 years, and is expanding to new countries including a transition to 
rural area from urban area (Figure 1.2). About 50-100 million dengue cases annually 
were estimated by the World Health Organization (Gubler, 2012; WHO, 2009). 
However, this number was re-evaluated and dengue incidence is now estimated to be 
more than 390 million infections per year resulting in more than 96 million 
symptomatic infections (Bhatt et al., 2013; Gubler, 2012). 
All four circulating serotypes of dengue viruses, DENV 1-4, are transmitted to 
human through the bite of infected female mosquito Aedes aegypti, or Aedes 
abopictus to a lesser extent. Aedes aegypti being the main vector is a highly 
domesticated mosquito that is closely associated with humans in urban areas and it 
bites multiple human hosts for blood meal during a single gonotrophic cycle thus 
providing an avenue for efficient transmission of DENV (Gubler, 1998). The 
increased incidence of dengue is attributable to the increased geographical distribution 
of the mosquito vector, resulting from factors such as increased international travel 
and trade, and uncontrolled and unplanned urbanization (Gubler, 2004, 2012; Gubler 
and Meltzer, 1999; Rigau-Perez et al., 1998) . The transmission of dengue is mostly 
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seasonal and dengue incidence increases during warm and rainy seasons (Halstead, 
2008). Moreover, all four serotypes can be found to be co-circulating in more places 
at any given time nowadays, in contrast to 20-30 years ago when only one specific 
serotype was observed (Mackenzie et al., 2004). 
The explosive urban epidemics of dengue have become a global health 
concern associated with a large economic, social and political impact worldwide 
(Simmons et al., 2012). The global burden of dengue has been computed to be 
approximately 528,000 disability-adjusted life years (DALYs) by the Disease 
estimated Control Priorities project for the year 2001, which corresponds to 264 
DALYs per million individuals per year for people living in dengue risk areas 
(Cattand et al., 2006). The economic burden of dengue in endemic areas are 
substantial and in Singapore an average of US$41.5 million per year was estimated to 
be spent on dengue management during 2000-2009 in Singapore (Carrasco et al., 
2011). 
 
Figure 1.1 Countries and areas at risk of dengue transmission in 2014. 
Dengue affects predominantly in tropical and subtropical countries in Southeast 
Asia, the Pacific and America, as shown in orange. The potential geographical 
limits of northern and southern hemispheres for vector Aedes aegypti are indicated 
as the contour lines labelled January isotherms and July isotherms. Figure is 
adapted from (WHO, 2014). 
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Figure 1.2 Average number of total dengue cases reported to WHO during year 
1955-2010. X-axis is the year for dengue cases reported; y-axis is the number of cases 
in log scale10 (WHO, 2012). 
 
1.2 Dengue pathogenesis 
Infection with dengue causes a broad spectrum of clinical symptoms ranging 
from asymptomatic infection to self-limiting dengue fever (DF) and more severe and 
life-threatening forms of disease, dengue hemorrhagic fever (DHF)/dengue shock 
syndrome (DSS), which result in more than 20% fatality without proper treatment 
(WHO, 2009). Also dengue infection could result in other rare but severe 
complications including internal haemorrhage and organ impairment (encephalopathy) 
(Figure 1.3). 
Dengue fever is the most commonly reported disease manifestation for the 
symptomatic cases (10-50% of total dengue infections). It is characterized by a 
sudden onset of high-grade fever, after 2 to 7 days incubation period, accompanied 
with non-specific constitutional symptoms including headache, retro-orbital pain, 
arthralgia, myalgia rash, flashing of the face, anorexia, nausea and abdominal pain. 
Usually, the symptoms resolve without complications within a week after disease 
onset (Simmons et al., 2012). However, in some cases, warning signs for severe 
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dengue may develop when the fever starts to decline (WHO, 2009). The warning 
signs include severe abdominal pain or persistent vomiting, red spots or patches on 
the skin, bleeding from nose or gums, and/or vomiting blood, which require strict 
observation and immediate medical intervention (Figure 1.3) that can stress the 
public hospital system during epidemics.  
In rare cases, dengue fever may progress to a more severe form of the disease 
(DHF/DSS) around the time of defervescence, with signs of thrombocytopenia 
(platelet count ≤ 100,000/mm3), haemorrhagic phenomena (i.e. petechiae, bleeding 
gums, gastrointestinal bleeding and etc) and enhanced vascular permeability with 
intravascular fluid leakage (Figure 1.3) (Halstead, 2007; WHO, 2009). 
 
Figure 1.3 Criteria for classification of dengue and severe dengue. Dengue 
cases are classified as probable dengue and dengue with warning signs as listed. 
Dengue patients with warning sign need strict observation and medical 
intervention as they have high chance of development of severe dengue. Figure is 
adapted from (WHO, 2009). (ALT = alanine aminotransferase; AST = aspartate 
aminotransferase; CNS = central nervous system; DSS =dengue shock syndrome; 




It is believed that primary infection with any of the four DENV serotypes is 
able to confer lifelong protection to the homologous serotype (homotypic immunity). 
In contrast, severe dengue cases are often associated with secondary infection with a 
different DENV serotype, which is now well documented in several clinical studies 
(reviewed by (Halstead, 2007)) and the occurrence of severe dengue during secondary 
infections are 15-80 times more frequent than during primary infection (Murphy and 
Whitehead, 2011). Halstead proposed that severe dengue pathogenesis occurs during 
secondary infections by a phenomenon referred to as antibody-dependent 
enhancement (ADE) (Halstead, 2003). During ADE, the cross-reactive antibodies that 
are generated during primary infection can bind to the new infecting serotype and 
enhance the viral entry into Fcγ-receptor bearing cells that are permissive to DENV 
infection, like monocytes, macrophages, dendritic cells (Figure 1.4). The increase 
viral uptake leads to increase number of infected cells and an increased viral burden 
early in infection, which subsequently triggers an imbalanced immune response, 
increased secretion of inflammatory cytokines and mediators (i.e. TNF-α, IFN-γ, IL-6, 
IL-8 and IL-10) causing capillary leakage, observed in severe dengue cases (Cardier 
et al., 2005). Also FcγR-mediated entry of virus may suppress the antiviral immune 
response as well (Guzman et al., 2010). 
Another explanation for severe dengue diseases during secondary infection 
has been attributed to the phenomenon of “original antigenic sin”. Antibody and T-
cell response during secondary infection with a heterogeneous serotype are more 
directed against targets in the primary infecting serotypes (original antigen). The 
reactivation of cross-reactive antibodies and low avidity T cells cause less efficient 
clearance of infection, thus resulting in high level of proinflammatory cytokine 
secretion and higher level of viremia (Mongkolsapaya et al., 2003).  
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However, both hypothesises cannot explain the observed severe dengue during 
primary infection (Chau et al., 2008; Duyen et al., 2011; Fried et al., 2010; Tricou et 
al., 2011). Other factors, including virus virulence, host genetic factors, cell and organ 
tropisms, and etc, are believed to related to DENV pathogenesis as well (Watanabe et 
al., 2015; Whitehorn and Simmons, 2011). 
 
Figure 1.4 Model for antibody-dependent enhancement (ADE) during dengue 
virus infection. During secondary infection with a heterogeneous serotype of dengue, 
non-neutralizing antibodies generated from the primary infection form Ab-virus 
complex. The Ab-virus complex can attach to the Fcγ-receptor on circulating 
monocytes and enter cells more efficiently than virus alone, resulting in increased 
viral load and development of severe dengue for dengue patient. Figure is adapted 








1.3 Phylogeny of dengue virus 
1.3.1 Flaviviridae 
Dengue virus belongs to Flaviviridae family, which is further diverged into 
four genera, consisting of hepacivirus (e.g, hepatitis C virus, HCV), pestivirus (e.g, 
bovine viral diarrhea virus, BVDV), flavivirus (e.g, Dengue virus, DENV), and the 
newly approved pegivirus (hepatitis G virus, HGV) (Stapleton et al., 2011). Viruses of 
Flaviviridae family has a positive, single strand RNA genome of about 10,000-12,000 
bases in size, and at both 5’ end and 3’ end of the genomes are untranslated regions 
(UTRs). Viral particles are spherical, enveloped, and are about 40-65 nm in diameter. 
All four genera shares similar virion morphology, genome organisation (Figure 1.5) 
and replication strategy yet, they display diverse biological properties and are not 
serologically cross-reactive (Lindenbach et al., 2007). 
1.3.2 Flavivirus 
Flaviviruses derive their name from yellow fever virus (YFV): the word 
“flavus’, means “yellow” in Latin, which signifies yellow jaundice in victim caused 
by YFV infection in 1744 (Ashburn et al., 2004; Reed and Carroll, 2001). Different 
from other Flaviviridae viruses which contain an internal ribosome entry site (IRES) 
in the 5’UTR, Flaviviruses have a type I cap structure at 5’UTR of viral genome 
(Figure 1.5) that will be explained in greater detail later.  
There are at least 70 viral species within Flavivirus genus, and they are sub-
divided taxonomically based on viral vector association and antigenic relationships 
into three groups: tick-borne, mosquito-borne and viruses with no known arthropod 
vector (Figure 1.6) (Vasilakis and Weaver, 2008). Among them, dengue virus 
(DENV 1-4), Japanese encephalitis virus (JEV), Murray Valley encephalitis virus 
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(MVEV), Saint Louis encephalitis virus (SLEV), Tick-borne encephalitis virus 
(TBEV), West Nile virus (WNV) and Yellow fever virus (YFV) are widely 
distributed throughout the word and well-known as medically important human 
pathogens that cause fevers, encephalitis and hemorrhagic fevers in human (Farrar et 
al., 2007; Lindenbach et al., 2007; Mackenzie et al., 2004).  
Figure 1.5 Genomic organization of members of the Flaviviridae. Viruses within 
Flaviviridae family have a single-stranded positive-sense RNA genome. At 5’end, the 
genome has a cap in flaviviruses or contains an IRES (internal ribosome entry site) in 
pestiviruses, pegiviruses hepaciviruses in 5’-UTR. At 3’end, all have 3’-UTR. Blue 
boxes represent the structure proteins, and orange boxes represent nonstructural 
proteins encoded. (Hulo et al., 2011; Kapoor et al., 2013; Leyssen et al., 2000; Quan 
et al., 2013). 
 
1.3.3 Dengue virus 
The four genetically distinct but antigenically related serotypes of dengue 
virus (DENV 1-4) share about 62-67% amino acid identity. Phylogenetically, DENV4 
is most diverged from the rest and closer to DENV2 than DENV1 and DENV3, which 
are more closely related. Each serotype is further classified into genetically distinct 
groups or genotypes based on complete genome sequences: DENV1 and 2 have five 
genotypes each, while DENV3 and 4 contain four genotypes (Vasilakis et al., 2008b). 
Based on nucleotide sequence the genotypes within a serotype show divergence of <= 
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6% and protein sequence identity >90% (Rico-Hesse, 1990; Vasilakis and Weaver, 
2008). 
Among Flaviviruses, DENV is top ranked to cause the highest morbidity and 
mortality (Halstead, 2007). A possible fifth serotype has been identified in humans 
during recent years. This finding could further complicate dengue vaccine 
development to find a vaccine, which can protect against all serotypes (Normile, 
2013). 
Figure 1.6 Phylogenetic tree of Flavivirius genus. The phylogenetic tree is 
constructed using neighbour joining method and derived by analysis of partial NS5 
amino acid sequences from Genebank library. Four serotypes of dengue are boxed 
and highlighted in gray. The numbers indicate bootstrap values in each major clade. 




1.4 Structural biology of dengue virus 
1.4.1 Virus particle  
The mature flavivirus particles are approximately 50 nm in diameter and 
contain ribonucleic core of approximately 30 nm (Lindenbach et al., 2007). The single 
strand, positive sense RNA genome is packed together with about 180 copies of virus 
capsid protein (C) and surrounded by a host-derived lipid bilayer with 180 copies 
each of two glycoproteins (E, envelope protein; M, membrane protein) (Lindenbach et 
al., 2007). The mature dengue virus particles after cryo-electron microscopy (cryoEM) 
reconstruction have been shown to have a smooth surface and icosahedral symmetry 
(Figure 1.7) (Kuhn et al., 2002; Zhang et al., 2003a). The outmost layer is composed 
of E proteins, which are organized into ninety copies of head-to-tail dimers in an 
unusual “herring-bone” manner, and with three monomer per asymmetric unit. 
Organized E protein dimers lie flat on the surface of the viral membrane to create the 
smooth surface of mature virus; in contrast, immature virions that have a spiky 
icosahedral shape, which is characterized by 60 spikes. Each spike consists of three 
copies of prM-E heterodimers, in which, E protein protrudes away from the viral 
membrane and prM covers the fusion loop on the outer tips of E protein to protect 
fusion during maturation (Figure 1.7). The maturation process requires 





Figure 1.7 Arrangement of the E protein dimer on surface of mature virus. 90 E 
homodimers are arranged on an icosahedral lattice. Figure is adapted from (Zhang, et 
al., 2007).  
 
1.4.2 Replication cycle 
1.4.2.1 Virus entry 
Flavivirus infection cycle starts when virus particles attach onto the surface of 
susceptible cells mediated by the binding of viral E protein onto cell surface receptors, 
including Fcγ receptors of macrophages and monocytes, DC-specific ICAM-grabbing 
non-integrin (DC-SIGN) (Navarro-Sanchez et al., 2003), glucose-regulating protein 
78 (GRP78/Bip) (Jindadamrongwech et al., 2004) and lipopolysaccharide CD14 
associated molecules (Chen et al., 1999) (Figure 1.8). After attachment, virus enters 
cell through receptor-mediated endocytosis (RME). 
1.4.2.2 Fusion and uncoating 
After endocytosis, fusion between viral envelope and endosome membrane is 
triggered by the low pH in late endosome, and mediated by fusion peptide of E-
protein. E protein dimmers undergo conformational changes upon acidification, to 
form trimers (Modis et al., 2004). The fusion loops are exposed and inserted into 
endosomal membrane. Further structural rearrangement of E trimers brings two 
membranes into close proximity to fuse, which is known as class II membrane fusion 
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process (Mukhopadhyay et al., 2005; Stiasny et al., 2006). Then virus nucleocapsid is 
disassembled probably due to low pH and viral genome is expelled into cytoplasm. 
Figure 1.8 Schematic depiction of the DENV replication cycle. (1) Virus enters the 
cell by receptor mediated endocytosis (RME). (2) Membrane fusion between viral 
envelope and host endosome membrane induced by low pH leads to the release of the 
nucleocapsid into the cytoplasm. (3) Released viral RNA is translated by ribosomes to 
produce a single polyprotein, which is co-and post-translational cleaved by viral and 
host proteases into three structural proteins (C, prM and E) and seven nonstructural 
(NS; NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5) proteins. (4) Replication takes 
place in ER-membrane associated RCs. (5) immature progeny virions are assembled 
in ER and transported to Golgi apparatus. (6). At TGN, prM from the immature virion 
is cleaved by furin for maturation. (7) Mature virions are released by exocytosis and 







Figure 1.9 Conformational changes of dengue sE monomer during membrane 
fusion and class II membrane fusion. (A) Pre-fusion conformation of E protein in E 
homodimer. (B) Post-fusion conformation of E protein in E trimer. Domain I is 
coloured red, Domain II is coloured yellow, and Domain III is coloured blue. Figure 
adapted from (Modis et al., 2004). (C) Class II membrane fusion. (a) Dimeric E 
protein lie on the virus surface with the fusion peptide (shown in green) buried. (b) In 
the acidic endosome, domain II swings outward towards the host cell membrane 
under low pH. (c) This conformational change allows the E proteins to rearrange with 
the fusion peptide inserted into the host cell membrane. (d) Further conformational 
changes in domain III of the E protein brings the viral membrane towards the fusion 
peptide and host cell membrane. (e) Hemifusion of the lipid membranes occurs as 
domain III moves towards domain II. (f) Finally E protein trimer forms where the 
transmembrane regions and the fusion peptide are in close proximity. Figure adapted 
from (Mukhopadhyay et al., 2005). 
 
1.4.2.3 Translation and polyprotein processing 
Upon delivery of the viral genome into the cell cytoplasm, the viral genomic 
RNA, which is a positive sense single strand RNA with a type I cap (
N7m
GpppA2’Om-
RNA) at 5’end, serves as mRNA for translation into viral polyprotein (Lindenbach et 
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al., 2007). The translated single chain polyprotein is co-and post-translationally 
processed by both viral and host protease into ten viral proteins, including three 
structural proteins (Capsid, C; Membrane, M; and Envelop, E) and seven 
nonstructural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5) (Figure 
1.10). Polyprotein processing is believed to be associated with convoluted membranes 
(CM) and paracrystalline (PC) structures derived from ER (Mackenzie and Westaway, 
2001; Welsch et al., 2009; Westaway et al., 2003). Viral NS2B-NS3 protease cleaves 
protein junctions between NS2A/NS2B, NS2B/NS3, NS3/NS4A, NS4A/NS4B and 
NS4B/NS5, and internal cleavage of C as well, from the cytoplasmic side of ER. The 
host signalase cleaves junctions between C/prM, E/NS1, and NS4A/NS4B the ER 
lumen (Lindenbach et al., 2007). In addition, for efficient cleavage by host signalase 
at C/prM junction, the internal cleavage of C by NS2B-NS3 protease occurs first, so 
that the released signal sequence directs translocation of prM and E across ER 
membrane into the ER lumen (Stocks and Lobigs, 1998). In trans-Golgi network 
(TGN), the cellular protease furin cleaves of pr peptide from prM on the surface of 
immature virus during the maturation process (Li et al., 2008; Stadler et al., 1997; Yu 
et al., 2008a). 
1.4.2.4 Genome replication 
After polyprotein translation and processing, nonstructrual proteins (NS 1-5) 
are available and they start to assemble into viral replication complex where new 
vRNA is synthesized (Figure 1.8) (Lindenbach et al., 2007). The replication complex 
(RC) is associated with ER membrane, resides in ER-derived membrane structures, 
called vesicle packets (VPs) in the cytoplasmic side, consisting of all seven non-
structural proteins and host factor (Bartholomeusz and Wright, 1993; De Nova-
Ocampo et al., 2002; Mackenzie et al., 1998). The utilization of membrane-associated 
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RC is a common replication strategy that shared among many positive strand RNA 
viruses (Denison, 2008; Salonen et al., 2005; Uchil and Satchidanandam, 2003a, b; 
Westaway et al., 2003). Section 1.5 will introduce the RC with more details. 
The first step during flaviviral RNA replication is the synthesis of negative 
strand RNA from the positive strand RNA genome, and together they form double 
stranded RNA named as replication form (RF) (Chu and Westaway, 1985, 1987). 
Then RF is template for synthesizing of positive strand RNAs in an asymmetric and 
semi-conservative manner, which leads to the formation of the replicative 
intermediate (RI) and the production of 10 times more positive strand RNA than 
negative strand RNA (Chu and Westaway, 1985, 1987). Only complete genomic (+) 
RNA has been detected in flavivirus infected cells, supporting that genomic RNA is 
the only virus-specific mRNA. 
Figure 1.10 Predicted membrane topology of DENV polyprotein on ER 
membrane and its cleavage sites. Structural proteins are coloured blue and NS 
proteins are coloured orange. Protease cleavage sites are indicated as black arrow 
(NS2BNS3 protease), green arrow (host signalase), red arrow (host furin) and 
question mark (unknown protease).  
 
1.4.2.5 Progeny viruses assembly, maturation and release 
After successive rounds of viral protein expression and genome replication, 
the progeny virions are assembled in the lumen of the rough ER when viral genome 
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RNA is encapsulated by capsid proteins to form nucleocapsid (Figure 1.8) (Zhang et 
al., 2007b). The nucleocapsid buds into ER lumen, where it is then enveloped with a 
ER-derived lipid membrane containing E and prM glycoproteins to give rise the 
immature virus paricle. Maturation of virus takes place as the immature virions pass 
through the Golgi and trans-Golgi network (TGN). At acidic TGN, conformational 
changes at virion E/prM proteins expose the furin-cleavage site. The cellular 
endoprotease furin processes prM into M protein, and the precursor peptide (pr) is still 
associated until virion is released to the extracellular milieu of neutral pH to form the 
mature infectious virions (Figure 1.8) (Li et al., 2008). However, maturation process 
for DENV is not very efficient, as a heterogeneous mixture of mature, partial mature 
and fully immature virus particles is detected from supernatant of DENV-infected 
cells (Junjhon et al., 2010). 
1.4.3 Structure of flaviviral genome RNA 
The single stranded, positive-sense RNA of flaviviral genome is 
approximately 10,500 nucleotides in length and has a single long open reading frame 
(ORF) flanked by 5’- and 3’-untranslated regions (UTRs) (Figure 1.11). The RNA 
genome has a type 1 cap structure (
N7m
GpppA2’Om) at its 5’end, but lacks a poly (A)-tail 
at its 3’end. At both ends, several RNA structure elements are conserved among 
flaviviruses and their functional insights are summarized in Table 1.1. 
The 5’UTR contains about 95 to 101 nucleotides (96 nts for DENV2), and it 
folds into two stem loops, stem loop A (SLA) and stem loop B (SLB), which are 
linked by an oligoU spacer (Figure 1.11). SLA is the first ~70 nucleotides and is 
predicted to form a Y-shaped structure with a side loop and a top loop, which was 
confirmed by enzymatic and chemical probing (Alvarez et al., 2005; Filomatori et al., 
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2006; Lodeiro et al., 2009; Polacek et al., 2009; Yu et al., 2008b). SLA is the 
promoter element for RNA replication, functioning to specifically recruit NS5 
polymerase (Villordo and Gamarnik, 2009). The SLB has 5’UAR (upstream AUG 
Region) sequences for long range RNA-RNA interaction with 3’UAR to form the 
circularized RNA structure during the first step of RNA synthesis to initiate the 
negative strand RNA synthesis. The other sequences facilitate the circularization of 
the complementary sequences (CS) located within capsid protein-coding region, 
called 5’CS and it interacts with 3’CS for genome RNA circularization (Friebe et al., 
2012). The oligo(U) spacer between SLA and SLB is reported to be essential for the 
proper function of SLA and SLB (Lodeiro et al., 2009). These conserved structural 
elements within 5’UTR of DENV are also common to other members of Flavivirus 
genus (Brinton and Dispoto, 1988; Charlier et al., 2002; Gritsun et al., 1997; Mandl et 
al., 1993). Apart from that, a stable hairpin (cHP) within the coding sequence and just 
downstream of the translation initiation codon AUG is also required for viral RNA 
synthesis and translation initiation (Clyde et al., 2008; Clyde and Harris, 2006). 
The 3’UTR for DENV genome is about 450 nucleotide long (454 nts for 
DENV2), and it is divided into three domains. Immediately after the stop codon is 
domain I, which is the most variable region (VR) within 3’UTR. The size for VR 
varies extensively between serotypes, from less than 50nts to more than 120nts 
(Aquino et al., 2006; Roche et al., 2007; Shurtleff et al., 2001; Silva et al., 2008; 
Vasilakis et al., 2008a; Zhou et al., 2006). Following is Domain II, characterized with 
a tandem-duplicated dumbbell structure (DB1 and DB2), which contains the 
conserved sequences (CS2 and RCS2, repeated CS2) observed in all mosquito-borne 
flaviviruses (Gritsun and Gould, 2007; Hahn et al., 1987; Olsthoorn and Bol, 2001; 
Romero et al., 2006). Moreover, the DB sequences could form pseudoknot structures 
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functioning in viral translation and RNA synthesis (Manzano et al., 2011). The most 
conserved region of 3’UTR is domain III (Figure 1.11). 3UTR is also present in 
subgenomic flaviviral RNAs (sfRNAs) produced by host cell exonuclease Xrn1, 
which play a role in flaviviral cytopathicity and pathogenesis (Chapman et al., 2014; 
Moon et al., 2012). 
Besides, all vector-borne flaviviral RNAs have the well known conserved 
dinucleotide sequences (5’-AG/UC-3’) at the ends of the genome or anti-genomes, 
which is known to be essential for viral replication (Khromykh et al., 2003; Markoff, 
2003; Rice et al., 1985; Tilgner and Shi, 2004; Wengler and Wengler, 1981).  
Figure 1.11 Schematic representation of predicted secondary structure of 5’ 
terminal region (Left) and RNA elements within 3’UTR (right) of DENV genome. 
The 5′UTR is approximately 100nts with highly structured regulatory SLA (Stem 
loop A), SLB (Stem loop B), oligo(U) spacer, translation initiator (AUG in blue), 
capsid region hairpin (cHP), and the 5'CS element. The 3’UTR is about 500nts and 
contains three domains: domain I (variable region, VR), domain II (dumbbell 
structures, DB1 and DB2), and domain III (conserved sequence CS1 and 3'SL). The 
conserved elements are indicated as RCS2, CS2, 3’CS and 3’UAR. Circularization of 
DENV genome is achieved through long distance RNA-RNA interactions between 








Table 1.1 RNA structure elements at 5’- and 3’-UTRs and their functions in 
flavivirus life cycle. 
RNA 
element 
Feature and functions References 
5’-AG/CU-
3’ 
Conserved dinucleotide at termini of 
flaviviral genome, important for RNA 
replication. 
(Khromykh et al., 2003; Markoff, 
2003; Rice et al., 1985; Tilgner and 
Shi, 2004; Wengler and Wengler, 
1981) 
5’SLA Y-shaped structure that functions as 
promoter and essential for RdRp 
recognition and initiation of RNA 
synthesis. 




Regulator for proper functioning of 
SLA and SLB. 
(Lodeiro et al., 2009) 
5’SLB Short stem loop with 5’UAR, 
conformational change upon genome 
circularization. 
(Filomatori et al., 2006; Polacek et 
al., 2009; Villordo and Gamarnik, 
2009) 
cHP Stem loop within capsid coding region, 
functions to direct initiation site for 
translation. 
(Clyde et al., 2008; Clyde and Harris, 
2006) 
3’SL Interact with NS3 and NS5 for negative 
strand RNA synthesis; also interact 
with host proteins required for viral 
replication (EF1α). 
(Chen et al., 1997; Villordo and 
Gamarnik, 2009; Yu et al., 2008b) 
5’CS-3’CS 5’CS is within cHP, 3’CS is upstream 
3’SL. Long range RNA-RNA 
interactions for genome circularization. 
(Friebe et al., 2012). 
5’UAR-
3’UAR 
5’UAR is within SLA and upstream of 
AUG translation initiator, 3’UAR is 
within 3’SL. Long range RNA-RNA 
interactions for genome circularization. 
(Alvarez et al., 2008) 
VR Variable region (Aquino et al., 2006; Roche et al., 
2007; Shurtleff et al., 2001; Silva et 
al., 2008; Vasilakis et al., 2008a; 
Zhou et al., 2006). 
CS2-RCS2 conserved sequences (CS2 and RCS2, 
repeated CS2) observed in all 
mosquito-borne flaviviruses 
(Gritsun and Gould, 2007; Hahn et 
al., 1987; Olsthoorn and Bol, 2001; 




1.4.4 Structure and functions of dengue proteins 
In general, structural proteins mainly function in virus entry, assembly, 
maturation, and releasing steps during virus replication cycle, and the non-structural 
proteins are extensively involved in polyprotein processing, RC formation, RNA 
synthesis and assembly steps (Lindenbach et al., 2007). Their structure features and 
 20 
 
known functions are summarized in Figure 1.12 and Table 1.2 and the details are 
discussed below. 
Figure 1.12 Schematic representations of dengue genome organization, 
polyprotein processing and structures of dengue viral proteins. Dengue genome 
has one single open reading and the translated single polyprotein is cleaved by host 
and viral proteases into three structural proteins (C, prM and E) and seven NS (NS1, 
NS2A, NS2B, NS3, NS4A, NS4B and NS5) proteins. Structure solved for each 
protein was showed in cartoon representations. The PBD codes for the following 
proteins are listed: C (1R6R), prM (3C6E), E (1UZG), NS1 (4O6B), NS2A (2M0S), 















Table 1.2 Summary of flaviviral proteins. 
Protein Feathers and Functions Structure 
(PDB ID) 
Reference 
Capsid, C ~11 kDa, highly positively charged and 
localized in nucleus, as nucleocapsid and 
chaperone for viral genome RNA 
1R6R (Jones et al., 2003; 
Ma et al., 2004; Pong 





~9 kDa, important for virus entry, 
maturation and exit. 




~56 kDa, responsible for virus entry and 
membrane fusion, important determinant 
for DENV antigenicity and pathogenesis. 
1UZG (Lindenbach et al., 
2007; Modis et al., 
2004) 
NS1 ~50 kDa, exists in hydrophobic dimer 
(mNS1) located to luminal side in 
replication complex and secreted soluble 
hexamer (sNS1) involved in DENV 
immunogenicity and pathogenesis. 
4O6B (Akey et al., 2014). 
NS2A ~22 kDa, involved in virus assembly and 
release 
2M0S (Leung et al., 2008; 
Mackenzie et al., 
1998; Munoz-Jordan 
et al., 2003). 
NS2B ~14 kDa, cofactor for NS3 protease, also 
anchor NS3-NS5 complex onto membrane  
 (Clum et al., 1997; 
Erbel et al., 2006; 
Falgout et al., 1991; 
Luo et al., 2008a) 
NS3 ~70 kDa, multifunctional protein with 
protease, NTPase, RTPase, helicase 
activities for polyprotein processing, RNA 
synthesis and RNA capping 
2VBC (Lescar et al., 2008; 
Luo et al., 2010; Luo 
et al., 2008a; Luo et 
al., 2008b) 
NS4A ~16 kDa, oligomerization induce membrane 
curvature formation, localized at VP and 




(Lin et al., 1993; 
Lindenbach and Rice, 
1999; Mackenzie et 
al., 1998; Miller et al., 
2007; Roosendaal et 
al., 2006; Westaway 
et al., 2003) 




(Umareddy et al., 
2006; Welsch et 
al., 2009; Zou et 
al., 2015a) 
NS5 ~100 kDa, N-terminal MTase domain with 
MTase and GTase activities for RNA 
capping; C-termial RdRp domain with 





Egloff et al., 2002; 
Guyatt et al., 2001; 
Tan et al., 1996; Yap 




1.4.4.1 Structural proteins 
a) Capsid protein 
Capsid (C) is highly basic and contains 114 amino acids (about 11 kDa in size). 
It encapsulates viral RNA genome to form the nucleocapsid. A solution structural 
study of capsid by NMR revealed a dimer conformation where each monomer 
contains four alpha helices (Jones et al., 2003). The C dimer has a high net charge and 
the basic residues are asymmetrically distributed on protein surface, presumably 
positioned for proper interaction with viral RNA from one side of the protein dimer, 
which has about half of the basic residues. The opposite side of the dimer is rich with 
conserved hydrophobic residues, for interaction with viral membrane (Figure 1.12) 
(Ma et al., 2004). Besides the high RNA binding affinity, C is also reported to 
facilitate viral RNA folding (Pong et al., 2011). C protein is predominantly localized 
to the nucleoli of nucleus in infected cells, which is mediated by nuclear localization 





RK impair its localization and induce apoptosis (Netsawang et al., 
2010). To a lesser content, C is also found on the surface of cytoplasmic droplets and 
plays a role in virus assembly (Samsa et al., 2009). The precise mechanism of 
decapsidation of nucleocpasid after virus entry as well as the process of capsidation 
during virion morphogenesis is not known at present.  
b) Membrane protein 
The precursor of Membrane protein, prM is about 26 kDa in size. Furin 
endoprotease in the trans-Golgi network (TGN) cleaves prM into pr peptide and 
membrane-associated M protein during virus maturation process. The pr peptide is 
composed of the N-terminal 91 residues of prM and followed by M protein, which 
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consists of the remaining 75 residues and is the second smallest dengue proteins of 
about 9kDa. Both M and prM are important for virus entry, maturation and exit of 
cells during the infection cycle. In mature dengue virus, M forms the external smooth 
surface together with envelope protein, while in immature virus, three copies of prM-
E heterodimer forms the spiky surface. The pr peptide remains associated with E 
protein, preventing premature fusion in TGN after furin cleavage, and is not 
dissociated until virion is released to neutral pH at the extracellular milieu 
(Lindenbach et al., 2007). prM consists of seven antiparallel β-strands stabilized by 
three disulfide bonds, and the crystal structure of prM-E protein complex revealed 
that pr peptide covered the hydrophobic fusion loop of E (Figure 1.12) (Li et al., 
2008). Moreover, the maturation process is very inefficient for DENV, since 
uncleaved prM is detected in a high proportion of progeny virions (Anderson et al., 
1997; He et al., 1995; Henchal et al., 1985; Murray et al., 1993; Randolph and Stollar, 
1990; van der Schaar et al., 2007; Wang et al., 1999). Though immature prM-
containing DENV retains low levels of infectivity, addition of prM antibody could 
compensate and restore the infectivity to WT level (Huang et al., 2005; Huang et al., 
2006; Randolph and Stollar, 1990), which might enter cells through Fcγ receptor 
mediated mechanism in ADE (Dejnirattisai et al., 2010; Richter et al., 2014; 
Rodenhuis-Zybert et al., 2010).  
c) Envelope 
Envelope (E) protein consists 495 amino acids and is a membrane associated 
glycoprotein of about 56 kDa. It is the outmost layer of the DENV, and arrangement 
of E protein defines the appearance of virion particles. E protein is involved in initial 
virus attachment with appropriate receptors and entry into host cells through receptor-
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mediated endocytosis. Besides E protein is one of the major determinants for DENV 
antigenicity and pathogenesis. 
E protein contains 12 conserved cysteines which form six-disulfide bonds 
upon proper folding and its proper folding requires the cosynthesis of prM protein 
(Lindenbach et al., 2007). The N-terminal (residues 1-400) of E protein is called 
soluble ectodomain, sE. The E protein is predominantly composed of β strands and is 
subdivided into three domains: domain I is the structural domain, domain II mediates 
dimer formation, domain III is the receptor binding domain. The fusion loop is 
located at the tip of domain II. E protein belongs to class II fusion proteins with a 
hydrophobic pocket lined by residues that affect the pH for fusion. During membrane 
fusion, the low pH-induced conformational rearrangement causes E protein dimer to 
form a trimer (Figure 1.9). The C-terminal of E protein is the stem region. It folds 
into two α-helices connected by a stretch of conserved sequences (CSs) and a anchor 
region, which has two trans-membrane domains that are involved in virus assembly 
and entry during DENV replication cycle (Lin et al., 2011). 
E has two N-linked glycosylation sites: one at N67, which is unique to DENV 
and the other one at N153, which is common for other flaviviruses. The glycosylation 
has been shown to be important for viral production and infection (Alen et al., 2012; 
Bryant et al., 2007; Lee et al., 2010; Mondotte et al., 2007). The sequence and 
structural variations of E protein complicates the development of effective antiviral 





1.4.4.2 Nonstructural proteins 
a) NS1 
NS1 is a glycoprotein that consists of 352 residues, and depending on the 
glycosylation status, the MW of NS1 is about 46-55 kDa. During polyprotein 
synthesis and processing, NS1 is translated in the ER lumen (Figure 1.10), where 
soluble NS1 monomer forms membrane-associated hydrophobic dimer (mNS1) 
(Winkler et al., 1989; Winkler et al., 1988) and colocalizes with double-stranded RNA 
(dsRNA) and other components of replication complex for viral replication 
(Lindenbach and Rice, 1997, 1999; Mackenzie et al., 1996; Parrish et al., 1991; 
Welsch et al., 2009; Winkler et al., 1989), though its functional role remains elusive. 
Alternatively, NS1 can exist as cell-surface-associated form via a glcosyl-
phosphatidylinositol group (GPI) anchor or secreted lipid-rich, extracellular 
(nonvirion) hexamer (sNS1). Both forms of NS1 are highly immunogenic and they 
were reported to function in dengue pathogenesis (Avirutnan et al., 2006; Falgout et 
al., 1990; Henchal et al., 1988; Schlesinger et al., 1987; Sun et al., 2007), which 
makes NS1 an attractive target for anti-dengue therapeutics. 
NS1 contains twelve conserved cysteines that form six disulfide bonds and 2-3 
N-linked glycosylation sites at residues N130, N175 and N207 (Lee et al., 1989; 
Mason, 1989). All glycosylation are involved in stabilization of NS1 dimer and 
membrane association (Pryor and Wright, 1994; Winkler et al., 1988). From the 
crystal structure (Figure 1.12), NS1 dimer is arranged with a central β-sheet domain, 
and each monomer contains three domains: (1) β-roll dimerization domain (1-29), 
functions in NS1 dimerization and forming a hydrophobic protrusion for the ER 
membrane association; (2) wing domain (30-180), resembles helicase domain of RIG-
I and MDA5 for prevent immune system; and (3) the core β-ladder domain (181-352), 
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folds into 18 antiparallel β strands with a “spaghetti loop” stabilized by 57 hydrogen 
bonds. The soluble NS1 hexamer is formed by three copies of NS1 dimers with their 
hydrophobic β rolls hidden inside and the glycosylation sites, wing and spaghetti loop 
facing outward (Akey et al., 2014). 
b) NS2A 
NS2A is a hydrophobic integral membrane protein of 218 residues and about 
22-kDa, produced by N-terminal cleavage at NS1/NS2A junction within ER lumen by 
unknown protease and C-terminal cleavage at NS2A/NS2B junction at cytoplasmic 
side by NS2B/NS3 protease (Falgout and Markoff, 1995). NS2A was shown to 
colocalize with dsRNA for viral replication (Mackenzie et al., 1998) and inhibit 
interferon α/β response to antagonize the host immune response (Munoz-Jordan et al., 
2003). Moreover, NS2A also functions in virion assembly with the evidence that I59N 
mutation in Kunjin virus (KUNV) blocked virus assembly and secretion (Leung et al., 
2008). However, the mechanism of NS2A in viral replication and its modulation of 
host immune response are yet unclear. 
The topology of NS2A from DENV2 on the ER membrane was proposed to 
contain five transmembrane (TM) helices in the middle, which are formed by residues 
69-209; the N-(first 68aa) and C-terminal (210-218aa) of NS2A are located in the ER 
lumen or cytoplasmic side of ER, respectively. The nuclear magnetic resonance 
(NMR) structure of the first TM domain (69-93) showed a “helix-breaker” (P85) 






NS2B consists of 130 residues and is about 14 kDa. It associates with ER 
membrane and forms stable complex with NS3 protease domain, functioning as the 
essential cofactor for NS3 protease activity (Chambers et al., 1993; Falgout et al., 
1991; Yusof et al., 2000). NS2B is proposed to anchor cytoplasmic components of RC 
(NS3 and NS5) onto the ER membrane, with the evidence that NS2B was also shown 
to colocalize with dsRNA in RC, suggesting its role in RC formation and viral 
replication (Welsch et al., 2009). 
NS2B has a central conserved hydrophilic region at cytoplasmic side of ER, 
flanked by two TM helices at N-terminal and membrane associated C-terminal 
domain. The 47 amino acids of the central hydrophilic domain (49-95aa) are required 
for NS3 proper folding and activities (Clum et al., 1997; Erbel et al., 2006; Falgout et 
al., 1991; Luo et al., 2008a). Besides, interactions between NS2B and NS3 protease 
modulate structure of protease domain for specific substrate binding and cleavage 
signal recognition (Zuo et al., 2009). 
d) NS3 
NS3 is the second largest multifunctional proteins for flavivirus of about 69 
kDa (618 residues) (Lindenbach et al., 2007). It harbours enzymatic domains for 
protease, helicase, nucleoside 5’-triphosphatase (NTPase) and 5’terminal RNA 
triphosphatase (RTPase) activities that are important for viral polyprotein processing 
and genome replication, as well as virus particle assembly (Benarroch et al., 2004; 
Cui et al., 1998; Preugschat et al., 1990; Xu et al., 2005). 
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The N-terminal of NS3 (residues 1-168) is the protease domain, belonging to 
the trypsin-like serine protease family, that requires NS2B cofactor (Chambers et al., 
1993; Falgout et al., 1991; Wengler et al., 1991; Yusof et al., 2000) for all the 
cleavage of the translated viral polyprotein at cytoplasmic side of ER membrane 
(Figure 1.10) (Lindenbach et al., 2007). With the typical catalytic triad of residues 
H53-D77-S138 in the active site, NS2B/NS3 protease preferentially recognizes the 
cleavage signal containing two basic residues (R or K) at P1 and P2 positions, 
followed by a small amino acid (G/A/S) at the P1’ position (Li et al., 2005). The 
NS2B cofactor, residues 49-95, is required for proper folding and activity of NS3 
protease domain, thus it is engineered to the N-terminal NS3 through a flexible linker 
(G4SG4) for expression of soluble NS3 protease and structure determination (NS2B49-
95-G4SG4-NS31-168) (Leung et al., 2001; Li et al., 2005). The protease domain reveals a 
chymotrypsin-like fold with two β- barrels. Each barrel is formed by six β-strands and 
the catalytic triad H53-D77-S138 is located at the interface of two β-barrels. NS2B 
forms an additional β-strand with residues 67-95 to wrap around the C-terminal β-
barrel of NS3, to give the closed conformation of WNV NS3 protease in presence of 
inhibitor (Bzl-Nle-Lys-Arg-Arg-H). In the closed conformation, the β-turn hairpin 
formed by residues 83-86 of NS2B is involved in hydrophobic S2 and S3 pockets 
formation for inhibitor binding (Aleshin et al., 2007; Erbel et al., 2006; Noble et al., 
2012), while in the structure for the catalytic inactive DENV NS2BNS3 protease 
(NS2B49-66-G4SG4-NS31-168), no inhibitor binding is observed by NMR spectroscopy 
(Figure 1.13) (Erbel et al., 2006). Collectively, it implies that residues 45-66 of NS2B 
are required for folding and expression of NS3 as soluble protein, while residues 67-
95 is essential to stabilize NS3 protease by providing the additional β-strands and 
constituting the substrate-binding sites. 
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The C-terminal of NS3 (residues 179-618) is the helicase domain, belonging 
to superfamily 2 (SF2) with the presence of conserved DEAH sequence motif 
(Gorbalenya et al., 1989; Luo et al., 2008b; Tanner and Linder, 2001; Xu et al., 2006). 
The helicase domain is responsible for (1) unwinding of RNA duplex and/or 
secondary structures ahead of RNA replication by NS5 RdRp domain, (2) hydrolysis 
of NTPs (NTPase activity) to provide energy for RNA unwinding, and (3) removal 
the γ-phosphate group from the 5’end of newly synthesized RNAs (RTPase activity) 
to form the type I cap structure at 5’end of progeny genome through collaboration 
with NS5 MTase domain. Besides the helicase domain is proposed to be involved in 
virus assembly (Benarroch et al., 2004; Borowski et al., 2000; Chambers et al., 1993; 
Lescar et al., 2008; Li et al., 1999; Patkar and Kuhn, 2008; Wengler et al., 1991). NS3 
helicase domain has three subdomains based on its crystal structures, which revealed  
the Rec-A like fold located in subdomains 1 and 2, which fold into six β-strands 
surrounded by four or three α-helices, respectively; subdomain 3 folds into five α-
helices with two β-strands (Luo et al., 2008b; Xu et al., 2005). Subdomain 1 and 2 are 
the functional domains with all known sequence motifs identified for SF2 helicase, 
and ssRNA binding groove is located at the interface fomed between subdomain 3 
positioned above subdoamins 1 and 2. Biochemical and mutagenesis studies 
suggested all three enzymatic activities of NS3 helicase domain were functionally 
coupled (Figure 1.14) (Bartelma and Padmanabhan, 2002; Benarroch et al., 2004; 
Sampath et al., 2006). Besides, subdomain 2 and 3 are responsible for interaction with 
NS4B for increased helicase activity (Umareddy et al., 2006; Zou et al., 2015a) and 
residues 566-585 of subdomain 3 mediate the interaction with NS5 polymerase 
domain for balanced synthesis of positive and negative strand RNA during RNA 
replication (Tay et al., 2015). 
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The full length structure for NS3 protein adopts an elongated shape with 
NS2B-NS3 protease domain near the entrance of NTPase active site (Figure 1.15). 
Two different conformations of NS3 full length were observed with different relative 
orientation between protease and helicase domains. The rotation of protease domain 
by about 161° relative the helicase domain results from the flexibility of the 
interdomain linker region (residues 169-179), which has evolved to an optimum 
length required for polyprotein processing and RNA replication (Figure 1.15) (Luo et 
al., 2010; Luo et al., 2008a).  
 
Figure 1.13 Structures of NS2BNS3protease in apo conformation (a, DENV) and 
inhibitor-bound conformation (b, WNV). Structures are rendered in cartoon 
representations. NS2B cofactor is coloured yellow, and NS3protease is coloured gray. 
The active site is shown as sticks and inhibitor (Bzl-Nle-Lys-Arg-Arg-H on the right) is 





Figure 1.14 Structures of NS3 helicase domain from DENV2. (A) Overall 
conformation of DENV2 helicase domain rendered in cartoon representation. 
Subdomain I and II are displayed as red β-strands and cyan α-helixes, subdomain III 
is displayed as yellow β-strands and green α-helixes. (B) The proposed "inchworm 
model” of DEN-2 helicase translocation. Figure adapted from (Luo et al., 2008.) 
 
Figure 1.15 Side by side view of two conformations of scNS2B18NS3. Structures 
are displayed as cartoon, with α-helixes coloured cyan and β-strands coloured 
magenta. Cofactor NS2B18 is in red. Linker (residues 169-179) between protease and 
helicase is coloured green. The relative orientation between protease and helicase is 




NS4A (150 residues) is a small integral membrane protein of about 16 kDa. At 
the C-terminal of NS4A, 23 residues, called 2K fragment (136-150aa), are highly 
hydrophilic and serve as a signal for NS4B translocation into ER lumen, where the 2K 
fragment is removed from NS4B by host signalase, after cleavage at NS4A/2K 
junction by NS2BNS3 protease (Lin et al., 1993; Roosendaal et al., 2006). NS4A was 
predicted to have two transmembrane (TM) helices (51–73aa and 103–120aa) and 
another helix (76-99aa) that resides in the luminal side of ER. NS4A is able to form 
oligomers that cause ER membrane rearrangement to induce membrane curvature 
which is essential for RC formation and viral replication (Miller et al., 2007). The 
ability of NS4A to oligomerize is attributed to its N-terminal amphipathic α-helix (3-
20aa) (Stern et al., 2013). Besides, NS4A was shown to colocalize with dsRNA, NS3 
and NS4B in vesicle packets (VPs) (sites of viral RNA replication, RC) (Miller et al., 
2007; Welsch et al., 2009; Zou et al., 2015b), and NS4A is also located within 
convoluted membranes (CMs) and paracrystalline (PCs) (site for polyprotein 
processing), which further implies the important roles of NS4A in viral replication 
(Lin et al., 1993; Lindenbach and Rice, 1999; Mackenzie et al., 1998; Miller et al., 
2007; Roosendaal et al., 2006; Westaway et al., 2003). However, the mechanism for 
NS4A induced membrane rearrangement and its role in viral replication need further 
studies. 
f) NS4B 
NS4B (about 27 kDa) consists of 248 residues and is the largest integral 
membrane protein consisting of at least three TM helices (Miller et al., 2006). 
Targeting of NS4B into ER lumen is mediated by the transmembrane 2K signal that 
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connects NS4A and NS4B. Oligomerization of NS4B was observed when it was 
expressed in vitro and in vivo (Zou et al., 2014). Besides, in infected cells, NS4B 
colocalizes with dsRNA, NS3 and NS4A in RC (Umareddy et al., 2006; Welsch et al., 
2009; Zou et al., 2015a) and the cytoplasmic loop (129-165aa) of NS4B was reported 
to interact with NS3 helicase domain to promote the ssRNA dissociation from NS3. 
Moreover, the first 125aa of NS4B could act as IFN antagonist to inhibit STAT1 
activation and Alpha/Beta interferon (IFN α/β) signalling (Kelley et al., 2011; Munoz-
Jordan et al., 2005). Recently, NS4B was shown to be N-glycosylated at residues N58 
and N62, and abolishing of these glycosylations dramatically reduces RNA 
replication without affecting secretion or infectivity of virions (Naik and Wu, 2015). 
These studies reveal that the functional role of NS4B in viral replication and dengue 
pathogenesis is more complex than previously envisaged. 
g) NS5 
NS5 is the largest and mostly conserved flaviviral proteins consisting of about 
900 amino acids (about 104 kDa). Its N-terminal domain (residues 1-262) is the 
Methyltransferase (MTase) domain, belonging to the S-adenosyl-L-methionine 
(SAM)-dependent MTase superfamily (Egloff et al., 2002), and the C-terminal 
domain (residues 273-900) is the RNA-dependent RNA polymerase (RdRp), required 
for the synthesis of both positive and negative strand RNAs (Ackermann and 
Padmanabhan, 2001; Guyatt et al., 2001; Tan et al., 1996; Yap et al., 2007). The 





1.5 Replication complex (RC) 
1.5.1 Advantages of membrane platform 
The RNA synthesis for all flaviviruses takes place in the machinery that has 
been localized to the perinuclear ER membrane of infected cells (Figure 1.16) 
(Muller and Young, 2013; Ng et al., 1983; Shi, 2014). The utilization of host 
intracellular membranes as platform for viral replication is commonly adapted 
strategy by almost all of the single stranded, positive-sense RNA viruses including 
members of the togaviridae, flaviviridae, coronaviridae, arteriviridae, bromoviridae, 
and picornaviridae (Strauss and Strauss, 1994; Wimmer et al., 1993). Ultrastructure 
studies of DENV using cryo-immunoelectron microscope has revealed viral infection 
induced membrane rearrangement of host ER membranes, leading to the formation of 
distinct structures called convoluted membranes (CM), paracrystalline (PC), and 
vesicle packets (VP) (Mackenzie et al., 1996; Westaway et al., 1997). Besides, 3D 
tomography studies using electron microscope have revealed the formation of 
flavivirus RC as the result of ER membrane invagination, and the within each vesicles, 
RC interior is connected to the cytoplasm by a pore, thus called vesicle packet 
(Figure 1.16) (Gillespie et al., 2010; Welsch et al., 2009). 
The associated ER membrane could provide a physical scaffold for RC 
assembly; also the membrane compartmentalization could increase the local 
concentration of essential enzymes and cofactors required for the viral replication. On 
the other hand, host-derived membrane could shield or sequester viral products 
(dsRNA intermediates, or 5’triphosphated RNAs) from host innate immune system 
for successive viral infection (Stapleford and Miller, 2010). Recently the functions of 
cellular lipids from RC-associated membrane have been investigated (reviewed by 
(Heaton and Randall, 2011)). HCV and enteroviruses were shown to co-opt lipid 
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signalling to direct cellular membrane trafficking to coalesce with viral proteins for 
RC formation. Membrane curvature could be induced and modified by the 
combination effect of lipids, viral proteins and host factors (for example, brome 
mosaic virus, BMV (Schwartz et al., 2004)). Moreover, virus infection stimulates de 
novo lipid synthesis for specific lipid composition that is required for membrane 
expansion and membrane fluidity during RC formation (for example, WNV 
(Mackenzie et al., 2007), DENV-NS3 (Heaton et al., 2010) and HCV-NS4B and 
NS5A (Reiss et al., 2011; Yu et al., 2006). 
 
1.5.2 Interactions between non-structural proteins within RC 
All seven non-structural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B and 
NS5), dsRNA and host factors (Bartholomeusz and Wright, 1993; De Nova-Ocampo 
et al., 2002; Mackenzie et al., 1998) are localized to ER-membrane associated RC. 
Two multifunctional proteins NS3 and NS5, possessing all of the enzymatic functions 
essential for RNA replication, constitute the core of flavivirus RC, and the remaining 
nonstructure (NS) proteins facilitate the formation of RC and provide support 
replication. Cytoplasmic proteins NS3 and NS5 are tethered to the membrane through 
extensive interactions with the rest NS proteins (Table 1.3). 
Transmembrane proteins NS4A and/ or NS4B oligomerization induces 
membrane curvature (Miller et al., 2007; Zou et al., 2014) and NS1 dimer is located at 
the luminal side with its β-roll hydrophobic protrusion and the dipeptide R10-Q11 
near the protrusion loop for the proposed function in mediating the attachment of ER 
membrane and interactions with NS4A and NS4B (Akey et al., 2014). Genetic 
interactions between NS4A and NS1, as well as NS4A and NS4B were reported in 
DENV and YFV through reverse mutagenesis (Lindenbach and Rice, 1999; Tajima et 
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al., 2011). Residues 40-76 (the first TM helix) of NS4A and residues 81-146 (the first 
TM helix) of NS4B are responsible for the nM interaction affinity between NS4A and 
NS4B in DENV2 (Zou et al., 2015b).Studies using combined imaging techniques of 
fluorescence resonance energy transfer (FRET), confocal microscopy and biologic 
fluorescence complementation (BiFC) revealed interaction pairs for NS2A-NS2B, 
NS2A-NS4B, NS2B-NS4A, NS2B-NS4B and NS4A-NS4B for WNV non-structural 
proteins. Also in the same studies, all four integral membrane proteins (NS2A, NS2B, 
NS4A and NS4B) in WNV infected cells colocalize with calnexin, marker for ER 
membrane, this is consistent with the scaffold function for the RC formation (Yu et al., 
2013).  
Besides, extensive interactions also exist between cytoplasmic proteins (NS3 
and NS5) or with transmembrane NS proteins and within RC. Interactions between 
NS3 and NS5 were observed in yeast two-hybridization (Y2H) and co-
immunoprecipitation (co-IP) studies (Brooks et al., 2002; Kapoor et al., 1995; 
Mairiang et al., 2013; Moreland et al., 2012), and regions involved in NS3-NS5 
interactions have been fine-mapped to residues 565-585 from NS3 helicase domain 
and residues 321-340 (a/bNLS) from NS5 RdRp domain recently (Tay et al., 2015). 
NS2B is the essential cofactor for NS3 protease, with residues 49-66 for NS3 folding 
and residues 67-96 for substrate binding and NS3 protease activities (Clum et al., 
1997; Erbel et al., 2006; Falgout et al., 1991; Luo et al., 2008a). NS2B is proposed to 
play central role in coordinating interactions among four transmembrane proteins, as 
well as anchoring of NS3-NS5 complex to RC in the cytoplasmic side. Regulation of 
ATPase activity and helicase activity of NS3 helicase domain was observed by NS4A 
in WNV and NS4B in DENV, respectively (Shiryaev et al., 2009; Umareddy et al., 
2006). Co-IP and in situ proximity ligation assay confirmed the colocalization of 
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NS4B and NS3, and demonstrated residues129-165 (cytoplasmic loop) from NS4B 
and subdomain 2 and 3 from NS3 helicase domain are the determinants for 
NS4B/NS3 interactions (Zou et al., 2015a). 
Figure 1.16 Schematic model of ER-membrane associated replication complex 
for flaviviruses. NS1 dimer is located at the luminal side of ER, four transmembrane 
proteins NS2A, NS2B, NS4A and NS4B anchors the cytoplasmic components NS3 
and NS5, together with RNAs to ER membrane. Also unknown host factors are also 
involved for RNA replication. The template RNA is represented as black line, and 
newly synthesized RNA is red line, and green line indicates the displaced RNA strand. 
Table 1.3 Mapped interactions within replication complex for flaviviruses. 
Protein: Residues Protein: Residues References 
NS1 NS4B (Lindenbach and Rice, 1999; 
Tajima et al., 2011) 
NS1 NS4A (Lindenbach and Rice, 1999; 
Tajima et al., 2011) 
NS4A: 40-76 NS4B: 81-146 (Zou et al., 2015b) 
NS3: 565-585 NS5 321-340 (Tay et al., 2015) 
NS3: protease  NS2B: 49-96 (Clum et al., 1997; Erbel et al., 
2006; Falgout et al., 1991; Luo 
et al., 2008a). 





1.6 Nonstructural protein 5 (NS5) 
Being the largest (about 104 kDa) and most conserved (more than 60% amino 
acid sequence identity) flaviviral protein, NS5 harbors essential enzymatic activities 
for viral RNA replication and capping.  
The N-terminal (aa 1-262) of NS5 encodes an S-adenosyl-L-methionine 
(SAM)-dependent methyltransferase (MTase), which is responsible for decoration of 
the flavivirus RNA at its 5’end with a conserved type I cap. Formation of the type I 
capped structure requires coordination of NS3 and NS5 enzymatic activities into four 
sequential reactions: (1) NS3 removes 5’γ-phosphate group from the newly 
synthesized progeny RNA by its RTPase activity (5’ppA-RNA) (Benarroch et al., 2004; 
Xu et al., 2005), (2) guanylyltransferase (GTase), which is postulated to reside within 
the MTase domain of NS5, transfers a GMP moiety to the 5’-diphosphate RNA to 
form a unique structure where an inverted Guanosine is linked to the first transcribed 
nucleotide (A) by a 5’-5’ triphosphate bridge (G5’-ppp-5’A-RNA) (Issur et al., 2009), (3) 
NS5 methylates  the capped guanosine by transferring methyl group from the cofactor 
S-adenosyl-L-methionine (AdoMet) onto N7 atom of the cap G (N7MTase activity) to 
form a type 0 capped RNA  (
N7m
G5’-ppp-5’A-RNA) (Zhou et al., 2007), and (4) lastly, 
NS5 also methylates the first Adenosine by  transferring methyl group from SAM 
cofactor onto the 2’O position of the ribose (2’OMTase activity) to form the flaviviral 
type I capped RNA (
N7m
G5’-ppp-5’A2’Om-RNA) (Egloff et al., 2002) (Figure 1.17). The 
type I cap is required for efficient polyprotein translation by host ribosome and 
protection against RNA degradation by exoribonucleases (Dong et al., 2008b; Egloff 
et al., 2002; Ferron et al., 2012; Ray et al., 2006; Zhou et al., 2007) (Zhou et al., 2007).  
 39 
 
Figure 1.17 Type I capped structure at 5’end of flaviviral genome and the 
enzymatic activities required for its formation. (A) The structure of 
N7m
GpppA2’O-
RNA: N7-methylated Guanosine is linked to first Adenine, which has a methyl group 
at 2’O position of its ribose through a 5’-5’ triphosphate linkage. (B) Four enzymatic 
reactions are required to form type I capped structure: (1) NS3 RTPase activity, (2) 
GTase activity, (3) NS5 N7-MTase activity, and (4) NS5 2’O-MTase activity. Figure 
is adapted from (Dong et al., 2014). 
 
The C-terminal domain of NS5 (273-900), was suggested to be viral RNA-
dependent RNA polymerase (RdRp) based on comparative analysis of flavivirus NS5 
sequences (Koonin, 1991{Poch, 1989 #2762)}. It firstly performs the de novo 
polymerase activity to catalyze the negative strand RNA synthesis using circularized 
genome as template; then using the dsRNA as template, it forms a replication fork to 
synthesise progeny viral genome RNA (positive strand) for protein translation and 
progeny virus packaging (Malet et al., 2007; Yap et al., 2007).  
The two enzymatic domains are connected by a linker fragment of about 10 
amino acids which is least conserved (Figure 1.18). 
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Figure 1.18 Schematic representation of flaviviral NS5 protein. N-terminal (1-262) 
is the MTase domain, colored yellow; C-terminal (273-900) is the RdRp domain, 
colored green; and two domains are connected by a 10-aa linker (263-272).  
 
1.6.1 N-terminal MTase domain and its activities 
The N-terminal (aa 1-262) of NS5 encodes an S-adenosyl-L-methionine 
(SAM)-dependent methyltransferase (MTase). Several crystal structures have been 
determined for flavivirus NS5 MTase domain, including DENV, WNV, and YFV etc 
(Zhou et al., 2007). They adopt similar conformation with a globular-fold, which is 
divided into three subdomains as shown in Figure 1.19. 
Subdomain 1 (red, 7-54) comprises a helix-turn-helix motif followed by a β-
strand and an α-helix. A conserved GTP-binding pocket is present within subdomain 
1. Using GTP-binding studies in combination with structural characterization of 






GpppGm) (Assenberg et al., 2007; Bollati et al., 2009; Egloff et al., 2007; Geiss et 
al., 2009; Yap et al., 2010) have clearly confirmed presence of the GTP-binding 
pocket and identified important contacts for defining rG-binding specificity of MTase 
domain. The important interactions include base stacking between F25 aromatic ring 
and guanine ring of GTP, as well as electrostatic interactions between L17, N18, L20 
and 2-amino group of the guanine base which together are highly selective for 
Guanine; while the conserved K14 and N18 residues are responsible for the 
ribonucleotides (2’-OH) specificity by forming hydrogen bonds. Ribavirin 5’-
triphosphate was reported to inhibit dengue NS5 2’OMTase activity by mimicking 
interactions between GTP and MTase domain (Benarroch et al., 2004). Mutations in 
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GTP binding pocket exert a larger impact on 2’OMTase activity than N7MTase 
activity, suggesting that the rG moiety of the RNA substrate for 2’O methylation is 
required to be positioned in the GTP binding pocket (Dong et al., 2008b). 
Subdomain 2 (yellow, 55-222) is the core domain for cofactor binding and 
catalytic activity. It folds into a seven-stranded β-sheet surrounded by four helices. 
The conserved central cleft for MTase is present between β-strands 1 and 4, which is 
the active site for SAM and substrate binding and the site for methyltransfer reaction 
to occur. During recombinant MTase protein purification from E.coli, the cofactor 
SAM or by-product SAH is usually co-purified because of the tight binding and slow 
dissociation (Kd of 826 nM) from the SAM-binding pocket (Brecher et al., 2015; Lim 
et al., 2011). Side chains of residues (T104, K105, V132, and I147) form a 
hydrophobic cavity to accommodate the adenine moiety of SAM, while residues 
(D131, K105, V132) stabilize the binding by forming hydrogen bonds with adenine. 
The conserved catalytic tetrad K61-D146-K180-E216 residues and spatial position in 
the active site lie nearest to the active 2’-OH group of the substrate, and was 
proposed as a characteristic of specific RNA 2’OMTase. In between GTP-binding 
pocket and SAM-binding pocket, a positively charged groove on MTase surface was 
suggested to be the RNA-bind site. However, recent structural models of DENV3 
MTase in complex with 5’-capped octameric RNA (GpppAGAACCUG) showed 
interactions only involve first two nucleotides (GpppA), which binds to the GTP-
binding pocket (Yap et al., 2010).  
Subdomain 3 (cyan, 223-262) consists of an α-helix and two β-strands, which 
is proposed to play a role in capped RNA recognition and correct positioning of the 
guanine N7 methylation site first and of the ribose 2’-O site subsequently. However, 
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the putative transition mechanisms between the two RNA binding modes remain 
elusive. 
Figure 1.19 Crystal structure of flaviviral NS5 MTase domain. (A) DENV3 
MTase (PDB: 3P97) is redered in cartoon representation. Domains are coloured as 
red (domain I), yellow (domain II), and cyan (domain III). Cofactor SAM is shown as 
sticks in blue. (B) Surface representation of MTase (positive surface charge is 
highlighted in blue, negative charge in red). GTP and SAH are shown as yellow stick. 
RNA binding site is indicated by the positively charged residues. 
 
N7MTase vs 2’OMTase activities: Though MTase domain catalyzes both N7 
methylation and 2’O methylation using SAM as methyl donor; the RNA substrate 
specificities are different for two reactions. N7 methylation activity of DENV and 
WNV requires the presence of viral specific 5’sequence and the unique secondary 
structure of Stem Loop A (SLA) (Dong et al., 2010a; Dong et al., 2008b; Dong et al., 
2008c; Ray et al., 2006), thus the in vitro biochemical assays for N7 methylation 
consists of RNA substrate of about 110nt from the 5’end of viral genome. In contrast, 
the 2’O methylation only requires a short type 0 capped RNA substrate, at least the 
first 6nt for DENV RNA (Egloff et al., 2002; Selisko et al., 2010) and first 20nt for 
WNV (Dong et al., 2008c). Besides, 2’O methylation of MTase from both DENV and 
WNV exhibited much higher activity with N7methylated RNA substrate (
N7m
G5’-ppp-
5’A-RNA) over unmethylated RNA (G5’-ppp-5’A-RNA), while the N7 methylation 
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displayed similar activity with two RNA substrate, G5’-ppp-5’A-RNA and G5’-ppp-
5’A2’Om-RNA. Thus the substrate requirements suggest that the sequential reaction of 
N7 methylation precedes 2’O methylation in line with the observed catalytic 
efficiencies of MTase of NS5 (Dong et al., 2008b). Recently, flaviviral NS5 MTase 
was shown to methylate internal adenosine at 2’O position of the ribose during viral 
replication to regulate viral RNA replication, protein translation and innate immune 
response (Dong et al., 2012). Mutagenesis studies revealed distinct amino acids were 
required for N7MTase and 2’OMTase activities: K61, D146, and E216 of the K-D-K-
E motif are essential for the 2′O methylation, whereas only D146 is essential for the 
N-7 activity (Dong et al., 2008b). Mutant DENV or WNV viruses with defective 
N7MTase activity are lethal (Dong et al., 2010a; Lim et al., 2011). On the other hand 
2’OMTase mutant viruses remain replicative in cell lines without interferon 
production, suggesting that the activity is non-essential for virus replication, but 
potentially essential for cap formation to avoid host immune response (Dong et al., 
2010a; Dong et al., 2008b). Recently, a mutant virus (NS5-E216A in DENV) with 
defective 2’OMTase activity was shown to be very sensitive to type I interferon 
response and it induced protection in mice and rhesus monkeys when challenged with 
virus of the same serotypes, supporting the rationale for developing DENV vaccine by 
targeting NS5 MTase activity (Zust et al., 2013). 
To date, there is no functionally meaningful structure of MTase domain in 
complex with RNA substrate available for flavivirus NS5 though multiple structures 
have been determined for MTase domain with cap analogues. Thus a crystal structure 
of RNA bound MTase domain with catalytically-relevant conformation is required to 
understand the molecular basis for RNA capping. 
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GTase activity: MTase domain was proposed to have guanylyltransferase 
(GTase) activity for adding GMP to 5’-diphosphate viral RNA as well, with the 
evidence that a covalent GMP-MTase complex was formed for Wesselsbron virus 
MTase. GMP is covalently bound to a lysine residue in the GTP binding pocket. 
Alanine substitution of the equivalent lysine residue in DENV MTase only reduces 
but does not abolish the formation of covalent GMP-MTase complex (Bollati et al., 
2009; Issur et al., 2009). However the exploration of GTase activity of NS5 MTase 
domain needs further validation. 
 
1.6.2 C-terminal RdRp domain and its activities 
The C-terminal (aa 273-900) of NS5 possesses RNA-dependent RNA 
polymerase (RdRp) activity. The overall folds of RdRp domains for flaviviruses are 
similar (Lim et al., 2013a; Malet et al., 2007; Yap et al., 2007). They have a roughly 
spherical shape and assume an architecture of “cupped right hand” consisting of 
fingers, palm and thumb, which resembles the characteristic of viral RdRp structure 
with six conserved motifs (A-F) essential for RNA replication (Figure 1.20 and 
Figure 1.21). Two tunnels perpendicular to each other are responsible for the entry of 
ssRNA template from the roof of RdRp and the exit of dsRNA from the front side of 
RdRp. RdRp domain from DENV3 assumes a relatively more “open” conformation 
compared with the RdRp from WNV with its fingers subdomain rotating away from 
the thumb by an angle of approximately 8º. Two zinc binding sites are observed in the 
thumb and fingers subdomains respectively, and they are proposed to contribute to 




Fingers subdomain comprises residues from 273 to 315, 416 to 496, and 543 
to 600, which serve to shape RNA template tunnel for RNA entry into active site cleft. 
It contains a core domain and extended loops (fingertips) that interconnect with the 
thumb subdomain to enclose the active site. Individual fingers were further defined 
into index (residues 302-364), pinky (residues 394-490), ring (residues 450-477) and 
middle (residues 575-585) (residue numbering as in DENV3 NS5) for better 
description of RdRp structure. Motif G (405-418) and motif F (460-480) are disorded 
in the apo-RdRp structures from DENV and JEV RdRp (Malet et al., 2007; Surana et 
al., 2014; Yap et al., 2007), which are believed to be flexible for interaction with NTP 
and RNA template during replication and conformational changes for transition 
between different forms of RdRp. Motif G is conserved in primer-dependent RdRps 
with yet unidentified role in de novo initiation and motif F loop contains positively 
charged residues that mediates interactions with incoming NTPs, and recent study 
showed two residues K456 and K457 before the F motif (F1 motif) of DENV was 
involved in promoter (SLA)-dependent viral RNA synthesis, leading the proposal that 
conformational change in NS5 to an active catalytic enzyme induced by the 
interaction of the promoter SLA with F1 motif (Iglesias et al., 2011). In the crystal 
structure of GTP-RdRp complex for JEV, F motif is ordered upon GTP binding and 
occupies the NTP entry tunnel, which represents the pre-initiation state of RdRp 
(Surana et al., 2014). Also Fingers subdomain contains functional nuclear localization 
sequences (bNLS and abNLS) that are responsible for DENV2 NS5 localization to the 
nucleus (Brooks et al., 2002; Forwood et al., 1999). 
Palm subdomain consists residues 497 to 542 and 601 to 705, with two 
antiparallel β-strands residing in the centre and surrounded by eight α-helices (Malet 
et al., 2007; Yap et al., 2007). It is the most conserved feature of RdRp structures with 
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four conserved motifs for metal ion binding, nucleotide binding, RNA binding as well 
as catalysis of phosphoryl transfer. Motif A and C contain strictly conserved aspartic 
acid residues (D533, D663 and D664) required for coordination of two Mg2+ and 
catalysis of phosphoryl transfer. Though Mg
2+
 coordination to D533 and D664 was 
not identified for catalytic conformation, it was proposed to function in initiation of 
RNA synthesis (Malet et al., 2007). 
Thumb subdomain constitutes the C-terminal 187 amino acids (709-900) of 
NS5, showing most diverse feature among viral RdRp structures. The loop (740-750) 
projecting towards fingers domain and in association with the fingertips contributes to 
shape RNA template tunnel. And the priming loop (792-804) with a potential GTP-
binding site forms a platform to stabilize the RNA initiation complex, and regulate the 
entry and exit of template from the active site by associating with motif G from 
fingers subdomain. Unlike the β-hairpin form of HCV priming loop, no secondary 
structural elements is present in flavivirus priming loop. It is stabilized by internal 
electrostatic interactions that are conserved in the flavivirus. The priming loop is an 
important feature to distinguish de novo-RdRps and primer-dependent RdRps. In 
addition, two cavities (A and B) in thumb subdomain are conserved among flavivirus 
RdRp. Mutagenesis analysis showed Cavity B (with conserved residue Leu-328, Trp-
859, and Ile-863) is essential for DENV replication, suggesting the potential for 






Figure 1.20 Structure based sequence alignment of Flavivirus RdRp domain based on DENV3 RdRp structure (PDB: 2J7U). Six 




Figure 1.21 Structure of DENV3 RdRp (PDB: 2J7U). Overall structure of RdRp 
domain from DENV3 in cartoon representation: three subdomains are Figures, Palm 
(Gray) and Thumb (cyan). Fingers are further divided into Index (orange), middle 
(red), ring (pink), and pinky (tint). Important structure elements are labelled: Motif C-
active site (GDD) is coloured blue and priming loop for de novo initiation is coloured 




(yellow). The RNA 
template entry tunnel is indicated as the arrow. 
 
Polymerase activities: Flavivirus NS5 can initiate new RNA synthesis from 
the 3’end of viral genome without the requirement of any primer, and is known as de 
novo initiation. During the initial RNA synthesis, negative strand RNA is made using 
the circularized viral genome as template. After circularization, the promoter SLA 
recruits NS5 and brings the RdRp domain in close proximity to the 3’end of the viral 
genome with the consensus 5’-CU-3’ sequence (Figure 1.22A). The 3’end of single 
stranded RNA is loaded onto RdRp domain from the RNA entry tunnel (at interface 
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between finger and thumb domains and shaped by L1, L2, L3, priming loop, and 
linker between α1 and α2 helix) (Yap et al., 2007). Next the first initiating nucleotide-
ATP, which was shown to be the absolute requirement for de novo initiation and is 
stabilized by priming loop (Selisko et al., 2012), enters the active site from the NTP 
entry site at the back aperture of exit tunnel, and basepairs with the first nucleotide (U) 
from the 3’end of the template strand. Then the second nucleotide-GTP comes to the 
active site and basepairs with C to form a stable initiation complex. After that the 
motif C (GDD) at the active site coordinates two Mg
2+
 ions to catalyze the 
phosphodiester bond formation between ATP and GTP (Steitz et al., 1994). Formation 
of 2-3 nt is required for completion of the rate-limiting initiation steps. After that, 
RdRp domain could adopt a more open conformation for successive elongation phase. 
It is believed that priming loop will move away from the active site to accommodate 
growing dsRNA (Appleby et al., 2015). It has been shown that de novo initiation of 
RNA synthesis requires minimum components including template RNA, ATP, NS5 
and high concentration of GTP (>500 uM) for preinitiation complexes (Nomaguchi et 
al., 2004), however presence of mutagenic ion Mn
2+
 could stimulates the de novo 
initiation even in the absence of viral specific template (Selisko et al., 2012). For 
synthesizing the positive strand RNA from the dsRNA template, RdRp domain as part 
of NS5 together with NS3 is recruited to the 3’end of the negative strand and the 
helicase activity of NS3 probably separates the ds template to displace the plus strand 
RNA.  A new plus strand is initiated and once a stable initiation complex is formed, 
NS5 may adopt an elongation competent conformation. Many of the details of these 
steps need biophysical verification and also the identification of host proteins 
involved is critical to getting a full structural and mechanistic understanding of 
flaviviral replication (Figure 1.22B). 
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3D structure of the active polymerase in complex with SLA, 3’-SL, and both 
are necessary for understanding the molecular details of the replication mechanism 
and the essential conformational changes for efficient viral RNA synthesis. 
Unravelling the mechanistic details of how NS5 can utilize both positive strand and 
negative strand template, would provide important insights for antiviral strategy. 
Figure 1.22 Proposed schematic models for polymerase activities of RdRp 
domain. (A) De novo initiation for negative strand RNA synthesis: viral genome 
circularization brings the 3’end into close proximity with the promoter-polymerase 
complex, in which the RdRp is recruited by promoter SLA for initiation at 3’end 
genome with consensus sequence (CU-3’). Genome circularization is induced through 
long range RNA-RNA interactions between sequences 5’-3’UAR (green) and 5’-3-CS 
(red). (B) Elongation model for making new positive strand RNA (red) from the 
dsRNA template by displacing existing positive strand (black). Negative strand RNA 
is indicated as green line. 
 
1.6.3 Other Structures of RdRp-RNA complex for RNA replication 
RNA-dependent RNA polymerase is essential viral-encoded proteins for all 
RNA viruses, responsible for viral genome replication in primer-independent (de novo) 
or primer-dependent manner. Several RdRp structures in apo-, inhibitor-bound, 
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nucleotide-bound, or RNA-bound form have been determined for viruses in family of 
(1) Flaviviridae: DENV(Lim et al., 2013a; Yap et al., 2007), WNV(Malet et al., 2007), 
JEV (Surana et al., 2014) , BVDV (Choi et al., 2006) and HCV (Appleby et al., 2015; 
Bressanelli et al., 2002; Wang et al., 2003); (2) Picornavirida: Poliovirus (Gong and 
Peersen, 2010; Thompson and Peersen, 2004), FMDV (foot-month diseases virus) 
(Ferrer-Orta et al., 2006); EV71 (Enterovirus 71) (Wu et al., 2010) and coxsackievirus 
(Campagnola et al., 2008) (3) Caliciviridae: sapporovirus (Fullerton et al., 2007), 
norovirus (Ng et al., 2004); (4) Orthomyxoviridae: avian influenza H5N1 virus (He et 
al., 2008) and (5) Birnaviridae: IBDV (infectious bursal disease virus) (Bahar et al., 
2013), IPNV (infectious-pancreatic necrosis virus) (Graham et al., 2011). Also 
structures for bacteriophage ϕ6 polymerase (Wright et al., 2012) and Qb replicase 
(Kidmose et al., 2010) are also available. All structures resemble the featured right-
handed architecture with three subdomains (Fingers, Palm and Thumb) and the 
conserved Palm subdomain comprising well-conserved motifs (A, B and C) for 
catalysis. The major structural difference between de novo-RdRp (ie, Flavivirus, HCV 
and ϕ6 polymerase) and primer-dependent-RdRp (ie, Caliciviruses and Picornaviruses) 
resides in the accessibility of the active site for RNA replication. Polymerases of 
polivirus and FMDV have a more open active site for accommodating RNA template-
primer complex for initiation. In comparison with flaviviral RdRps, the active site is 
occluded by the protruding extensions of the thumb domains (priming loop in DENV 
and WNV; β-loop in HCV; residues Y630 in ϕ6 polymerase), resulting in a compact 
conformation allowing RNA template and NTP entry through positively charged 
tunnel. Moreover, the extension loops not only stabilize the initiation complex as 
priming platform, and prevent back priming reaction, but also serves as the 
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checkpoint for conformational transition of the correctly de novo initiated primer into 
elongation complex.  
Several models have been proposed for RNA replication based on the 
polymerase-RNA complex structures for FMDV (Ferrer-Orta et al., 2006; Ferrer-Orta 
et al., 2004), Poliovirus (Gong et al., 2013; Gong and Peersen, 2010), HCV (Appleby 
et al., 2015; O'Farrell et al., 2003), and bacteriophage ϕ6 (Butcher et al., 2001; Wright 
et al., 2012) that have revealed the molecular basis for initiation or elongation steps 
(Figure 1.23-1.25). 
A model with sequential stages for bacteriophage ϕ6 RdRp catalyzed RNA 
replication was proposed (Figure 1.23): (1) in its apo form, Mn
2+
 binding could 
increase structural fluidity for a higher initiation activity than Mg
2+
-bound form. (2) at 
the preinitiation step, NTP-Mg
2+
 complex enters site I and is stabilized by positively 
charge residues (R/K), and RNA template can enter and exit from the site S. (3) a 
stable initiation complex is formed at the platform provided by C-terminal domain 
(with contribution from residue Y630), when two NTPs (D1 and D2) basepair with 
the last two nucleotides (T1 and T2) of the RNA template. (4) a active catalysis 
reaction occurs for formation of phosphodiester bond between D1 and D2. (5) C-
terminal domain displacement results in structure transition into successive elongation 
stage. 
Similar for HCV NS5B polymerase, which can de novo initiate RNA synthesis, 
a model with β-loop replacement for transition between initiation and elongation is 
proposed (Figure 1.24) (Appleby et al., 2015).(1) In the apo-NS5B, the RNA binding 
site is occluded by C-terminal region and β-loop. (2) During de novo initiation, 
priming NTPs and 3’ end of the RNA template enter the active site and form the 
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initial dinucleotide primer. (3) Further retraction of the β-loop and C-terminus vacates 
the active site for the template-primer duplex. The complex at this stage is unstable, 
resulting in synthesis of 2-4 nts abortive transcripts. (4) It is stabilized when the 
primer is extended into about 4-5 nucleotides, and the C-terminus and β-loop are 
completely expelled out of the RNA binding groove for transition to rapid, processive 
elongation state. 
Figure 1.23 Proposed model with sequential stages for bacteriophage ϕ6 RdRp-
RNA polymerization. (1) Apo form with bound Mn2+. Binding sites and important residues 
are labelled (PDB: 1HHS). (2) pre-initation complex with either NTP (PDB: 1HI1) or RNA 
template (PDB: 1HHT). (3) Initiation complex (PDB: 1HI0). (4) Catalysis. (5) 
Transition to elongation stage (PDB: 4A8S). Figure is adapted from (Wright et al., 
2012). 
 
Figure 1.24 Proposed model of RNA replication by HCV NS5B. In the apo form, 
C terminus (blue line) and the b loop (yellow) block a portion of the RNA binding 
groove. NTPs and RNA template enter the active site and initial dinucleotide primer is 
formed (first slow step). Further movement of the b loop and C terminus out of RNA 
binding site results to transit into the elongation state. 
Different from bacteriophage ϕ6 RdRp and HCV NS5B, FMDV uses VPg1 
protein, which is covalently linked to the 5’end of its genome, to initiate RNA 
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synthesis. In the structure for RdRp-VPg1-UTP-RNA template complex, primer VPg1 
accesses to the catalytic site from the front and it is located close to NTP entry site 
with uridylylation at its side chain of residues Y3 in the active site (Ferrer-Orta et al., 
2006; Ferrer-Orta et al., 2004). 
Structures of elongation complex (EC) undergoing multiple nucleotide 
addition cycles for poliovirus RNA polymerization have been determined and a six-
state elongation catalytic cycle is proposed (Figure 1.25) (Gong and Peersen, 2010). 
(1) the active site of the initial EC without the presence of NTP is open; (2) A 
canonical NTP comes and is stabilized via stacking and base-paring interactions, 
waiting for active site closure and catalysis to occur in step (3); (4) after catalysis, 
active site remains closed, the n+1 NTP is incorporated into the growing RNA chain; 
then (5) active site is reset to open for translocation; (6) translocation intermediate 
with active site opened will resume the conformation in stage (1). 
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Figure 1.25 Proposed a six-state elongation catalytic cycle. Top: Structures of the 
elongation complex and its complexes with NTPs are arranged according to the 
proposed catalytic cycle shown in the box. (1) the active site of the initial EC without 
the presence of NTP is open; (2) A canonical NTP comes and is stabilized via 
stacking and base-paring interactions, waiting for active site closure and catalysis to 
occur in step (3); (4) after catalysis, active site remains closed, the n+1 NTP is 
incorporated into the growing RNA chain; then (5) active site is reset to open for 
translocation; (6) translocation intermediate with active site opened will resume the 






1.6.4 Full length structure of NS5 
Though structural and functional studies on two functional domains of NS5 
have been extensively studied, it was only recently that research on the complete NS5 
protein has been initiated by several research groups. The difficulty comes from 
relative low yield of NS5 using almost any recombinant expression systems and the 
tendency for the protein to be proteolysed during expression/purification into its 
component MTase domain and RdRp domains. Reverse genetic analysis revealed a 
genetic interaction between MTase domain (residue 46-49) and RdRp domain 
(residue 512) for NS5 from WNV, and a model was proposed by in silico docking.  In 
the model, the MTase domain is placed in front of RdRp domain. In this orientation, 
the KDKE catalytic tetrad and RNA-binding site are near the dsRNA exit tunnel of 
the RdRp domain, so that the newly synthesized positive strand RNA could be readily 
cap methylated at the 5’end of the nascent genome (Figure 1. 26A) (Malet et al., 
2007). However this model was disproved by a later study using the co-expression 
system for MTase domain and RdRp domain in mammalian cells. The introduced 
mutations in the proposed interface for WNV NS5 (residues E46, R47, and I49) 
displayed no effect on domain interactions (Tan et al., 2013). Studies of NS5 from 
DENV3 using small angle X-ray scattering (SAXS) revealed NS5 is flexible in 
solution and it can adopt multiple conformations from compact conformation, where 
MTase domain interacts with RdRp domain, to more extended conformation, where 
no interactions between domains is observed in a concentration dependent manner 
(Bussetta and Choi, 2012). Previous study also reported that the RdRp activity was 
not affected by the MTase domain, suggesting the functional independence of RdRp 
domain for RNA synthesis and MTase domain for RNA capping (Selisko et al., 2006). 
While recently, newly determined 3D structure for full length NS5 from JEV revealed 
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that NS5 adopt a compact conformation, in which MTase domain is located at the 
backside of the RdRp domain and two domains cross-talk through an interface rich in 
hydrophobic residues (Figure 1.26B). Mutagenesis analysis of the interface residues 
showed virus replication and in vitro NS5 polymerase activities were affected, 
implying the essential role for the inter-domain interactions (Li et al., 2014b; Wu et 
al., 2015). Besides, a longer RdRp domain construct with extra residues from the 
linker region (265-900) displayed significantly increased thermostability (Tm: 5.5°C 
higher than RdRp273-900) and higher de novo RNA polymerization activity (about 3-
fold more active than RdRp273-900) (Lim et al., 2013a). More recently, MTase 
domain was shown to stimulate both de novo initiation and elongation activities of 
RdRp domain from DENV2 (NGC strain) by increasing affinity between NS5 and 
single-strand RNA template, priming ATP upon de novo initiation, as well as 
increasing catalytic efficiency upon elongation. Most importantly, the stimulatory 
effect of MTase domain on RdRp domain was only observed when two domains were 
in cis, or physically connected, which implies the importance of the inter-domain 
linker to covalently connecting two domains (Potisopon et al., 2014). 
Clearly, further studies of full length NS5 from flavivirus are needed to clarify 
the inter-domain cross-regulatory effects, to reveal different conformations to 





Figure 1.26 Structure representation of full length flaviviral NS5. (A) Full length 
NS5 model proposed based on reverse genetic studies in WNV. MTase domain is in 
cyan and RdRp domain is in magenta. (B) Crystal structure of JEV NS5 (PDB: 4K6M) 
rendered in cartoon representation. MTase domain is in cyan and RdRp domain is in magenta. 
Cofactor SAH is shown as red sticks, and priming loop is coloured blue. Two Zinc ions is are 
shown as green sphere. 
 
 
1.6.5 Non-enzymatic roles of NS5 
NS5 also plays other functional roles during flavivirus replication. In infected 
cells, NS5 interacts with NS3 in the replication complex. NS5 can stimulate NS3 
activity and coordination of NS3 and NS5 proteins balance the synthesis of positive 
and negative strand RNA synthesis. Also nuclear localization of NS5 protein is 
observed for DENV through interaction with importin α/β and exporter CRM-1 
mediated by the nuclear localization sequences (NLS) (Brooks et al., 2002; Forwood 
et al., 1999; Johansson et al., 2001; Kumar et al., 2013; Pryor et al., 2007; Rawlinson 
et al., 2009).  Interestingly, NS5 has been shown to display differential subcellular 
localization among four serotypes of DENV at 24hour post infection: NS5 from 
DENV2 and DENV3 are predominantly localized to nucleus, while NS5 from 
DENV1 and DENV4 are observed in mostly in cytoplasmic (Hannemann et al., 2013; 
Tay et al., 2013). Besides, NS5 can interact with STAT2 and promote STAT2 
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degradation by the ubiquitin-proteosome pathway consisting UBR4 and E3 ligase, 
resulting in the inhibition of type I interferon signalling (Ashour et al., 2009; Mazzon 
et al., 2009; Morrison et al., 2013). 
The multifunctional role of NS5 in viral replication and modulating host 
immune response make NS5 a good drug target for designing anti-viral compounds 
against flaviviruses (Lescar et al., 2008; Malet et al., 2008; Rawlinson et al., 2006; 
Sampath and Padmanabhan, 2009; Vasudevan et al., 2001). 
 
1.7 Dengue prevention and control 
Despite the more than fifty-year research on dengue, there is still no licensed 
vaccine and effective therapeutics to prevent and treat for dengue infections, and 
vector control and personal protection from mosquito bites remain the most effective 
strategy to prevent dengue transmission (NEA, 2014, 2015; Ooi et al., 2006). In 
addition to surveillance and environmental sanitation to reduce mosquito breeding 
sites new approaches such as (1) biologics and/or specific chemicals can be used to 
kill larval and adult mosquitoes, and (2) Wolbachia-infected mosquitoes that are 
unable to infect human with dengue can be used to replace natural populations of 
mosquito (Hancock et al., 2011). 
An effective vaccine for dengue should be able to provide lifelong protection 
against all four serotypes, however, due to the phenomenon of ADE, which could lead 
to severe forms of dengue (DHF/DSS), dengue vaccine research and development has 
been hampered (Thisyakorn and Thisyakorn, 2014). Several vaccines are in pre-
clinical or clinical phases including live attenuated virus vaccine, chimeric vaccine, 
inactivated virus vaccine, DNA and recombinant subunit vaccines (reviewed by 
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(Murrell et al., 2011)). Currently the vaccine in phase III clinical trial is the life-
attenuated tetravalent chimeric vaccine, which consists of the structural proteins from 
DENV and replicating backbone from yellow fever 17D vaccine strain. 
It is difficult and time consuming to develop a safe and efficacious vaccine, 
thus identification and development of anti-DENV therapeutics are also used for 
treatment of DENV. Molecular understanding of dengue replication cycle and the 
functions of viral proteins, as well as host proteins in dengue replication and 
pathogenesis has advanced the progress in identifying the drug target and 
development of small molecules for intervention. For example, viral entry can be 
interfered by targeting the receptor binding property of E protein; enzymatic functions 
required for polyprotein processing (NS2B-NS3 protease activity) and RNA 
replication (NS3 helicase, NTPase, and RTPase activities; NS5 MTase, GTase and 
RdRp activities) are also attractive antiviral targets.  Table 1.4 summarizes previously 
identified inhibitors that target on NS5 protein enzymatic activities. Four main 
approaches have been employed for screening anti-DENV inhibitors, including cell-
based virus replication assay, in vitro viral protein enzymatic assay, structure-based in 
silico docking and repurposing HCV inhibitors. Despite the extensive effort on 
identifying anti-DENV inhibitors, there are only few compounds that has been tested 
in clinical trials: (1) Balapiravir, a pro-drug for nucleoside analogue for anti-HCV infection, 
failed in DENV clinical trial due to lack of potency (Nguyen et al., 2013); (2) Celgosivir, 
which is an oral pro-drug for the castanospermine and host alpha-glucosidase I 
inhibitor, showed efficacy against four serotypes of DENV both in vitro and in mouse 
model (Rathore et al., 2011), and it is recently tested to be safe in phase 1a trial (Low 




There are still challenges to combat dengue; more research is required to 
understand the molecular basis of dengue replication and pathogenesis to facilitate the 
development of effective dengue vaccine and antiviral compounds. 
Table 1.4 Dengue virus NS5 methyltransferase and RdRp inhibitors. Table is 
adapted from (Lim et al., 2015). 
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Compound 10 MTase 
active 
site 
0.82 ± 0.06 (N7) 




Lim et al., 2011 
 BG-323 MTase 
GTP 
pocket 
7.5 * (30.8 ± 1.3/ 
184 ± 42) 
No information 
available 







2 No information 
available 
Milani et al., 2009 
 
4-HPR unknown 1-2.5/13.5 Efficacy in DENV 
mouse 
models demonstrated 
Carocci et al., 2015; 
Fraser et al., 2014 
 
Ivermectin unknown 1-3/7-10 phase II/III clinical 
trial 
planned 







0.64/>100 toxicity issues in 
preclinical 
studies 







1.9/ND No efficacy in phase 
II 
clinical trial 




1.8 Scope of this thesis 
Dengue threatens more than half world’s population by causing epidemic 
infections in more than a 100 counties in the tropical- subtropical regions. Thus it has 
become a major public health concern that needs vaccine and effective antiviral 
treatment as potential countermeasures. Dengue replication takes place in the ER-
membrane associated replication complex (RC) with the largest flaviviral protein NS5 
functioning in the heart of RC. NS5, the most conserved protein, is endowed with 
viral methyltransferase (MTase), RNA-dependent RNA polymerase (RdRp) and 
postulated Guanylyltransferase (GTase) activities. Therefore, NS5 is an attractive 
target for development of specific anti-viral inhibitors. In the recent years, structures 
for individual domains of NS5, N-terminal MTase domain and C-terminal RdRp 
domain, have been determined and the structural insights of individual enzymatic 
activities facilitated the structure-guided drug design. However these efforts have not 
yet led to any potent directly acting antiviral inhibitor against dengue. 
As a multifunctional protein, NS5 has an N-terminal MTase domain for RNA 
capping to form the type I capped structure at 5’end flaviviral genome for efficient 
translation with host ribosome and escaping from host immune response, and a C-
terminal RdRp domain for RNA synthesis to make both negative strand RNA as 
template and positive strand RNA for translation and progeny virus assembly. Hence, 
our hypothesis is that structural studies of the full length NS5 protein is needed to 
understand the molecular basis for inter-domain crosstalk and the conformational 
flexibility for accommodating its various enzymatic activities that can lead to unique 
insights that can drive the efforts to discover potent NS5 inhibitors.  The studies can 
lead to gain structural insights about the dynamic properties for replication complex 
assembly for viral replication. Moreover, the molecular mechanisms for individual 
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enzymatic activity, including N7-MTase, 2’O-MTase and RNA polymerase, remain 
elusive and structural studies of NS5 with RNA ligands are necessary to give 
structural insight and provide useful information for designing more suitable antiviral 
compounds. 
Specifically, the aims of this thesis are: 
1. To identify and characterize NS5 specific antibodies, which will be a useful 
toolbox for functional and interactional studies of NS5. 
There have been a lack of NS5 specific antibody that is cross-reactive to four 
serotypes of dengue, and previous studies on NS5 have been focused on DENV2 NS5 
and observed its nucleus localization pattern. Also antibody-facilitated protein 
crystallizations have been reported. Thus, we performed phage-display screening of a 
naïve human Fab-phage library against purified NS5 proteins. Then the identified 
NS5 specific antibodies were detailed characterized (Chapter 3.1). 
2.  To obtain structure insight into crystal structure of full length NS5 protein and 
understand molecular basis for inter-domain crosstalk. 
Most researches have been focused on individual enzymatic domains of NS5, and 
structure studies of full length NS5 have been obstructed by its instability and 
flexibility. We determined the crystal structure for full length NS5 and investigated 
the functional significance of this structure by reverse genetics studies (Chapter 3.2). 
3. To obtain structure insight into mechanism of MTase 2’O methylation. 
Though several structures with small ligands (GTP, cap analogue, and octameric 
RNA) have been determined for MTase domain, indicating MTase domain for 2’O-
MTase activity, none of them depicts the molecular basis behind. We determined the 
structure for NS5 with type 0 capped RNA in catalytically-relevant  
conformation, elucidating the mechanism for flaviviral RNA capping (Chapter 3.3). 
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Chapter 2: Materials and Methods 
2.1 Molecular cloning 
DNA sequences corresponding to NS5 proteins from DENV1, DENV3, and 
DENV4 were amplified by polymerase chain reaction (PCR) using primer pairs listed 
in Table 2.1. Then the amplified PCR products were excised from a 1% agarose gel 
and purified using QIAquick Gel Extraction kit (Qiagen, The Netherlands). The 
expression vectors were linearized by digestion with NcoI and SalI restriction 
enzymes from New England Biolabs. The purified inserts were cloned into pProEx-
HTb vector using ligation independent cloning methods with the CloneEZ PCR 
Cloning Kit (GeneScript) (Aslanidis and de Jong, 1990). Then the constructs were 
transformed into XL1-blue cells (Stratagene, USA) via the heat-shock method. 
Transformed XL1-blue cells were grown overnight on Luria-Bertani (LB) agar plate 
containing 100µg/ml ampicillin (LB-ampicillin) at 37°C. Colonies were screened by 
colony PCR using forward and reverse primers for sequencing (SeqFP: 5'-
GGATAACAATTTCACACAGG-3' and SeqRP: 5'-
GATTTAATCTGTATCAGGCTG-3'). Positive clones were grown overnight in 10 
ml LB-ampicillin media or LB-kanamycin at 37°C with shaking. Plasmids were 
purified using QIAprep Miiprep Kit (Qiagen) and the sequences for inserts were 
confirmed as correct by automated sequencing (1
st
 BASE, Singapore). 
Mutations of DENV3 NS56-895 were obtained using the QuikChange II XL 
site-directed mutagenesis kit (Stratagene) according to the manufacturer’s protocol. 
The list of primers used was summarized in Table 2.2. Positive clones were grown 
overnight in 10 ml LB-ampicillin media or LB-kanamycin at 37°C with shaking. 
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Plasmids were purified using QIAprep Miiprep Kit (Qiagen) and the sequences for 
inserts were confirmed as correct by automated sequencing (1
st
 BASE, Singapore). 
2.2 NS5 Protein expression and purification 
All NS5 constructs were transformed into Escherichia coli BL21 CodonPlus 
(DE3)-RIL cells (Stratagene, USA) for protein expression. Table 2.3 summarized 
expression conditions and purification buffers.  
NS5 MTase domain (NS51-296): Expression of NS5 MTase domain was 
performed as previously published conditions (Kroschewski et al., 2008). E.coli BL21 
Codon Plus (DE3)-RIL cells (Stratagen) containing the expression constructs for 
His6tag-NS5 MTase were grown at 37°C in Luria-Bertani  (LB) medium containing 
appropriate antibiotics (100 μg/ml ampicillin and 10 μg/ml kanamycin) with shaking 
until an absorbance of around 0.5 at 600 nm. The expression of NS5 MTase domain 
was by adding isopropyl 1-thio-β-D-galactopyranoside (IPTG) to a final concentration 
of 0.4 mM, and growth was continued for a further 5 hour at 30°C. Cells were 
centrifuged at 8,000×g for 20 min at 4°C, and the cell pellets was stored at -80°C. 
The supernatant was purified by metal affinity using a HisTrap HP column 
(Amersham Bioscience) equilibrated with buffer A (50 mM Tris, pH 7.5, 300 mM 
NaCl, 5 mM imidazole, 10% (v/v) glycerol). Proteins were eluted using a linear 
gradient of imidazole from 40 mM to 500mM. The fraction containing His6-MTase 
was dialyzed against buffer C (50 mM Tris, pH 7.5, 150 mM NaCl, 1 mM 
dithiothreitol, and 10% (v/v) glycerol) at 4°C for approximately 24 h. Concentrated 
NS5MTase proteins were subjected to a final polishing step through a HiPrep 
Superdex-75 gel-filtration column (Amersham Bioscience) in buffer C. Fractions 
containing pure NS5MTase protein were pooled and concentrated to 5mg/ml or above 
with batch to batch variations. Protein concentration was determined by measuring the 
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absorbance of the protein solution at 280nm with NanoDrop (thermo scientific).  
NS5 RdRp domain (NS5273-900): Expression of NS5 RdRp domain was 
performed as previously published conditions (Yap et al., 2007). E.coli BL21 Codon 
Plus (DE3)-RIL cells (Stratagen) containing the expression constructs for His6tag-
NS5 RdRp domains were grown at 37°C in Luria-Bertani  (LB) medium containing 
appropriate antibiotics (100 ug/ml ampicillin + 34ug/ml chloramphenicol) with 
shaking until an absorbance of around 0.6 to 0.8 at 600 nm. The expression of NS5 
MTase domain was induced at 16°C by adding isopropyl 1-thio-β-D-
galactopyranoside (IPTG) to a final concentration of 0.4mM. After overnight growth, 
cells were centrifuged at 8,000×g for 20 min at 4°C, and the cell pellets were stored at 
-80°C. 
The protein was purified by metal affinity using a HisTrap HP column 
(Amersham Bioscience) equilibrated with buffer A (20 mM Tris-HCl, pH 7.5, 500 
mM NaCl, 10 mM β-mercaptoethanol, and 10% glycerol, 10mM imidazole). Proteins 
were eluted using a linear gradient of imidazole from 40 mM to 500mM. The fraction 
containing His6-MTase was dialyzed against buffer C (20 mM Hepes at pH 7.4, 300 
mM NaCl, 5mM DTT) at 4°C for approximately 24 h. Concentrated NS5MTase 
proteins were subjected to a final polishing step through a HiPrep Superdex-75 gel-
filtration column (Amersham Bioscience) in buffer C. Fractions containing pure 
NS5RdRp protein were pooled and concentrated to 8mg/ml or above with batch to 
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Table 2.1.Detail of NS5 constructs. Constructs design, primers used for PCR amplification and cloning, expression vectors and restriction 














V264G For GGATTTAGGAGCAGGAACTCGACATGGTAATGCGGAACCAGAAACACCC 
 Rev GGGTGTTTCTGGTTCCGCATTACCATGTCGAGTTCCTGCTCCTAAATCC 
   
V264P For GGATTTAGGAGCAGGAACTCGACATCCGAATGCGGAACCAGAAACACCC 
 Rev GGGTGTTTCTGGTTCCGCATTCGGATGTCGAGTTCCTGCTCCTAAATCC 
   
VGN For GGATTTAGGAGCAGGAACTCGACATGTTGGTAATGCGGAACCAGAAACACCC 
 Rev GGGTGTTTCTGGTTCCGCATTACCAACATGTCGAGTTCCTGCTCCTAAATCC 
   
VPN For GGATTTAGGAGCAGGAACTCGACATGTTCCGAATGCGGAACCAGAAACACCC 
 Rev GGGTGTTTCTGGTTCCGCATTCGGAACATGTCGAGTTCCTGCTCCTAAATCC 
a
 Mutations generated using QuikChange II XL SDM kit. 
b





NS5 Full length (NS51-900): E.coli BL21 Codon Plus (DE3)-RIL cells 
(Stratagen) containing the expression constructs for pProEx-HTb-NS5 full length 
proteins were grown at 37°C in Luria-Bertani  (LB) medium containing appropriate 
antibiotics (100 ug/ml ampicillin + 34ug/ml chloramphenicol) with shaking until an 
absorbance of around 0.6 to 0.8 at 600 nm. The expression of full length NS5 proteins 
were induced at 16°C by adding isopropyl 1-thio-β-D-galactopyranoside (IPTG) to a 
final concentration of 0.5mM. After overnight growth, cells were centrifuged at 
8,000×g for 20 min at 4°C, and the cell pellets was stored at -80°C. 
The supernatant was purified by metal affinity using a HisTrap HP column 
(Amersham Bioscience) equilibrated with buffer A (50 mM Tris pH 7.5, 500mM 
NaCl, 10% glycerol, 10mM β-mercaptoethanol, 10 mM imidazole). Proteins were 
eluted using a linear gradient of imidazole from 40 mM to 500mM. The fraction 
containing His6-MTase was dialyzed against buffer C (20 Hepes pH 7.5, 300mM 
NaCl, 10% glycerol, 2mM DTT) at 4°C for approximately 24 h. Concentrated 
NS5MTase proteins were subjected to a final polishing step through a HiPrep 
Superdex-75 gel-filtration column (Amersham Bioscience) in buffer C. Fractions 
containing pure NS5MTase protein were pooled and concentrated to 5mg/ml or above 
with batch to batch variations.  
DENV3 NS56-895 and its mutants: E. coli BL21-CodonPlus cells (Stratagene) 
transformed with pNIC-Bsa-NS5 were grown at 37 °C in LB medium supplemented 
with 50 µg/ml kanamycin and 50µg/ml chloramphenicol to an OD600nm of 0.6 to 
0.8. His6-NS56-895 protein expression was induced at 16°C by adding IPTG with a 
final concentration of 0.5 mM. After overnight growth, cells were harvested by 
centrifugation at 8,000 × g for 10 min at 4°C and stored at –20°C.  
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The cell pellets were resuspended in buffer A (50 mM Tris pH 7.5, 500mM 
NaCl, 10% glycerol, 10mM β-mercaptoethanol, 10mM imidazole) supplemented with 
an EDTA- free protease inhibitor tablet (Roche)) (4ml/g cell pellet) and were lysed by 
sonication at 60% amplitude for 5 min (1 second pulse on, 4 second pulse off) or 
lysed by homogenizer. The insoluble was removed by centrifugation at 30,000×g for 
30 min at 4°C. The supernatant was filtered with a 0.45µm syringe-driven filter unit 
(Milipore, USA) and purified by immobilized metal-ion affinity chromatography 
(IMAC) using a HisTrap HP column (GE Healthcare). Column was pre-equilibrated 
with lysis buffer and washed with lysis buffer supplemented with 20 mM imidazole. 
Protein fractions were then eluted with a linear gradient of imidazole ranging from 40 
to 500 mM using buffer B (50 mM Tris pH 7.5, 500mM NaCl, 10% glycerol, 10mM 
β-mercaptoethanol, 500mM imidazole). Fractions containing NS5 were analyzed by 
10% sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) 
before pooled and dialyzed overnight against dialysis buffer (buffer C: 20 Hepes pH 
7.5, 300mM NaCl, 10% glycerol, 2mM DTT), with concomitant cleavage of the N-
terminal 6xHis-tag by adding. TEV (Tobacco Etch Virus) protease (final protease to 
protein mass ratio of 1:40). Then the TEV-treated proteins were applied to a pre-
equilibrated HisTrap HP column to remove any His-tag containing proteins. As the 
final polishing step, NS5 proteins were purified with Superdex 200 column (GE 
Healthcare) with buffer C. The eluted monomeric NS5 proteins were pooled 
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MTase was also 





Expression conditions for respective NS5 related proteins that were used in this study 
Details for large scale protein purification buffers that are described in material and 
methods. This table also contains respective column used in the purification process. 
 
2.3 NS5 antibody screening by phage display- (Initiated by Dr Moreland Nicole J, 
former Research Fellow in Subhash’s lab) 
In vitro biotinylation of proteins was performed as described previously 
(Moreland et al., 2010). Purified MTase and RdRp proteins in their respective SEC 
buffer were dialyzed overnight against phosphate buffer saline (PBS, pH 7.5) to 
remove Tris prior to biotinylation. Biotinylated proteins were purified by SEC using 
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PBS pH 7.5 buffers. Fractions containing the biotinylated proteins were analyzed 
using SDS-PAGE before being pooled and concentrated. Library screening was 
performed following methods described previously (Lim et al., 2008a; Moreland et al., 
2010). Biopanning was used to screen for specific antigen binding fragment (Fab) that 
binds to DENV3 MTase and RdRp from the naïve human fab phage display library 
HX02 (Humanyx Pte Ltd, Singapore). Streptavidin magnetic beads (Invitrogen) were 
used to immobilize the antigen (biotinylated DENV3 MTase, and DENV3 RdRp) 
during library panning. After four rounds of solution panning, individual clones were 
rescued with M13K07 helper phage and their reactivity against DENV3 MTase and 
DENV3 Rdrp were screened by enzyme-linked immunosorbent assay (ELISA). 
Positive clones were detected by anti-M13-horse radish peroxidase (HRP) conjugate 
(GE Healthcare) with an absorbance value two times higher than background levels. 
Then clone uniqueness was assessed by a BstN1 restriction digest following PCR 
amplification of the Fab coding region of the phagemid, and clones with unique DNA 
fingerprints were subject to automated sequencing. 
2.4 Antibody (Fab-fusion protein) expression and purification 
Expression and purification Fab fusion proteins were performed as described 
previously (Moreland et al., 2010). Gene III coding sequence from unique Fab-phage 
clones were removed by SalI digestion and re-ligated with T4 DNA ligase. The 
recombinant Fab construct with His6- and c-myc-tag was transformed into E.coli 
Top10 F’ cells (invitrogen). Transformed cells were grown at 30°C in 2xTY medium 
containing 100µg/ml ampicillin with shaking until an absorbance of around 0.6 to 0.8 
at 600 nm. Cultures were induced with 1mM IPTG and growth was continued for 
overnight at 25°C with shaking. Cells were harvested by centrifugation at 8000g for 
20 minutes at 4°C and cell pellets were lysed by osmotic shock extraction method 
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using TES buffer (0.2 M Tris, pH 8, 0.5 mM EDTA, and 0.5 M sucrose supplemented 
with supplemented with a complete protease inhibitor tablet (Roche)) and the lysate 
was clarified by centrifugation at 30,000×g for 30 min at 4°C. The supernatant was 
filtered with a 0.45µm syringe-driven filter unit (Milipore, USA) and purified by 
immobilized metal-ion affinity chromatography (IMAC) using a HisTrap HP column 
(GE Healthcare). Column was pre-equilibrated with Fab buffer A (50 mM Tris-HCl, 
pH 8, 250 mM NaCl, 20 mM imidazole). Protein fractions were then eluted with a 
linear gradient of imidazole ranging from20 to 500 mM using Fab buffer B (50 mM 
Tris-HCl, pH 8, 250 mM NaCl, 500 mM imidazole). Fractions containing Fab were 
analyzed by 15% SDS-PAGE before pooled and dialyzed overnight against dialysis 
buffer containing TBS130 (20 mM Tris-HCl, pH 7.5, 130 mM NaCl). Then Fab was 
concentrated using a 10K centrifuge filter unit (Milipore). Finally Fab showed >90% 
purity and were stored at -80°C. 
2.5 Characterisation of antibodies 
2.5.1 ELISA  
Maxisorb 96-well immunoplate (Nunc, USA) was coated with 50 μl well of 5 
μg/ml NS5 proteins overnight at 4°C and washed twice with PBS. The coated plate 
was blocked with 300 μl/well of MT buffer (PBS supplemented with 5% skim milk 
power and 2% Tween-20) for 1 hour at room temperature and washed twice with 
PBST. 50 μl of Fab with two-fold serial dilution in MT buffer were added to 
respective wells and allowed to bind for 1 hour at room temperature. The plate was 
washed five times with PBST to remove unbound Fab and 100 μl of diluted (1:1000 
in MT buffer) HRP-anti-c-myc conjugate (Roche) was added. After 1 hour incubation 
at room temperature, the plate was washed three times with PBST and one time with 
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PBS. 50 μl/well of 3.3’, 5.5’-tetramethyl benzidine substrate (Sigma, USA) was added 
and incubated for blue colour development. 12.5 μl/well of 3M HCl was added to stop 
the reaction and absorbance was measured at 450 nm on an optical density plate 
reader. 
2.5.2 Western blot  
Purified NS5 proteins or crude cell lysates were separated on 10-12 % SDS 
PAGE gel and transferred to Hybond-P PVDF membrane (Amersham) using BioRad 
Trans-blot SD semi-dry electrophoretic transfer cell. And membrane was blocked for 
1 hour at RT with blocking buffer (3% milk in 1xPBST buffer). Proteins were 
incubated with primary mouse anti-His antibody or anti-NS5 Fab for 1h, followed by 
secondary peroxidase-conjugated goat anti-mouse IgG or anti-c-myc-peroxidase 
(Roche). Detection was carried out using Amersham Biosciences ECL detection kit as 
described in the manufacturer’s manual. 
2.5.3 SPR 
Affinity measurements were performed on ProteOn XPR 36 instrument 
(BioRad). All experiments were conducted at 25°C in HBS-EP (10 mm HEPES, pH 
7.4, 150 mm NaCl, 3.4 mm EDTA, and 0.005% P-20). Four serotypes of NS5 full 
length protein were amine-coupled onto the GLC sensor chip (ProteoOn, BioRad) at a 
flow rate of 10 μl/min. A 3-fold serially diluted Fabs was injected in triplicate for 75 
second at 80 μl/min, and dissociation was monitored for 10 min. Regeneration of chip 
surface was achieved with a short pulse (12 second) of 10 mM glycine hydrochloride 
pH 2.5 at high flow rate (150 μl/min) to remove residual bound analytes to prepare for 
the next injection cycle. Raw sensorgram data were aligned, solvent-corrected, and 
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double-referenced using ProtoOn Manager software (ProteOn, BioRad) and fitted to 
Langmuir (1:1) model for global kinetic analysis as appropriate. 
2.5.4 Peptide competition ELISA 
The epitope was mapped by peptide competition ELISA reported previously 
(Moreland et al., 2010). An array of overlapping 15-mer peptides (Minotopes) that 
span NS5 protein (DENV-2 strain D2/SG/05K4155DK1/2005) were used for epitope 
mapping. 5M1 Fab at a concentration of 13.5 nM was preincubated with 60 µM of 
peptide for 30 min at 25°C, and then added to NS5 protein-coated immunoplate 
(5µg/ml in PBS, pH 7.2). Anti-c-myc-HRP conjugate were used to detect bound 
antibody. Measurements were repeated in triplicate. Same procedures were followed 
for mapping 5R3 epitope. 
2.5.5 Peptide phage display 
Peptide phage display method was performed for Fab epitope mapping 
following panning process described in the New England Biolab Instruction Manual. 
Purified Fab was immobilized onto magnetic Ni-NTA agarose beads (Qiagen), 
followed by incubation with the Ph.D-12 random dodecapeptide library (1×1011 pfu 
phage) for 15 min at 25°C. Then the bound phage were eluted with Glycine Elution 
Buffer (200 mM Glycine-HCl pH, 1mg/ml BSA) and immediately neutralized with 
240 μl of 1M Tris-HCl, pH 9.1. Elute were amplified and further enriched by another 
two rounds of selection. Individual phage clones after third round selection were 
amplified and tested by phage ELISA for their reactivity to Fab. Single stranded DNA 
were isolated and sequenced from the positive phage clones. 
2.6 Protein-Fab complex screening by size-exclusion chromatography (SEC) 
 77 
 
Analytical size-exclusion chromatography (SEC) was carried out on an AKTA 
FPLC system (GE Healthcare). NS5 domain proteins and Fabs were incubated on ice 
for 1 hour before the mixture were loaded on to Superdex 200 10/300 GL column (GE 
Healthcare) equilibrated with a buffer containing 50 mM Tris-HCl (pH 7.5), 130 mM 
NaCl, 2 mM EDTA, 2 mM 5 mM β-mercaptoethanol. The eluate was monitored by 
ultraviolet absorbance at 280 nm. And fractions containing the elaute were collected 
and analyzed by SDS-PAGE. 
2.7 Studies of Protein-Fab complex by Small Angle X rays Scattering (SAXS) 
(conducted in collaboration with Jade Forwood from Sturt Charls University) 
SAXS experiments were performed on DENV3 NS5FL, MTase/5M3 complex 
and NS5FL/5M3 complex according to standard procedures (Forwood et al., 2010). 
Scattering intensities I(q) for sample and buffer were recorded as a function of 
scattering vector q. The scattering profiles were calculated after subtracting the 
scattering contributions of buffer. Guinier plot were used to analyze quality and 
folding status of samples. Theoretical scattering curves of the 3-D model (PDB 
coordinates) were computed using CRYSOL after an inter-connected ensemble of 
known subunits constructed using SASREF (Svergun et al., 2001). The program EOM 
was subsequently employed to estimate the conformational flexibility of proteins in 
solution (Bernado et al., 2007). 
2.8 Structural studies of NS5 
2.8.1 Protein crystallisation 
6mg/ml of purified NS5 protein in buffer C was used to set up crystallization 
trials using the Phoenix crystallization robot (Art Robbin Instruments) using sitting 
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drop vapour diffusion at 20°C. Commercial screens (Hampton Research) were used in 
high throughput initial screening. Sitting drop was set up in 96-well intelli-plates 
(Rigaku) with a mixture of 0.15ul protein and 0.15ul crystallization condition solution 
sitting in a 56ul reservoir solution. Small rhomboidal shaped crystals were obtained 
using precipitants containing divalent metal salts, including calcium acetate, 
magnesium acetate and magnesium formate. Crystallization conditions include 
conditions 18 and 46 (Crystal Screen HR2-110, Hampton Research), condition 20 
(PEG/Ion Screen, HR2-126, Hampton Research) and condition 55 (Index screen HR2-
144, Hampton Research). 
Optimisation trays were set up manually using the hanging drop method at 
20°C by mixing a volume of 1 µl of NS5 protein with 1 µl of precipitation solution in 
24-well VDX plates (Hampton Research), varying the buffer pH, protein 
concentration, salt concentration and percentage of precipitants. Larger crystals of 
rhombus or trapezoid shape were obtained over 2–5 days.  
2.8.2 Soaking experiment and co-crystallization 
To obtain crystals for NS5 complexed with GTP or RNA, strategies of co-
crystallization and soaking were employed. For co-crystallisation, 6 mg/ml (~60uM) 
NS5 and 0.4 mM GTP were mixed and incubated on ice for 30min before setting up 
crystallization using hanging drop method. Crystals for the NS5-GTP complex were 
obtained by using a slightly different precipitating solution (0.1 M sodium cacodylate 
(pH 6.4), 0.2 M magnesium acetate or 0.2 M calcium acetate and 14% polyethylene 
glycol 8000) at 20°C. Crystals for NS5-GTP complex were also obtained by soaking 
of NS5 crystal in precipitating solution supplemented with 5mM GTP for overnight. 
Although these crystals grow in slightly different conditions, they are isomorphous. 
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Similarly, crystals for the NS5-RNA complex were obtained by soaking of 
NS5 crystals in the precipitation solution supplemented with 1mM RNA for overnight. 
2.8.3 Data collection 
For data collection, crystals were soaked for few seconds in a cryoprotecting 
solution (precipitation solution supplemented with 20% glycerol) before being 
mounted and flash-cooled in liquid nitrogen (Oxford Cryosystems). Diffraction 
intensities for apo-NS5 and NS5-RNA-SAH complex were collected at the PXIII 
(X10SA) beamline at the Swiss Light Source, Paul Scherrer Institut, Villigen, 
Switzerland. Diffraction intensities for cocrystals with GTP were collected at National 
Synchrotron Radiation Research Center, beamline 13B1 (Hsinchu, Taiwan).  
Integration, scaling, and merging of the intensities were carried out using 
programs MOSFLM and SCALA from the CCP4 suite (CCP4, 1994). The 
asymmetric unit contains one NS5 molecule with S-adenosyl-L-homocysteine (SAH) 
copurified from E. coli, bound to the MTase domain. 
2.8.4 Structure solution, refinement and analysis 
The crystal for NS5 contains one monomer per asymmetric unit with an 
estimated solvent content of 50.2% based on a Matthews coefficient (Vm) value of 
2.47 (Matthews, 1968). NS5 structure was solved by molecular replacement with the 
program PHASER (Storoni et al., 2004) using DENV3 MTase (Protein Data Bank 
[PDB] accession number 3P97) (Lim et al., 2011) and DENV3 RdRp (PDB accession 
number 2J7U) (Yap et al., 2007) as search probes. Structures for NS5-GTP and NS5-
RNA complexes were solved by molecular replacement with  the program PHASER 
(Storoni et al., 2004) using refined DENV3 NS5 structure as a search probe. 
Refinement cycles carried out using REFMAC5 (Collaborative Computational Project, 
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1994) and PHENIX refine (Adams et al., 2010) and TLS (translation, liberation, 
screw-rotation displacement) refinement was introduced in the last refinement steps. 
Refinement cycles were interspersed with manual model rebuilding using Coot 
(Emsley and Cowtan, 2004) at the computer graphics. The quality of the structure was 
analyzed using Molprobity (Chen et al., 2010). The summary of the data collection 
and structure refinement statistics is given in Table 4.2, 4.3 and 5.1. Solvent-
accessible surfaces areas were calculated using CCP4 program AREAIMOL with a 
1.4-Å radius sphere as a probe. Superimpositions of structures were carried out using 
the program LSQKAB from the CCP4 suite. Figures were prepared using the program 
Pymol (Schrödinger, 2010). PISA server (www.ebi.ac.uk/pisa) was used to calculate 
the buried surface areas by defining both MTase domain residues (6-262 for DENV3 
NS5 and 6-265 for JEV NS5) and RdRp domain residues (273-883 for DENV3 NS5 
and 276-896 for JEV NS5), as summarized in Table 4.9 (Krissinel and Henrick, 
2007). Program DynDom was used to calculate the relative reorientation between 
domains (Hayward and Lee, 2002). All refined coordinates were deposited in the PDB 
under accession number 4V0Q (NS5-SAH) and 4V0R (NS5-SAH-GTP). Structure for 
NS5-SAH-Cap0 RNA has not submitted. 
2.9 Solution Studies of NS5 by HDX (conducted in collaboration with Dr Jie 
Zheng from NTU) 
2.9.1 Hydrogen-Deuterium exchange (HDX) 
The buffer for HDX on-exchange was of the same composition except that 
H2O was replaced with D2O (99.99%) and glycerol was removed. 4 μl of full length 
NS5 (18 μM), MTase (18 μM), or RdRp protein (18uM) was mixed with 16 μl D2O 
buffer (final D2O concentration was 80%) or H2O buffer for 0s samples, and 
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incubated at 4°C at various time intervals, e.g 30s, 60s, 600s, 1800s. 20 μl ice-cold 
quench solution consisting of 1 M guanidine hydrochloride and 1.5 % (v/v) formic 
acid was added to each on-exchanged samples after specific time intervals prior to 
rapid freezing by liquid nitrogen until HDX MS analysis. 
2.9.2 LC-MS/MS under quenched condition 
For capillary-flow LC, buffer A was H2O containing 0.3% (v/v) formic acid. 
Buffer B was acetonitrile containing 0.3% (v/v) fomic acid. Protein samples were then 
digested online by passing through an immobilized pepsin-coupled column (2.1 mm 
i.d. x 30 mm) (Invitrogen) and were de-salted for 3 min on a house-packed C4 trap 
(0.75 mm i.d. x 10 mm, C4 beads purchased from Michrom). The mobile phase for 
on-line pepsin digestion was buffer A and the flow rate was 150 μl min-1 driven by the 
LC loading pump (Dionex 3000 RSLC). A 20 min gradient on a house-packed C4 
column (0.3 mm i.d. x 50 mm, C4 beads purchased from Michrom) was used to 
separate and elute peptic peptides prior to MS analysis. All parts are connected by 
1/16” OD x 50 μM ID PEEK tubing and the flow rate was 15 μl min-1 driven by LC 
NC pumps. The gradient started from 5 % buffer B and increased to 35 % buffer B 
within 20 min, followed by washing with 90 % buffer B for 3 min and equilibration 
with 1 % buffer B for 5 min. MS raw data were acquired in the range of m/z 300-2000 
for 30 min in positive mode on a LTQ-Orbitrap mass spectrometer (Thermo Fisher 
Scientific) equipped with an ESI source (capillary temperature 275°C and spray 
voltage of 5 kV). All the HDX systems were strictly performed at 0°C (fully buried in 
ice and water) and on-line pepsin digestion was carried out at 16°C. Blank injections 
were made between every two samples to remove carryover peptides. Data for each 
time point was repeated three times. All HDX data were normalized to 100 % D2O 
content, corrected for an estimated average deuterium recovery of 70 %, and analyzed 
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by the software HD Desktop (Pascal et al., 2009). Initial peptic peptide identifications 
were performed with the same HDX set up as described above. 4μl of protein sample 
(20 μM) was injected into the HDX MS system. Product ion (MS/MS) spectra were 
acquired in linear ion trap LTQ with eight most abundant ions selected in the 
precursor (MS) scan with a 7.5 sec exclusion time. MS and tandem MS files were 
extracted and searched by using the Global proteome machine 
(http://www.thegpm.org) for high-confident peptide identification. 
2.10 Functional studies of NS5 mutants in DENV2 full-length cDNA clone 
2.10.1 Generation of mutant viral cDNA clones 
Interface mutants (K95A, Y119A, E268A and R353A) and linker mutants 
(I265G, I265P, IGG and IPG) were constructed into full-length DENV2 cDNA clone 
(GeneBank accession EU081177.1) as described (Tay et al., 2015). Schematic 
representation of generation mutant full-length DENV2 cDNA clone was shown in 
Figure 2.1. Basically, NS5 mutations were introduced into pWSK29 D2 fragment 3 
using QuikChange II XL site-directed mutagenesis kit (Stratagene) according to the 
manufacturer’s protocol. Primers used for mutagenesis are listed in Table 2.4. Mutant 
pWSK29 D2 fragment 3 plasmids were sequenced by automated DNA sequencing 
service (1
st
 Base, Singapore) for confirming the presence of mutation. WT DENV2 
infectious cDNA clone was digested with XbaI and SacI to generate linearized 
pWSK29-D2 fragment 1+2 fragment containing WT first two fragments. Fagment 3 
bearing the NS5 mutation was excised from the pWSK29 D2 fragment 3 plasmid by 
same restriction enzymes XbaI and SacI. Then the mutant fragment 3 was inserted by 




Figure 2.1 Schematic representation of full-length DENV2 cDNA clone. The 
DENV2 genome (represented approximately to scale) contains a single open reading 
frame that encodes three structural proteins (C, prM and E) and seven NS proteins 
(NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5). The cDNA clone was subdivided 
into three fragments based on unique restriction sites that are present within the 
genome to facilitate the assembly of full-length clone. The complete DENV2 clone 
has T7 promoter at 5’ end for in vitro transcription and SacI site at 3’ end for 














K95A For GGTCATACTATTGTGGGGGACTAGCGAATGTAAAAGAAGTCAAAGGCC 
 Rev GGCCTTTGACTTCTTTTACATTCGCTAGTCCCCCACAATAGTATGACC 
   
Y119A For CCTATTCCCATGTCAACAGCCGGTTGGAATCTGGTGCGTCTTCAAAGTGG 
 Rev CCACTTTGAAGACGCACCAGATTCCAACCGGCTGTTGACATGGGAATAGG 
   
E268A For GGAACTCGCAATATCGGAATTGCAAGTGAGACACCAAATTTAGAC 
 Rev GTCTAAATTTGGTGTCTCACTTGCAATTCCGATATTGCGAGTTCC 
   
R353A For CGACTCCATTTGGACAACAGGCCGTTTTCAAAGAGAAGGTGGACACG 
 Rev CGTGTCCACCTTCTCTTTGAAAACGGCCTGTTGTCCAAATGGAGTCG 
   
I265G For CGGAAGTGGAACTCGCAATGGCGGAATTGAAAGTGAGACACC 
 Rev GGTGTCTCACTTTCAATTCCGCCATTGCGAGTTCCACTTCCG 
   
I265P For CGGAAGTGGAACTCGCAATCCCGGAATTGAAAGTGAGACACC 
 Rev GGTGTCTCACTTTCAATTCCGGGATTGCGAGTTCCACTTCCG 
   
IGG For CGGAAGTGGAACTCGCAATATCGGCGGAATTGAAAGTGAGACACC 
 Rev GGTGTCTCACTTTCAATTCCGCCGATATTGCGAGTTCCACTTCCG 
   
IPG For GGAAGTGGAACTCGCAATATCCCCGGAATTGAAAGTGAGACACC 
 Rev GGTGTCTCACTTTCAATTCCGGGGATATTGCGAGTTCCACTTCC 
a
 Mutations generated using QuikChange II XL SDM kit.  
b





2.10.2 Linearization and in vitro transcription 
10ug of the genome-length wild-type and mutant DENV2 infectious clone 
plasmids were linearized with SacI (NEB) digestion in the presence of BSA and NEB 
buffer 4 in a 100ul reaction mixture for 3 hour at 37 °C. Then the linearized plasmids 
were purified with phenol-chloroform extraction method. Briefly, 100ul of 
phenol/chloroform/isoamylalcohol (25:24:1) was added to the digestion mixture. The 
mixture was mixed thoroughly and spun for 2 minutes at 13,200 rpm and 100µl was 
transferred to a fresh eppendorf tube. Then chloroform (100ul) was added to the 
supernatant, mixed thoroughly and spun for 2 minutes at 13,200rpm. 60µl of 
supernatant was transferred to a fresh tube. 140µl of water was added to the remaining 
40ul of supernatant, mixed thoroughly and spun for 2 minutes at 13,200 rpm. 140µl of 
diluted supernatant was transferred and mixed with the initial 60µl of supernatant, 
giving a total 200µl supernatant. 3M sodium acetate pH 5.2 (20µl) and 100% ethanol 
(500µl) were added to precipitated DNA at -80°C for at least 1 hour. The mixture was 
spun for 10 minutes at 13,200 rpm (4°C). Supernatant was discarded. 1ml of 70% 
ethanol was added to wash the DNA pellet. The mixture was spun for 10 minutes at 
13,200 rpm (4°C). Supernatant was removed and the DNA pellet was air-dried at RT. 
Then DNA pellet was resuspended in RNase-free water and its concentration was 
measured by NanoDrop 2000 Spectrophotometer. 
About 2ug of linearized full length DENV2 cDNA infectious clone was used 
for in vitro transcription with T7 mMESSAGE mMACHINE kit (Ambion). 5.6 µl of 
linearized DNA (≤3 µg), was mixted with rGTP, rCTP and rUTP (2 µl each), 0.4 µ1 
of rATP, 3 µl of m7G(5')ppp(5')A RNA Cap Structure Analog (total 2.5 units), 1 µ1 
RNAse inhibitor, 2 µ1 T7 RNA polymerase and 2 µ1 10× reaction buffer. After 
incubation of the reaction mixture for 30min at 37°C, 1.8 µl rATP and 0.2 µl 10× 
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buffer was added to spike the reaction. After two hours incubation at 37°C, 1 µl of 
TURBO DNase was added to remove DNA template by incubation for 15 minutes at 
37°C. 27 µL Nuclease-free water and 30 µL lithium chloride were added to 
precipitate RNA for overnight at -80°C. RNA pellet was obtained by spinning for 15 
minutes at 13,200 rpm (4°C). The pellet was washed with 1 ml of 70% ethanol and 
spun for 10 minutes at 13,200 rpm (4°C) to remove supernatant. The RNA pellet was 
air dried at RT. The RNA pellet was resuspended in RNase-free water and its 
concentration was measured by NanoDrop 2000 UV-Vis Spectrophotometer. RNA 
integrity was checked by running 0.6% agarose gel. 
2.10.3 Electroporation of DENV RNAs into mammalian cells 
BHK-21 cells in the log phase of growth were trypsinized, washed twice with 
cold PBS pH7.4 and resuspended in Opti-MEM (Gibco) at a cell density of 1 × 10
7
 
cells/ml. 10µg of in vitro transcribed RNA (wild-type DENV2 and mutants) were 
mixed with 800µl cell suspension in a pre-chilled 0.4cm cuvette (Bio-rad, Germany), 
and electroporated at settings of 850V and 25µF, 2 pulses at an interval of 3 seconds 
with a Gene Pulser Xcell system (Bio-rad). Electroporated cells were allowed to 
recover at room temperature for 10 minutes prior. Then cells were diluted to a cell 
density of 3 × 10
5
 cells/ml in complete RPMI 1640 media supplemented with 
10%FBS and 1%P/S. 3 × 10
5
 cells were then seeded into each well of a 12-well plate 
and incubated at 37
o
C in the presence of 5% CO2. Media was changed to 2% FBS 
maintenance media after 6 hours post-electroporation. Samples were harvested at 24, 
48, 72, 96 and 120 hours post-transfection. Supernatants were harvested and clarified 
for standard plaque assay on BHK-21 cells to determine virus titer and real time RT-
PCR to quantify extracellular viral RNA level. Cells were washed with PBS and lysed 
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with Trizol reagent (Invitrogen) for real time RT-PCR to quantify total intracellular 
viral RNA level. 
2.10.4 Quantitative real time PCR (RT-PCR), immunofluorescence assay and 
plaque assay 
For extracellular viral RNA quantification, viral RNA from supernatant was 
extracted using QIAamp Viral RNA Mini Kit (Qiagen) according to the 
manufacturer’s instructions. iTaq universal SYBR Green One-Step kit (Bio-Rad) was 
used to carry out real time RT-PCR for its quantification with the use of primers 
(forward, 5’- CAGGCTATGGCACTGTCACGAT -3’; and reverse, 5’-
CCATTTGCAGCAACACCATCTC-3’) targeting for DENV2 E region (adopted 
from (Johnson et al., 2005)). Based on the standard curve generated from ENV2-3295 
plasmid containing the E region, absolute copy numbers of viral RNA was calculated 
and reported as absolute viral RNA copies (in log scale ) per ml of the supernatant 
used for real-time RT-PCR. 
For intracellular viral RNA quantification, total intracellular RNA from cells 
was extracted using Trizol extraction method. 500ng RNA was used for reverse 
transcription to synthesize cDNA using Improm II Reverse Transcription kit 
(Promega) in a 10ul reaction with random primers according to manufacturer’s 
instructions. 40ng of cDNA was used for real-time quantification of intracellular viral 
RNA. Real time RT-PCR was carried out in Bio-Rad Real-time thermal cycler 
CFX96 by the use of iQ SYBR green supermix (Bio-Rad) with primers mentioned 
above (forward: 5’- CAGGCTATGGCACTGTCACGAT -3’; reverse: 5’- 
CCATTTGCAGCAACACCATCTC -3’) targeting the DENV2 E region (adopted 
from (Johnson et al., 2005)). Plasmid containing the E region of DENV2-3295 
(GenBank accession EU081177.1) was used to make standard curve for the 
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quantification of absolute viral genome copy number. The calculated absolute viral 
copies were normalized to actin level with primers (forward, 5’- 
TCACCACACACTGTGCCCATCTACGA-3’; and reverse, 5’- 
CAGGGGAACCGCTCATTGCCAATGG- 3’) and reported as viral RNA copies per 
ug RNA  
At indicated time point post-electroporation, BHK-21 cells were fixed with 
ice-cold methanol:acetone (1:1) for 15miutes at -20 ºC. And then cells were washed 
once with PBS and probed with antibodies against dsRNA (anti-dsRNA mAb J2 from 
Scicons) and NS5 (anti-NS5 hAb 5R3) as previously described (Moreland et al., 
2012). Secondary antibodies coupled with Alexa-Fluor 488 or Alexa Fluor 594 
(Invitrogen) were applied for detection. Prolong Gold antifade reagent with DAPI 
(Invitrogen) was used to mount coverslips. Images were captured on an inverted 
fluorescence microscope (Olympus IX71, Center Valley, USA) at 20× magnification 
and image analysis was done with ImageJ software. 
2x10
5
 BHK-21 cells per well were seeded into each well of a 24-well plate and 
incubated for overnight at 37
o
C in the presence of 5% CO2. 10-fold serial dilutions of 
supernatants harvested at indicated time point were diluted with RPMI medium, and 
aspirated to add to BHK-21 cells for incubation at 37°C for 1 hour. Then supernatant 
was removed and replaced with 0.8% methyl-cellulose in maintenance medium 
(RPMI 1640 medium supplemented with 2% FCS and 1% P/S). After 4-5 days 
incubation at 37°C, the plates were fixed with 4% formaldehyde at RT for 20 minutes. 
Then the plate was washed thoroughly with water, and stained with 0.5 ml of 1% (w/v) 
crystal violet for 20 minutes. After staining, the plates were washed, dried and the 
plaque forming units per ml (pfu/ml) was calculated. 
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2.11 Functional studies of NS5 mutants in NS5 protein (conducted in 
collaboration with Sherryl Soh from NTU and NITD) 
2.11.1 NS5 methyltransferase in vitro assays 
N7- and 2’O-MTase assays were performed as previously described (Lim et 
al., 2011; Lim et al., 2008b). Basically, in the N7-MTase reaction, 25 nM protein was 
mixed with 240 nM biotinylated GpppA-DENV nt 1-110 in vitro transcribed RNA, 
320 nM [
3
H-methyl]-SAM in 50 mM Tris-HCl, pH 7.5, 20 mM NaCl, and 0.05% (v/v) 
CHAPS. In the 2’O-MTase reaction, 25 nM protein was mixed with 40 nM GpppA-
7mer RNA (Trilink), 320 nM [
3
H-methyl]-SAM in 50 mM Tris-HCl, pH 7.5, 10 mM 
KCl, 2 mM MgCl2, and 0.05% CHAPS. Buffer, RNA substrate, and enzyme were 
first mixed in a single well in a 96-well half- area, white opaque plates (Corning 
Costar, Acton, MA). The reaction was initiated by addition of [
3
H-methyl]-SAM. The 
N7- and 2’O-MTase reactions were incubated at RT for 15 min and 1 hr, respectively. 
The reaction was stopped with 25 μl of 2× stop solution (100 mM Tris/HCl, pH 7, 100 
mM EDTA, 600 mM NaCl, 4 mg/ml streptavidin–SPA beads and 62.5 μM cold 
AdoMet) and shaken for 20 min at 750 RT followed by centrifugation for 2 mins at 
1200rpm. The plate was read in a Trilux microbeta counter (PerkinElmer, Boston, 
MA) with a counting time of 1 min per well. All data points were measured in 
duplicate. 
2.11.2 NS5 polymerase in vitro assays 
The de novo initiation/elongation assay were performed as previously 
described (Lim et al., 2013b; Niyomrattanakit et al., 2010). Briefly, 100 nM DENV4 
NS5 was mixed with 100 nM in vitro transcribed DENV4 5´UTR-3´UTR RNA, 20 
μM ATP, 20 μM GTP, 20 μM UTP, and 5 μM Atto-CTP (Trilink Biotechnologies) in 
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a volume of 15 μl of the assay buffer (50 mM Tris-HCl, pH 7.5, 10 mM KCl, 1 mM 
MgCl2, 0.3 mM MnCl2, 0.001% Triton X-100 and 10 μM cysteine). The elongation 
assay reaction comprised 100 nM IVT 244 nt heteropolymeric RNA template, 
annealed with four primers (C1 primer 3’-AGTCAGTCAGTCAGTGT-biotin-5’, A1 
primer 3’-GTCAGTCAGTCAGTCTC-biotin-5’, G1 primer 3’-
TCAGTCAGTCAGTCACA-biotin-5’, T1 primer 3’-CAGTCAGTCAGTCAGAG-
biotin-5’) (Hung et al., 2002), 2 µM ATP, 2 µM GTP, 2 µM UTP, 0.5 µM Atto-CTP,  
and 100 nM of DENV4 NS5 in 15 µl in assay buffer (50 mM Tris-HCl at pH 7.5, 10 
mM KCl, 0.5 mM MnCl2, 0.01% Triton X-100, and 10 μM cysteine). RNA was 
separately pre-annealed with four primers at a ratio of 1:2 (w / w) by heating at 95 
o
C 
for 3 min, and cooled to RT before mixing and used for the assay. All reactions were 
allowed to proceed for up to 3 hrs at RT. At the indicated time-points, 10 μl of 2.5× 
STOP buffer (200 mM NaCl, 25 mM MgCl2, 1.5 M DEA, pH 10; Promega) with 25 
nM calf intestinal alkaline phosphatase (CIP; New England Biolabs) was added to the 
wells to terminate the reactions. The plate was shaken and centrifuged briefly at 1200 
rpm, followed by incubation at RT for 60 min and the released AttoPhos was 
monitored by reading on a Tecan Saffire II microplate reader at excitationmax and 
emissionmax wavelengths 422 nm and 566 nm respectively. All data points were 
measured in triplicate in 384-well black opaque plates (Corning). 
2.12 Functional studies of NS5 mutants in replicon (conducted in collaboration 
with Sherryl Soh from NTU and NITD) 
2.12.1 Generation of DENV4 NS5 mutant replicons 
The K95A, Y119A, R263A, E268A, E270A and R353A mutants in the 
DENV4 NS5 sequence (GenBank accession number AF326825) were engineered into 
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the subclone, pACYC-DENV4-F shuttle plasmid using the QuikChange II XL site-
directed mutagenesis kit (Stratagene) according to the manufacturer’s protocol. The 
list of primers used for cloning and mutagenesis is available in Table 2.5. The 
pACYC-DENV4-F shuttle plasmid plasmid contains nucleotides 7564-10653 (from 
NS3-3’UTR) of DENV4 MY01-22713 strain, followed by the Hepatitis D virus 
ribozyme (HDENVr) sequence at the 3’ end (Avis et al., 2012). The mutant plasmids 
were confirmed by automated DNA sequencing (1
st
 base, Singapore) and digested 
with NotI and KpnI. The PCR product comprising the sequence spanning nucleotides 
1-7563 under the control of the upstream T7 promoter were inserted. Within 1-7563, 
the region from nucleotides 217-2291 had been replaced by renilla luciferase and 
foot-and-mouth disease virus 2A protease cDNAs (Lim et al., 2011). 
2.12.2 In vitro transcription, RNA transfection, and renilla luciferase (RenLUC) 
measurements 
The WT and mutant replicon cDNA plasmids were linearized with s with 
XhoI, and linearized plasmids were subjected to in vitro transcription (IVT) using a 
T7 mMESSAGE mMACHINE kit according to the manufacturer’s protocol (Ambion; 
Austin, Texas, USA). 10ug of RNAs were electroporated into 8×10
6
 BHK-21 cells, 
and the transfected cells were re-suspended in 25 ml of DMEM medium with 10% 
FBS. 0.5 ml cell suspensions were seeded each well in a 12-well plate; and the cells 
were assayed for luciferase activities at 4, 24, 48, 72, and 96 h post-transfection. For 
each data point, duplicate wells were seeded. The RenLUC assay system was used to 













K95A For GTCCTATTACATGGCGACACTCGCAAACGTGACTGAAGTGAAAGGAT 
 Rev ATCCTTTCACTTCAGTCACGTTTGCGAGTGTCGCCATGTAATAGGAC 
   
Y119A For ATGAAGAACCAATCCCCATGGCTACTGCAGGCTGGAATTTGGTCA 
 Rev TGACCAAATTCCAGCCTGCAGTAGCCATGGGGATTGGTTCTTCAT 
   
R263A For GATCTTGGGGCAGGAACGGCAAGTGTCTCCACTGAAAC 
 Rev GTTTCAGTGGAGACACTTGCCGTTCCTGCCCCAAGATC 
   
E268A For CGAGAAGTGTCTCCACTGCAACAGAAAAACCAGACAT 
 Rev ATGTCTGGTTTTTCTGTTGCAGTGGAGACACTTCTCG 
   
E270A For GAAGTGTCTCCACTGAAACAGCAAAACCAGACATGACAATTAT 
 Rev ATAATTGTCATGTCTGGTTTTGCTGTTTCAGTGGAGACACTTC 
   
   
R353A For CAACCCCTTTTGGGCAACAAGCAGTGTTCAAGGAGAAGGT 
 Rev ACCTTCTCCTTGAACACTGCTTGTTGCCCAAAAGGGGTTG 
a
 Mutations generated using QuikChange II XL SDM kit.  
b
 Double mutation generated using QuikChange multi SDM kit.  
c





Chapter 3: Results and Discussion 
3.1 Identification and characterisation of NS5 specific monoclonal antibodies 
Given that NS5 resides at the heart of the flaviviral replication complex and 
plays a vital role in viral replication, well characterized anti-NS5 antibodies would be 
valuable tools for studying viral replication in detail and detecting DENV infected 
cells. However, there has been a lack of cross-reactive NS5 antibodies available for 
the DENV research, and for this reason much of the NS5 research to date has focused 
on DENV2 using DENV2 specific polyclonal antibodies (Kumar et al., 2013; Pryor et 
al., 2007). This has hindered studies to investigate serotype differences and how these 
impact on DENV pathogenesis. Thus in this work, phage antibody technology 
(Barbas et al., 1991; Hoogenboom et al., 1991; Moreland et al., 2010) was used to 
identify and characterize NS5 specific, human antibody fragments (Fab). Full-length 
NS5 from DENV1-4 was expressed and purified in a bacterial expression system and 
the cross-reactivity, binding affinities and epitopes of the Fabs were defined using 
these NS5 proteins. 
 
3.1.1 Expression and purification of NS5 proteins 
For this study, both MTase domain (typically 10-20 mg from one liter of 
bacterial culture) and RdRp domain (5-10 mg from one liter of bacterial culture) of 
DENV2 and DENV3 were purified using two-step purification as described 
previously (Kroschewski et al., 2008; Yap et al., 2007). Recombinant NS5FL proteins 
from DENV1-4 were also purified with yields ranging 1-2 mg from one liter of 
bacterial culture.  The proteins were first purified using IMAC before SDS-PAGE 
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analysis. Fractions containing the eluted proteins were pooled, concentrated and 
filtered before subjected to SEC, followed by SDS-PAGE analysis. Fractions 
containing the eluted proteins were pooled, concentrated and aliquoted before storage 
in -80°C. Figure 3.1.1 shows the schematic of the proteins constructed and purified 
for this study and aliquots (1 µg) of the purified protein (> 90% purity) were resolved 
by 12% SDS-PAGE.  
 
Figure 3.1.1 Recombinant DENV NS5 proteins constructed and purified. (A) 
Dengue polyprotein organization and the NS5 protein constructs used in this work. 
NS5FL from DENV1-4, MTase domain (aa 1-296) from DENV2 and DENV3, RdRp 
domain (aa 273-900) from DENV2 and DENV3. (B) Purified recombinant NS5 
constructs were resolved by 12% SDS-PAGE. Lane numbering corresponds with 
construct numbering in the schematic (3.1A).  Lanes 1-4 corresponds to full length 
NS5 protein from four DENV serotypes: lane 1, DENV 1 (EU081230.1); lane 2, 
DENV2 (M29095); lane 3, DENV3 (AY662691); and lane 4, DENV4 (GQ398256). 
Lane 5 is MTase domain from DENV2, lane 6 is RdRp domain from DENV2, lane 7 
is MTase from DENV3, and lane 8 is RdRp from DENV3.  
 
3.1.2 Fab phage display screening 
To get domain specific antibodies, the DENV3 MTase and RdRp domains 
were immobilized onto streptavidin magnetic beads after chemical biotinylation and 
used as bait for panning against a naïve human Fab-phage library as previously 
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described (Moreland et al., 2010). The panning process was done following the flow 
chart in Figure 3.1.2A. After four rounds of selection, six unique Fab-phage clones 
(5M2, 5M3, 5R1, 5R2, 5R4, and 5R5) were identified. The binding specificity of 
identified Fab-phage clones were confirmed by ELISA and the result showed two of 
them, 5M2 and 5M3 specifically recognize DENV3 MTase domain, and the rest 5R1, 
5R2, 5R4 and 5R5 were able to detect DENV3 RdRp domain (Figure 3.1.2B).  
To obtain Fabs that are cross-reactive with other serotypes of DENV NS5, 
biotinylated DENV3 MTase or RdRp were used for panning in the first and third 
round of selection, and DENV2 MTase or RdRp were used in the second and fourth 
round of selection. A total of 198 clones were screened by ELISA. Two unique clones, 
5M1 and 5R3 that showed cross-reactivity towards DENV 2 and 3 MTase (5M1 Fab), 
or DENV 2 and 3 RdRp (5R3 Fab) were identified (Figure 3.1.2C). 
Subsequently, the identified NS5 specific phage-Fabs were sequenced and 
analyzed with IMGT/V-QUEST (Table 3.1.1). All selected Fabs for MTase domain 
consist of variable heavy chain (VH) sequences belonging to VH3 family and variable 
light chain (VL) sequences belonging to Vλ6 family. While sequences of VH and VL 
for Fabs bound to Rdrp domain are derived from different gene families (VH1, VH3, 





Figure 3.1.2 Monoclonal antibody discovery workflow by phage display and 
unique Fab-phage clones specific to NS5 identified. (A) Workflow of phage display 
technique to screen monoclonal antibody. (B) Binding specificity of phage clones as 
measured by ELISA. Two unique Fab-Phage clones (5M2 and 5M3) were shown to 
bind DENV3 MTase, and the rest (5R1, 5R2, 5R4, and 5R5) were confirmed to bind 
DENV3 RdRp. (C) An ELISA with Cross-reactive antibodies 5M1 and 5R3 identified. 




Table 3.1.1 Sequence analysis and variable gene usage of anti-NS5 Fab. Shown 
are the complementary determining region 3 (CDR3) and variable gene family 





3.1.3  Characterization of NS5-specific monoclonal antibody 
In order to further characterize the unique phage clones identified above they 
were expressed as recombinant Fabs with histidine and c-myc tag in E.coli Top 10F’ 
cells and were purified from periplasmic space by IMAC as previously reported 
(Moreland et al., 2010). Typically about 1-2 mg of the recombinant antibodies in Fab 
form were purified from one liter of bacterial expression culture. Three Fabs (5M1, 
5R3 and 5M3) were characterized by western blot and ELISA, and also their binding 
epitopes were mapped by combination of western blot, peptide competition ELISA 
and peptide phage display methods. Furthermore the binding affinities of the two 
cross-reactive antibodies were measured in real-time using SPR.  
 
3.1.3.1 Characterization of 5M1 Fab 
5M1 antibody was obtained by alternative panning against MTase domain 
from DENV3 and DENV2. Thus the Western blotting of 5M1 showed it could detect 
NS5FL from all four serotypes as well as MTase domains of DENV 2 and 3 that were 
tested (Figure 3.1.3A). Also NS5 from DENV 1-4 infected Huh-7 cell lysates that 
were separated by SDS-PAGE and western blotted were detected by 5M1 (Figure 
3.1.3B). This indicates 5M1 recognizes a linear or continuous amino sequence in 
MTase domain of DENV NS5 protein that is conserved among four serotypes.  
An ELISA with a two-fold serial dilution of 5M1 Fab (ranging from 0 to1µM) 
showed 5M1 gave a concentration-dependent binding towards all four serotypes of 
NS5FL protein coated (Figure 3.1.3C), which further confirmed that 5M1 cross-
reacts with NS5 protein of the serotypes. 
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To measure the binding affinities of 5M1, SPR experiment in real time was 
carried out on ProteOn XPR 36 instrument (BioRad). DENV1-4 NS5 proteins were 
immobilized on a GLC sensor chip, and kinetics studies were performed using 5M1 
Fab concentrations ranging from 6.17 nM to 500 nM (Figure 3.3D). Table 3.1.2 
summarizes the binding affinities of the 5M1 to NS5 proteins. 5M1 had the highest 
affinity to DENV3 NS5 (33 nM) and lowest affinity to DENV4 NS5 (456 nM). 
To determine the binding sites for 5M1, peptide competition ELISA were 
performed using overlapping 15-mer synthetic peptides covering DENV2 NS5FL 
protein (178 peptides in total). In Figure 3.1.3E, the pre-incubation of 5M1 with the 
MTase domain in solution resulted in the reduction of binding of 5M1 to the coated 
MTase protein in the competitive ELISA. Similarly, peptide corresponding to residues 
6-20 also competed with 5M1 binding site. Also a positive phage clones with 
sequence DAQWKSKLNNWR identified from peptide phage display aligned well 
with residues 6-20 (identical residues were underlined). Thus 5M1 binding epitope in 
MTase domain was mapped and shown in Figure 3.1.3F. The sequence alignment of 






Figure 3.1.3 Characterization of 5M1 Fab. (A) Western blot of NS5 proteins 
(200ng of each, lane numbering follows that in Figure 3.1B) probed by 5M1 Fab, 
indicating 5M1 cross-reacts to a linear epitope of NS5 present in MTase domain. (B) 
Western blot of dengue infected Huh-7 cell lysate probed by 5M1. All four serotypes 
of NS5 can be detected. (C) ELISA with 5M1 Fab (0-1000 nM) against 4 DENV NS5. 
(D) Kinetic analysis of 5M1 at 6.17-500 nM using SPR (Black). Aligned and 
background-subtracted responses were fit to 1:1 binding model (Red). (E) Peptide 
competition ELISA for mapping 5M1epitope, peptide 6-20 showed complete 
competition for 5M1 binding to DENV3 MTase. (F) Crystal structure of MTase 
(3P97) is shown in cartoon representation and 5M1 epitope is colored red.  
 
 
Table 3.1.2 Summary of resultant kinetic constants and binding affinities for 







3.1.3.2 Characterization of 5R3 Fab 
5R3 antibody was obtained by alternative panning against RdRp domain from 
DENV3 and DENV2. By western blotting, 5R3 Fab failed to detect any purified NS5 
or NS5 from dengue infected Huh-7 cell lysate (Figure 3.1.4A). However, when 5R3 
was used in dot blot, it can detect the native RdRp from both DENV2 and DENV3, 
rather than boiled RdRp (Figure 3.1.4B), which suggests the binding site for 5R3 Fab 
could be a conformational epitope.  
The ELISA of 5R3 Fab (0-1µM) in two-fold serial dilution displayed similar 
concentration-dependent binding curve towards all four serotypes of NS5FL protein 
coated (Figure 3.1.4C). Thus it confirmed the cross-reactivity of 5R3 Fab against 
NS5. 
Kinetics studies of SPR on 5R3 was also performed using concentrations 
ranging from 6.17 nM to 500 nM against NS5FL proteins coated on GLC-chip to 
obtain its binding affinities (Figure 3.1.4D). Table 3.1.3 gives a summary of the 
binding affinities of the 5R3 to NS5 proteins. 5R3 was shown to bind DENV3 NS5 
with the highest affinity (KD of 5.19 nM) compared to the rest [DENV1 NS5 (55.3 
nM), DENV2 NS5 (146 nM), and DENV4 NS5 (224 nM)].  
Similar to 5M1, the binding site for 5R3 was mapped by peptide competition 
ELISA. The pre-incubation of the overlapping peptides spanning RdRp domain 
showed that the peptide corresponding to NS5 residues 786-800 strongly reduced the 
5R3 binding to the coated RdRp while the remaining peptides showed no competition 
(Figure 3.1.4E). Thus the 5R3 epitope can be mapped to residues 786-800 in NS5 
protein, which corresponds to part of the priming loop (782-809) of RdRp. The 5R3 
epitope (green) was shown on the surface of RdRp in Figure 3.1.4F. Priming loop 
occludes the active site and regulates dsRNA template access and exit into the 
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polymerase active site. Consistent with the observed cross-reactivity of 5R3, the 
amino acid sequence alignment of the region shows that aa 786-800 is completely 
conserved amongst the four serotypes.  
 
 
Figure 3.1.4 Characterization of 5R3 Fab. (A) Western blot of dengue infected 
Huh-7 cell lysate probed by 5R3. NS5 cannot be detected. (B) Dot blot of native and 
boiled RdRp protein from DENV2 and 3 (1.5μg of each) probed by 5R3 Fab, 5R3 
could detect RdRp in native form. (C) An ELISA with serial dilutions of 5R3 Fab 
confirms its cross-reactivity against four serotypes of NS5FL. (D) Kinetic analysis of 
5R3 at 6.17-500 nM using SPR (Black). Aligned and background-subtracted 
responses were fit to a 1:1 binding model (Red). (E) Peptide competition ELISA for 
mapping 5R3 epitope, peptide covering residues 786-800 compete with 5R3 binding 
to D2 RdRp. (F) Residues compromising 5R3 epitope from four DENV NS5 are 
aligned and residues are colored in green. Crystal structure of RdRp (2J7U) is 
rendered in surface representation and 5R3 epitope is shown in green. 
 
 
Table 3.1.3 Summary of resultant Kinetic constants and binding affinities for 




3.1.3.3 Characterization of 5M3 Fab 
5M3 was shown to recognize DENV3 specific NS5FL and MTase from 
western blot (Figure 3.1.5A). And in Figure 3.1.5B, an ELISA with serial dilution of 
5M3 (0-2µM) showed DENV3 specific antibody 5M3 also gave a concentration-
dependence binding curve towards DENV3 NS5FL. 
Since 5M3 recognized DENV3 specific MTase, the epitope mapping was done 
using truncated fragments of DENV3 MTase and western blotting. Seven of the nine 
constructs were over expressed in E.coli and were able to be detected by anti-His 
antibody from crude bacterial lysate after induction, while MTase1-54 and MTase1-
104 failed to be detected, probably due to inappropriate truncation, mis-folding or 
susceptibility to protease attack (Figure 3.1.5C). 5M3 can only detect four expressed 
fragments with truncation from C-terminal of MTase (Figure 3.1.5D). A schematic 
representation of the truncated fragments used and the western blotting results were 
summarized in Figure 3.1.5E. Failure of 5M3 to detect N-terminally truncated 
fragments including MTase55-272, MTase105-272, and MTase152-272 indicates 
5M3 recognizes a linear epitope located in the first 54 residues of MTase.  
Phage peptide screening using the Ph.D-12 random dodecapeptide library was 
also employed for mapping 5M3 epitope. Peptide inserts obtained after four rounds of 
panning were sequenced. One of the twenty sequenced clones showed affinity for 
5M3 in a phage ELISA and it displayed sequence similarity to residues 19-29 of 
DENV3 MTase1-54. The sequence identified was RPTRKNTDLRYR and residues 
underlined were identical to DENV3 MTase, while these same residues are not 
present in MTase from other serotypes of DENV NS5, which explains the serotype 
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specificity of 5M3 to DENV3 MTase. The epitope for 5M3 is shown in magenta in 
Figure 3.1.5F.  
 
Figure 3.1.5 Characterization of 5M3 Fab. (A) Western blot of NS5 proteins 
(200ng of each) probed by 5M3 Fab, 5M3 recognizes a linear epitope present in 
MTase domain specific to DENV3 NS5. (B) An ELISA with serial dilutions of 5M3 
Fab against DENV3 NS5. (C) E.coli cell lysate for expression of MTase truncates 
probed by anti-His antibody. (D) E.coli cell lysate for expression of MTase truncates 
probed by 5M3 antibody. (E) Schematic representation of mapping 5M3 binding site 
by using N-and C-terminally truncated DENV3 MTase in western blot. (*) indicates 
constructs did not expressed. (F) Crystal structure of MTase (3P97) is rendered in 
surface representation and 5M3 epitope (residues 19-29) is colored magenta).  
 
3.1.4 Summary 
In this work, we expressed full-length NS5 from four DENV serotypes and 
carried out panning against a naïve human phage library. Our panning and detection 
strategy yielded 8 candidate antibodies specific for NS5. Three of antibodies bind 
specifically to the NS5 MTase domain (5M1, 5M2 and 5M3), and the other five show 
specificity to RdRp domain (5R1, 5R2, 5R3, 5R4, and 5R5). Cross reactive antibody 
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5M1 recognizes the linear epitope region present in the first alpha helix (residues 6-20) 
of MTase domain, and 5R3 cross-reacts to NS5 of four serotypes through binding to 
residues 786-800 in the native conformation. 5R3 had relative higher binding affinity 
to all serotypes of NS5 compared to 5M1 antibody, and it can be used for pull down 
NS5 protein and its interaction partners from dengue infected cells to identify the 
components of replication complex. Another antibody 5M3 binds specifically to NS5 
from DENV3, and the epitope for 5M3 has been mapped to residues 19-29 of MTase. 
The two cross-reactive, NS5 specific antibody fragments identified in this study (5M1 
and 5R3) have been converted into full-length human IgG and expressed in HEK293T 
cells as previously described (Moreland et al., 2012). These IgGs have enabled the 
kinetics of NS5 nuclear localisation to be compared between all four DENV serotypes 
for the first time (Tay et al., 2013).Figure 3.1.6. Studies are currently underway in 
which these IgG are used to pull-down NS5 and its interaction partners from DENV 
infected cells to identify the components of DENV replication complex across 
serotypes. Further application of these epitope-mapped NS5 specific monoclonal 
antibodies could provide significant insight into the replication complex and help 




Figure 3.1.6 NS5 from DENV1-4 exhibits differential subcellular localization. 
Huh-7 cells were mock-infected or infected with DENV1-4 [DENV1 (EU081230), 
DENV2 (EU081177), DENV3 (EU081190) and DENV4 (GQ398256)] at an MOI of 
10 and fixed at 24h p.i., and anti-NS5 and -envelope (not shown) antibodies used for 
immunostaining. Images were captured by confocal laser scanning microscopy 












3.2 Crystal structure of full length NS5 from DENV3 
Being the largest and most conserved flaviviral protein, the multifunctional 
protein NS5 is the critical catalytic subunit of replication complex and harbours both 
methyltransferase at N-terminal (aa 1-262) and polymerase activities at C-terminal (aa 
273-900) essential for viral replication. A ten residue linker (aa 263-272) physically 
connects the two domains, and is prone to be cleaved by bacterial proteases when 
NS5FL is expressed. The difficulty to obtain sufficient amount of full length NS5 
protein in good quality has been a limitation in its functional and structural studies.  
To get around this limitation, most of the research on NS5 has been carried out on the 
two separate domains. However, the relative spatial arrangements of two domains as 
well as the potential cross-talk between the two domains remain elusive. Thus the 
three dimensional structure of NS5FL may provide new insight into the mechanism 
behind the coupled RNA capping and RNA replication functions which can be 
valuable for structure-based design of anti-dengue drugs. 
 
3.2.1 Purification of NS5FL-Fab complex for crystallization 
The strategy of using antibody as chaperone to facilitate protein crystallization 
has been well recognised (Griffin and Lawson, 2011). In general, antibodies can assist 
in structural studies by (1) using its solubility and decent specificity to effectively 
transform aggregated protein into soluble form,  (2) acting as a molecular clamp that 
immobilize a region of the protein to reduce protein flexibility to enhance conformational 




3.2.1.1 Complex formation 
With those well-characterized NS5 specific monoclonal antibodies reported in 
Chapter 3.1, we set out to co-purify and co-crystallize of NS5FL in the presence of 
Fab. Size exclusion chromatography (SEC) was used to examine the formation of 
stable complexes based on the rationale that the Fab-protein complex elutes earlier 
than either Fab or protein alone. Then we screened purified Fabs for their ability to 
form stable complex with NS5FL protein by SEC (Figure 3.2.1). In Figure 3.2.1A, 
D3RdRp alone eluted at 15.31 ml, while 5R3 Fab eluted at 16.11ml. SEC of the 
D3RdRp and 5R3 mixture (at 1:1 molar ratio) showed two proteins co-eluted from 
column with elution volume of 15.44ml, rather than forming protein complex. In 
contrast, a stable 5M3-MTase complex was formed and eluted (14.21) earlier than 
either MTase (21.27ml) or 5M3 Fab (15.69ml) alone (Figure 3.2.1B). Fractions 
corresponding to each peak were collected and analyzed by 12% SDS-PAGE (Figure 
3.2.1C), and it confirmed the presence of both MTase and 5M3 Fab (lane 
corresponding to the pink arrow) in samples from the first peak (indicated with pink 
arrow) and thus suggesting the formation of stable protein-Fab complex. Fab antibody 
is composed of a heavy chain (about 28kDa) and a light chain (about25kDa), which 
are connected through disulfide bonds, thus under reducing and denaturing condition 
(loading dye with DTT and SDS), it runs as two bands of an equal sign on the SDS-
PAGE (Figure 3.2.1C, cyan arrow) . Next, DENV3 NS5FL-5M3 complex was 
purified after incubation NS5 with 5M3 Fab at molar ratio of 1:2 for overnight at 4°C 
(Figure 3.2.1D). Peak one containing both NS5FL and 5M3 Fab was observed by 12% 





Figure 3.2.1 Screening and purification of NS5-Fab protein complex by size 
exclusion chromatography. (A) Profile for RdRp, 5R3 and mixture of RdRp and 
5R3. D3RdRp alone eluted at 15.31 ml, while 5R3 Fab eluted at 16.11ml. Mixture 
eluted at 15.44ml, which was in between individual protein alone. (B) Profile for 
MTase, 5M3 and mixture of MTase and 5M3. D3MTase alone eluted at 21.27 ml, 
while 5M3 Fab eluted at 15.69ml. Mixture eluted at 14.21ml, which was ahead of 
individual protein alone. (C) Fractions from Figure 4.1B were resolved on12% SDS-
PAGE. Arrows were coloured correspondingly. (D) SEC chromatogram of DENV3 
NS5FL protein and 5M3 Fab mixture, which were pre-incubated at 4°C for one hour. 
(E) 12% SDS-PAGE of samples from peak 1 and 2 separated by gel filtration. Peak 1 
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contains both NS5FL and 5M3, indicating a complex of DENV3 NS5FL-5M3 
complex formed and purified; peak 2 corresponds to the excess 5M3. 
 
3.2.1.2 Solution study of NS5FL-5M3 complex by small angle X-ray scattering 
(SAXS) 
The purified NS5FL-5M3 complexes were used to set up crystallization 
screening. However, no crystal hits were observed even after six months. Therefore, 
the purified MTase-5M3 complex, NS5FL, and NS5FL-5M3 complex were subjected 
to SAXS study to obtain a low resolution, 3D molecular envelope of NS5 protein in 
solution (Blanchet and Svergun, 2013). Of the three samples, NS5FL-5M3 complex 
was shown to be polydispersed from scattering profile and dynamic light scattering 
though it eluted from SEC as a single peak and thus discontinued from further 
analysis. The experimental scattering pattern MTase-5M3 complex is presented as 
green dots in Figure 3.2.2A. The linearity of the Guinier plots at low angles 
suggested that MTase-5M3 complex were monodispersed and not aggregated in 
solution (Figure 3.2.2B) and the program CRYSOL was used to calculate the 
theoretical scattering profile after a quaternary structure modeled with MTase (3P97) 
and Fab (1F90) using program SASREF. The SAXS profile calculated from the 
model was shown to agree with experimental solution data (red line in Figure 3.2.2A).  
Similarly, the NS5FL model was built based on available crystallographic 
structures of MTase (3P97) and RdRp (2J7U) using program SASREF. The gross 
NS5FL shape and the SAXS profile calculated from the model (blue line in Figure 
3.2.2C) were shown to agree with experimental solution data (red dots in Figure 
3.2.2C). Also the linearity of Guinier plots for NS5FL indicated the non-aggregated 
and mono-disperse samples at 1mg/ml (Figure 3.2.2D). The averaged model from 
individual reconstructions was superimposed on the crystallographic structures of two 
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domains (MTase, 3P97 (aa1-262); RdRp, 2J7U (272-900)) using a distance restriction 
(1.0-2.5nm) that mimics the 10-residue linker (Figure 3.2.2E). Conformational 
flexibility of NS5FL in solution was also accessed as previously published (Bussetta 
and Choi, 2012) with program EOM (Ensemble Optimization Method). Interestingly a 
sub-ensemble of models that best fits the experimental data from the random 
ensemble shows a distribution of Rg range from 31.8 to 38.2 Å, which is much tighter 
compared to the solution status of NS51-878 reported, thus it indicates most our NS5FL 
are in compact conformation (Figure 3.2.2F). In these models, potential intra-
molecular interactions were also identified according to proximity, which consist 
residues 94-99 (LKKVTE) from MTase domain and residues 294-297 (DDEN) from 






Figure 3.2.2 Solution structure of NS5. (A) Experimental SAXS profile from 
MTase/5M3 complex (red dots) and theoretical scattering curve calculated with 
MTase (3P97) and Fab (1F90) (computed by use of SASREF CRYSOL program). (B) 
Guinier plot for MTase/5M3 complex scattered intensities. The slop is linear in the 
Guinier region. (C) Experimental scattering patterns for NS5FL (1-900) (Red dots) 
and theoretical scattering profile for NS5FL calculated with MTase (3P97) and RdRp 
(2J7U) (blue line). (D) Guinier plot for NS5FL scattering intensities. (E) Two Views 
of one reconstituted NS5FL structures in the selected pool. MTase domain is shown in 
green and RdRp domain is shown in magenta. (F) EOM analysis of NS5FL structures: 
random pool (red) and selected pool (green). 
3.2.2 Purification of NS56-895 for crystallization 
By performing structure alignment of the available structures for DENV 
MTase and RdRp, we identified that residues 1-5 from MTase domain and residues 
883-900 from RdRp domain were absent due to their flexibility. Thus we designed 
several truncated constructs of NS5 from all four serotypes. Of them, DENV3 NS56-
895 with five amino acids deletion at both N- and C- termini gave crystal hits after 
extensive robotic crystallization trials. Small rhomboidal shaped crystals were 





: 0.1M Sodium Cacodylate pH6.5, 18% PEG 8000, 0.2M Magnesium 
acetate; (2) Crystal Screen HR2-110, Hampton Research, 46
th
: 0.1M Sodium 
Cacodylate pH6.5, 18% PEG 8000, 0.2M Calcium acetate; (3) PEG/Ion Screen, HR2-
126, Hampton Research, 20
th
: 0.2M Magnesium formate, pH7.0, 20% PEG 3350; (4) 
Index screen HR2-144, Hampton Research, 55
th
: 0.05M Magnesium Chloride, 0.1M 
Hepes pH7.5, 30% PEG MME 550. Crystals were inspected with ultraviolet (UV) 
imaging to distinguish protein crystals from salt crystals, and results turned out that all 
crystal hits were protein crystal (Figure 3.2.3).  Larger crystals of rhombus or 
trapezoid shape were obtained over 2-5 days by mixing a volume of 1µl NS5 at 4-
6mg/ml with 1µl of precipitation solution: (1) 0.1M Sodium Cacodylate pH6.4, 10-20% 
PEG 8000, 0.2M Magnesium acetate; (2) 0.1M Sodium Cacodylate pH6.4, 10-20% 
PEG 8000, 0.2M Calcium acetate; or (3) 0.2M Magnesium formate, pH7.0, 15-25% 
PEG 3350. 
 
Figure 3.2.3 Typical crystals obtained during initial crystal screening. (A) Crystal 
Screen HR2-110, Hampton Research, 46
th
 condition: 0.1M Sodium Cacodylate pH6.5, 
18% PEG 8000, 0.2M Calcium acetate. Upper: white light, lower: UV light. (B) 
PEG/Ion Screen, HR2-126, Hampton Research, 20
th
: 0.2M Magnesium formate, 
pH7.0, 20% PEG 3350. Upper: white light, lower: UV light. (C) Index screen HR2-
144, Hampton Research, 55
th
: 0.05M Magnesium Chloride, 0.1M Hepes pH7.5, 30% 
PEG MME 550. Upper: white light, lower: UV light. 
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3.2.3 Overall structure of NS56-895 from DENV3 
We crystallized the full length NS5 protein from DENV3 and determined its 
crystal structure at 2.3 Å resolution, bound to SAH (NS5-SAH), which was copurified 
with NS5 from E.coli, and also in the presence of GTP (NS5-SAH-GTP). A summary 
of the crystallographic data collection and refinement statistics is shown in Table 
3.2.2 and Table 3.2.3. The overall conformation of NS5 in the crystal structure for 
NS5-GTP-SAH complex is same as NS5-SAH structure. The root mean square 
deviation (r.m.s.d.) is 0.17 Å for a total of 719 Cα atoms superimposed. A total 
number of 854 residues are visible in the refined electron density map, including 
residues for inter-domain linker aa 262-273. Residues within regions of 406 -417 and 
455-468, and thirteen residues at the C-terminus of NS5 are missing from the refined 
model. A cartoon representation of NS56-895 is shown in Figure 3.2.4. The NS56-895 
from DENV3 adopts a compact shape with approximate overall dimensions of 87 Å × 
72 Å × 55 Å. The N-terminal MTase domain resides on top of the fingers subdomain 
and attached to the backside of RdRp domain, near the proposed NTP entry site 
(Figure 3.2.4). At this conformation, not only the functional sites for MTase domain, 
the K61-D146-K180-E216 catalytic tetrad, the GTP-binding pocket and the cofactor SAH-
biding site locate far away from the inter-domain interface, but also the functional 
sites for RdRp domain, including RNA template tunnel, the NTP entrance and the 
G662-D663-D664 catalytic motif remain accessible. The main contacts realized between 
MTase domain and RdRp domain are boxed in Figure4.4B, and will be described and 




Figure 3.2.4 Global view of DENV3 NS5 structure in cartoon representation. 
Structure of NS5 is shown in orientation. (A) Front view by looking into the RNA 
template tunnel of RdRp domain. (B) Top view by looking from the top of RdRp 
domain, and (C) Bottom view which is rotated by 180° around a vertical axis as in (B). 
MTase is in yellow, RdRp fingers in green, palm in blue, thumb in salmon. The linker 
helix (residues 263-267) between the two domains is in orange. GTP and co-factor 




Table 3.2.2 Data collection statistics for NS5 and NS5-GTP. 
Parameters NS5-SAH NS5-SAH-GTP 
Wavelength (Å)   
Resolution range (Å) 39.18 - 2.30 (2.39 - 2.30)* 29.88 - 2.40 (2.50 - 2.40) 
Space group P 21212 P 21212 








No. of observed reflections 142,366 (12,688) 230,234 (26,360) 
No. of unique reflections 41,247 (4,050) 39,648 (4,402) 
Multiplicity 3.5 (3.1) 5.8 (6.0) 
Completeness (%) 91.8 (86.8) 99.75 (99.95) 
Mean I/sigma(I) 9.5 (2.6) 11.2 (3.5) 
R-merge 0.077 (0.333) 0.115 (0.500) 
*The numbers in parentheses refers to the last (highest) resolution shell. 
 
Table 3.2.3 Refinement statistics for NS5 and NS5-GTP. 
Parameters NS5-SAH NS5-SAH-GTP 
R-work 0.191 (0.266) * 0.188 (0.210) 
R-free 0.246 (0.337) 0.237 (0.280) 
Number of non-hydrogen atoms 7,168 7,332 
  macromolecules 6,859 6,875 
  ligands 32 51 
  water 277 406 
Protein residues 854 854 
RMS(bonds, Å) 0.004 0.004 
RMS(angles, °) 0.80 0.83 
Ramachandran plot (%)   
favored  96.45 96.34 
allowed   3.31 3.31 
outliers 0.24 0.35 
Clash score 4.91 7.22 
Average B-factor 39.30 42.00 
  macromolecules 39.30 42.10 
  ligands 45.00 60.50 
  solvent 37.40 38.40 




3.2.3.1 N-terminal MTase domain 
The DENV3 MTase domain from the NS56-895 molecule retains the same 
conformation with the corresponding isolated domain from other flaviviruses: 
DENV2 (1L9K), DENV3 (3P97), WNV (2OY0), MVEV (2PX2), Wesselsbron Virus 
(3ELU), YFV (3EVA), Yokose (3GCZ) and Modoc virus (2WA2) (Table 3.2.4). 
Structural variations are mainly limited to both N-termianl (aa 6-10) and C-terminal 
(aa 255-262) of MTase domain, and the fragment of aa 245-250. These regions are 
lack of secondary structural and more exposed to solvent (Figure 3.2.5A). 
Superposition with MTase domain from DENV3 (Lim et al., 2011) and DENV2 
(Egloff et al., 2002) returns RMSD values of 0.42 Å (for 221 Cα) and 0.40 Å (for 219 
Cα) respectively. Thus the presence of RdRp domain does not affect the folding of 
MTase domain into an active catalytic subunit.  In the MTase domain, catalytic triad 
(K61-D146-K180-E216 motif) appears to adopt the same orientation and an AdoHcy 
(SAH) molecule, which is co-purified with NS5 from E.coli, resides in the cofactor-
binding pocket, and is stabilized by a network of hydrogen bonds and van der Waals 
contacts to specific residues, which is essentially identical to those MTase-SAM/SAH 
complex structures reported earlier (Benarroch et al., 2004; Egloff et al., 2002; Egloff 
et al., 2007) (Figure 3.2.5B and 3.2.5C). A strong electron density for GTP molecule 
in the putative GTP-binding pocket of MTase domain was also found in NS5-SAH-
GTP complex structure.  It is stabilized by base stacking with the aromatic ring of F25 
and electrostatic interactions with residues L17, N18, and L20 (Figure 3.2.5D), which 




Figure 3.2.5 Structure of MTase domain in NS5. (A) Structure alignment of MTase 
domain from NS56-895 (in Cartoon representation, red) with other flaviviral MTase 
domain (in ribbon representation). 1L9K (DENV2 green), 3P97 (DENV3 tint), 2OY0 
(WNV magentas), 2PX2 (MVEV cyan), 3ELU (Wesselsbron Virus blue), 3EVA 
(YFV yellow), 3GCZ (Yokose virus gray), 2WA2 (Modoc virus orange). (B) The 
final electron density maps of SAH with Fourier coefficients |2Fobs-Fcalc| are 
contoured at 1.0 σ (blue). (C) Amino acids involved in SAH binding are numbered 
and colored in gray, blue, and red for C, N, and O, respectively. (D) The final electron 
density maps of GTP-Mg2+ with Fourier coefficients |2Fobs-Fcalc| are contoured at 
1.0 σ (blue). Residues involved in GTP binding is shown in stick and labelled.  
 
3.2.3.2 C-terminal RdRp domain 
Likewise, RdRp domain from the DENV3 NS56-895 molecule can superpose 
well with the isolated RdRp domain from DENV3 2J7U (RMSD values of 0.47 Å for 
492 Cα) and 4C11 (0.43Å for 495 Cα atoms). Besides DENV3, two RdRp domains 
from other flaviviruses were available: WNV (2HCN) and JEV (4MTP, 4HDG, 
4HDH) (Table 3.2.4) (Figure 3.2.6A). G motif (aa 406-417 in DENV3 NS5), which 
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regulate access of the ssRNA substrate to the template tunnel (Yap et al., 2007), is 
missing from the RdRp domain strucrures for DENV3 (2J7U, 4C11), WNV (2HCN) 
and JEV in apo form (4MTP), while it is well resolved for JEV RdRp with ATP 
(4HDH) or GTP (4HDG) (Figure 3.2.6B).  F motif (aa 455-468 in DENV3 NS5), 
which was proposed to bind Stem Loop A of 5’UTR of flaviviral genome, the viral 
promoter, prior to viral RNA replication (Iglesias et al., 2011), is also missing for 
DENV3 and WNV. However, in the JEV RdRp structures, it folds into a pair of anti-
parallel β-strands with connecting loop. Interestingly, the connection loop adopts 
different conformations for the JEV RdRp in apo form and GTP/ATP-bound form 
(Figure 3.2.6C), which was suspected to be pre-initiation conformation for JEV 





Figure 3.2.6 Structure of RdRp domain in NS5. (A) Structure alignment of RdRp 
domain from NS56-895 (in Cartoon representation, red) with other flaviviral MTase 
domain (in ribbon representation). 4C11 (DENV3 magentas), 2J7U (DENV3 yellow), 
2HCN (WNV, blue), 4MPT (JEV green), 4HDH (JEV cyan), 4HDG (JEV orange). (B) 
Comparison of G motif structures. (C) Comparison of F motif structures. 
 






3.2.3.3 GTP stabilization effect of DENV3 NS5 
Previous studies with isolated domains of NS5 protein successfully 
crystallized MTase-GTP, RdRp-GTP or RdRp-ATP: electron density for GTP in 
DENV2 MTase domain (Egloff et al., 2002; Egloff et al., 2007), the triphosphate (tP) 
moieties of 3’dGTP near the priming loop in DENV3 RdRP domain (Yap et al., 2007), 
and GTP or ATP in JEV RdRP domain (Surana et al., 2014) were observed. While in 
our NS5-SAH-GTP complex structure, we observed GTP occupancy of the GTP-
binding site in MTase domain only, the RdRP domain was devoid of any density for 
the presence of GTP. To investigate the effect of GTP and its various analogues on 
NS5 proteins, we performed the thermoshift assay with DENV3 NS5, as well as 
isolated MTase and RdRP domains. Thermal stability of DENV3 NS5 protein 
increases significantly in the presence of all guanine moiety containing ligands from 
37.2°C (protein only) to a temperature between 38.2°C (at 0.6mM capped GG) and 
39.2°C (at 0.6mM GTP). While ATP has only mild effect on the heat stability of 
DENV3 NS5, displaying only a slight increase in Tm to 37.5°C. Among those ligands 
containing guanine moiety, the stabilization effects were ranked in the order of 
GTP >= ppGpp > GDP > pGp >= GMP= capped GG (Figure 3.2.7A). Similarly, 
DENV3 MTase is also stabilized by those guanine moieties containing ligands and 
displayed similar pattern of stabilization effect (Figure 3.2.7B). Interestingly, all 
ligands tested exert little or no effect on the thermal stability of DENV3 RdRp 
(Figure 3.2.7C). This is consistent with our NS5-SAH-GTP complex structure where 
only one GTP was observed in the GTP-binding pocket in MTase domain, rather than 
in the RdRp domain. GTP-stabilizing effect and its specificity towards NS5 can be 
explained structurally in Figure 3.2.5D: (1) residues L17, N18, L20 specifically 
recognize 2-amino group of guanine through electrostatic interactions, thus ensuring 
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selectivity of GTP over ATP; and aromatic ring of F25 forms base stacking with the 
guanine ring; and (3) positively charged residues K29 and R211interact with β-
phosphate group of GTP. 
 
Figure 3.2.7: Melting temperature of NS5 proteins upon ligand binding from 




3.2.4 Cross-talking between MTase and RdRp domains 
As shown in Figure 3.2.4, we observed unique inter-domain interfaces for 
DENV3 NS5 structure, that is comprised of two contact areas involving linker 
residues (267-269), the fingers subdomain from the RdRp and three segments 
(residues 63-69, 95-96 and 252-256) from the MTase domain (Figure 3.2.8A and 
Figure 3.2.8B). Residues involved in stabilizing the interface are summarized in 
Table 3.2.5. In the first cluster, two linker residues E267 and E269 mediate inter-
domain crosstalk through several polar interactions: (1) the side chain of E267 forms 
two hydrogen bonds with MTase domain via residues Y119 and R262; and (2) the 
side chain of residue E269 and main chain carbonyl group of E267 form salt bridges 
and hydrogen bonds with the guanidinium group of R361 from the RdRp domain. 
Meanwhile, MTase domain directly interacts with RdRp domain through the 
following residues: (1) the side chain NH3
+
 group of residue K95 acts as hydrogen 
donor and forms two hydrogen bonds with OD1 of N297 and OH of Y299, and (2) 
K96 interacts with E296 throug a hydrogen bond and a salt bridge (Figure 3.2.8A). 
On the other hand, residues from helix α5 (residues F348-K357), which belongs to the 
evolutionarily conserved bNLS motif (Malet et al., 2007; Yap et al., 2007)of the 
RdRp domain constitute the centre of the second cluster interactions. Projecting from 
helix α5, the guanidinium side chain of residue R352 plays a central role: (1) R352 
forms two hydrogen bonds and four salt bridges with E67; (2) R352 interacts with 
side chain of Q67 through a salt bride; and (3) R352 interacts with E252 through two 
hydrogen bonds and two salt bridges.  Besides, there are also polar interactions 
formed between D256-K357 pair: one salt bridge and one hydrogen bond. Different 
from the hydrophobic interface between MTase and RdRp domains of NS5 from JEV, 
the interface of NS5 from DENV3 mainly comprises charged residues and the only 
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hydrophobic contacts are formed between W64, 568, F348 and P582 through base 
stacking (Figure 3.2.8B).  
 
 
Figure 3.2.8 Close-up views of the interface between the MTase domain and 
RdRp domain as indicated in Figure 4.4B. (A) The first cluster interactions. (B) 
The second cluster interactions.  Key residues for inter-domain interactions are shown 
as sticks and labelled.  
 
Table 3.2.5 Pairs of residues from MTase and RdRp that are involved in inter-
domain interactions. 














W64/R68/F348/P582 Hydrophobic interactions 
*HB: Hydrogen bond; SB: Salt bridge. 
 
3.2.4.1  Effect of the interface mutants on in vitro enzymatic activities of NS5 
We assessed whether residues involved in inter-domain interactions are 













 in the context of the DENV4 
NS5FL protein. And the in vitro polymerase and MTase activities of these mutant 
proteins were compared against WT protein (Figure 3.2.9, Table 3.2.6).  
Firstly all mutant proteins were constructed, expressed and purified following 
same procedure as WT NS5 protein. The purified mutant proteins showed similar 
melting temperature (Tm) determined by thermofluoresence assay as compared with 
WT, suggesting proper folding of the mutant proteins.  
The polymerase activities were assessed by both the de novo 
initiation/elongation assay and the elongation assay as reported (Lim et al., 2013a). 
The former uses the viral UTR sequence as template to start a new RNA chain while 
the latter employs a heteropolymeric RNA template annealed with four primers, 
which is extended during the course of the assay (Lim et al., 2013b; Niyomrattanakit 
et al., 2010). 
Of those mutants, K95A showed about two-fold higher activity in both 
polymerase activity assays.  Mutants Y119A R263A and E268A displayed slight 
increases (about 24-50%) in de novo initiation/elongation activities and showed 
similar activities in the elongation assay comparable to that of WT protein. In contrast, 
E270A is the only mutant that exhibited reduction in both polymerase activities (about 
30-60%). Mutant R353A showed similar de novo initiation/elongation activity, and 
about 2-fold more active than WT in the elongation assay. Mutant R362A exhibited 
about two-fold increase in de novo initiation/elongation activities and elongation 
activity comparable to WT (Figure 3.2.9A and B, Table 3.2.6). 
 The MTase activities of the mutant proteins were accessed by both N7 and 
2’O MTase assays (Lim et al., 2011; Lim et al., 2008b). Of them, mutant Y119A had 
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minimal 2’O MTase activity (<10%) and less than 50% N7 MTase activity compared 
to WT protein. Mutant R263A exhibited completely abolished MTase activity in both 
N7 and 2’O MTase assays. On the other hand, the rest of the mutants did not exhibit 
significant impairment on MTase activities. E268A and E270A retained 65-74% of 
both MTase activities. They are connected to the C-terminal to the MTase domain via 
the inter-domain linker, thus there might be minor allosteric effects from the RdRp 
domain transmitted via the inter-domain interface. In contrast, mutants K95A, R353A, 
and R362A appear to have little impact on the MTase activities, despite their elevated 
polymerase activities (Figure 3.2.9C and D, Table 3.2.6). 
 
Figure 3.2.9 In vitro enzymatic activities of DENV4 NS5 and its mutants (A) De 
novo initiation/elongation activities and (B) Elongation activities of DENV4 WT and 
mutant NS5FL proteins. (C) N7 MTase and (D) 2’-O MTase of DENV4 WT and 




Table 3.2.6 Enzymatic activities and thermo-stabilities of DENV4 WT and 
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Polymerase activities DENV4 WT and mutant NS5 (full length) proteins measured in 
de novo initiation and elongation FAPA assays. Results shown are the average 
percentage activity compared against DENV4 WT NS5 protein derived from average 
relative fluorescence units (RFU) obtained for each protein from one experiment. All 
data points were performed in duplicate wells. N7 and 2’-O MTase of DENV4 WT 
and mutant NS5 proteins measured in SPA assays. Results shown are the average 
percentage activity compared against DENV4 WT NS5 protein derived from average 
corrected counts per minute (CCPM) obtained for each protein. Thermo-stability was 
assessed using the thermo-denaturation assay (*(Lim et al., 2013a). The effect of 
alanine mutations of E268 (E267 in DENV3),  and E270(E269 in DENV3),  on de 
novo initiation/elongation activities of polymerase were previously studied in Lim et 




3.2.4.2 Effect of the interface mutants on virus replication 
We assessed the functional importance of the interface residues in virus 
replication by using reverse geneic stratergy. Alanine mutations at position K95, 
Y119, R263, E270 and R353 were introduced into a DENV4 subgenomic RNA 
replicon, bearing a renilla luciferase reporter (Lim et al., 2013a). Replicon cDNAs for 
both WT and mutants were in vitro transcribed and electroporated into BHK-21 cells 
and the luciferace activities were monitored at 4, 24, 48, 72 and 96 hr post-
electroporation. For WT DENV4 replicon, the luciferase activity reached a peak level 
at approximately 24 to 48 hr post-electroporation (about 3320-fold above background 
levels) and steadily declined from 48 - 96 hr post-electroporation. Of those mutant 
replicons, significant luciferase actives that are almost comparable to WT at 48 hr 
point were detected for K95A, E268A and R353A, although the mutants had some 
delay at the first 24 hrs. In contrast, mutant replions Y119A, R263A and E270A 
exhibited little or no luciferase activity throughout the four days post-electroporation 
(Figure 3.2.10).  
We also introduced four alanine mutations into the DENV2 infectious clone to 
further validate the biological significance of the interface. Mutant DENV2 NS5: 
K95A, Y119A, E268A and R353A cDNA clone was constructed by site-directed 
mutagenesis, and then they were in vitro transcribed and electroporated into BHK-21 
cells (Tay et al., 2015). The phenotype in viral protein synthesis and infectious virus 
production for both WT and mutant DENV2 infectious clones were examined over 
the course of 5-day post electroporation. In this experiment, defective DENV2 NS5: 
K330A mutant clone was constructed as a negative control (Tay et al., 2015; Zou et 
al., 2011). For both Y119A and R353A mutant clones, no infectious virus particle was 
recovered even when neat supernatant were used for tittering (Figure 3.2.11A).  In 
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agreement with the absence of infectious virus, extracellular viral RNA levels for Y119A and 
R353A were at the limit of detection of viral RNA by real-time RT-PCR and did not change 
over the course of 5-day, suggesting that both mutants are inviable did not produce any 
viable virus (Figure 3.2.11B and C). The defectiveness of Y119A mutant virus is 
likely attributetable to the defective MTase activities (Figure 3.2.9C and D, Table 
3.2.6). The non-viable mutant infectious clone R353A is likely due to the disruption 
of the interface between MTase and RdRp domains, even though the in vitro 
enzymatic activities were unaffected. Besides, K95A mutant yield fewer infectious 
particles and it displayed about 10-fold lower intracellular and extracellular RNA 
level at 72 hr post electroporation, when viral RNA for WT reached maximal detection 
that stabilized until 120 hours (Figure 3.2.11 A, B, and C). In contrast, E268A mutant did 
not show significant difference in growth kinetics, extracellular RNA level and 
infectious virus recovery as compared to WT (Figure 3.2.11 A, B, and C). The lack of 
infectious virus might be due to the defect in virus packing and/or release of 
infectious virion. Thus we checked the level of NS5 protein with anti-NS5 antibody 
(5R3) and dsRNA with mouse anti-dsRNA antibody by IFA to assess protein 
synthesis. In agreement with intracellular RNA levels, we could not detect any NS5 
protein (<1%) or dsRNA for Y119A and R353A mutants. About 30-40% of 
transfected cells with K95A mutant were NS5 positive, compared to E268A mutant 
(50-60%), which displayed comparable level of NS5 positive cells for WT (60-70%) 
(Figure 3.2.11D).  
Taken together, the results imply that K95 and R353, the conserved residues 
among flaviviruses that play central role in the interface, are critical in virus RNA 
replication and infectivity, though these mutants did not affect in vitro enzymatic 
activities. E267, residue conserved among dengue viruses, does not affect either 
 129 
 
enzymatic activities of NS5 or virus RNA replication and infectivity. Residue Y119 
from MTase domain affects MTase enzymatic activities, and thus important for virus 




Figure 3.2.10 Renilla luciferase activities of DENV4 WT and mutant replicons. 
Equal amounts of replicon RNA (WT or mutants) were electroporated into BHK-21 
cells. At the indicated time points, the transfected cells were lysed and assayed for 
luciferase activities. The y axis shows the log10 value of Renilla luciferase activity 





Figure 3.2.11 Growth kinetics of BHK-21 cells that were transfected with 
DENV2 WT and NS5 interface mutants were monitored over the course of 5-day. 
10µg in vitro transcribed infectious clone RNA was electroporated into BHK-21 cells 
and viral replication was monitored over a course of 5 days. (A) Plaque morphologies 
of WT and the mutants at 72 hours post electroporation. (B) Intracellular viral RNA 
replication as detected by qRT-PCR. The grey dotted line represents the background 
detection of uninfected cells. (C) Extracellular viral RNA in the supernatants detected 
by qRT-PCR. The grey dotted line denotes background signal of uninfected 
supernatant. (D) Infected cells were analysed by IFA for presence of NS5 with anti-
NS5 antibody (5R3) and dsRNA with mouse anti-dsRNA antibody on 72 hours post-





3.2.5 Physical Linker between MTase and RdRp domains 
Early crystal structural studies on DENV NS5, with different constructs for 
MTase domain (1-296, 1-273, 1-262) or RdRp domain (273-900) alone, observed 
electron density covering residues 6-262 (for MTase domain) (1L9K, 3P97), and 
residues 272-882 (for RdRp) (2J7U). Also limited proteolysis studies in combination 
with mass determination with NS5FL identified residues 263-272 (sequence: 
HVNAEPETPN in DENV3 NS5) to be the interdomain linker. Solution studies of 
NS5FL with small angle x-ray scattering (SAXS) proposed that NS5 could adopt 
different conformations imposed by the flexible linker that connects two globular 
enzymatic domains (Bussetta and Choi, 2012).  Recently crystal structure for RdRp 
domain bearing an N-terminal extension comprising residues 265-900 of NS5 protein, 
which showed significantly improved thermostability (Tm: 5.5°C higher than 
RdRp273-900) and higher de novo RNA polymerization activity (about 3-fold more 
active than RdRp273-900), was determined. In this structure, region 268-272 forms a 
loop preceding the globular RdRp domain, and interacts with residues R361 and K595 
through salt bridges (Lim et al., 2013a).  More recently, MTase domain was shown to 
stimulate both de novo initiation and elongation activities of RdRp domain from 
DENV2 (NGC strain) by increase affinity between NS5 and single-strand RNA 
template. Most importantly, the stimulatory effect of MTase domain on RdRp domain 
was only observed when two domains were in cis, or physically connected, which 
implies the importance of the inter-domain linker to covalently connecting two 
domains (Potisopon et al., 2014).   
For the first time, the linker region (aa 263-272) has been fully resolved. In 
our NS56-895 structure, it is well ordered with clear electron density (Figure 3.2.12A). 
Extending from MTase domain, residues 263-266 fold into a 310-helix followed by a 
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short loop (aa 267-272), and continue with the first helix (starting from M273) of 
RdRp domain.  The residues H263-V264-N265-A266 (in DENV3 NS5) are the least 
evolutionarily conserved through full length flaviviral NS5 sequences (Figure 
3.2.12B). The 310 –helix structure, a compact conformation, brings MTase domain 
and RdRp domain into close proximity to form a large interface and give the overall 
globular shape of NS5 protein, Such that the observed cis-stimulatory effect of MTase 
on RdRp domain can be explained (Potisopon et al., 2014). In contrast, residues 
E267-P268-E269-T270-P271-N272 (in DENV3 NS5) forms a short loop and interacts 
with residues from both MTase domain and RdRp domain as depicted in Figure 
3.2.7A, especially residues E267 and E270, which are conserved across four dengue 
serotypes but not across other flaviviruses. Residues T270 and N272 form several salt 
bridges with residues in RdRp domain. Thus we further delineated the exact 
boundaries for RdRp domains based on our NS5 structure in combination with 
previously solved domain structures (Egloff et al., 2002; Lim et al., 2013a; Lim et al., 
2011; Yap et al., 2007). Crystal structure for RdRp domain from DENV3 reveals 
ordered residues up to 268 at N-terminal of RdRp domain using protein construct 
265-900 (4C11) (Lim et al., 2013a). Remarkably, fragment 268-272 adopts exact 
same conformation (a short loop) in RdRp domain structure and our NS5 structure 
(Figure 3.2.12C and D), and residues 267-272 are stabilized by several intra-
molecular interactions. Therefore residues 267-272 should be considered as an 
integral part of the RdRp domain.  
The C-terminal boundary for MTase domain was delineated to residue R262, 
which has been strictly conserved among flaviviruses and interacts with the main-
chain carbonyl oxygen of V97 in most MTase structures (Lim et al., 2011). Taken 
together, DENV NS5 seems to contain a short four-amino acid linker (H263-V264-
 133 
 
N265-A266), and structural transition at the linker from compact helix to extended 
loop could induce conformational flexibility of NS5 protein as well as the relative 
orientation between two domains (Vieira-Pires and Morais-Cabral, 2010). 
 
 
Figure 3.2.12 Linker between MTase and RdRp domain. (A) The simulated 
annealing mFobs – DFcalc omit maps are in green, contoured at 3σ and in magenta, 
contoured at 5σ. (B) Sequence conservation of the linker region of DENV 1-4 and 
representative flaviviruses. Figure is generated with WebLogo (Crooks et al., 2004). 
(C) Structure alignments of DENV3 NS5 with NS5-MTase and NS5-RdRp domains. 
(A) DENV3 NS5 is in purple, DENV3 NS5-MTase (PDB code: 3P97) is in yellow, 
DENV2 NS5-MTase (PDB code: 1L9K) in orange, DENV3 NS5-RdRp (PDB code: 
4C11) in Cyan, DENV3 NS5-RdRp (2J7U) in gray. N’ and C’ stands for N-terminal 
and C-terminal of NS5 protein; G: motif G, residues 406-417; F: motif F, residues 
455-468; Zn1 and Zn2 are two zinc cations in their binding sites. (D) Zoom-in view of 





3.2.5.1 Effect of the linker mutants on in vitro enzymatic activities of NS5 
Our DENV3 NS5 structure reveals the fully resolved physical linkers 
connecting MTase and RdRp domain.  The four-amino-acid linker adopts a short 310-
helix, and acts as a hinge that could be able to transit into extended conformation to 
regulate NS5 overall conformation and relative domain orientations. Sequence 
alignment of flavivirus NS5 showed the linker was the least conserved with one 
exception: residue Valine264 (in DENV3) is almost 100% conserved (Isoleucine265 
in DENV2 NS5, which shares similar property as Valine) (Figure 3.2.12B). We 
hypothesized this strictly conserved V or I plays a structural as well as functional role 
in the observed biochemical coupling between the NS3MTase and NS5RdRp, and 
also virus replication. 
To characterize the enzymatic function of the linker mutants, the recombinant 
DENV3 NS5 and its mutants V264G, V264P, VGN (insert one G after V) and VPN (insert 
one P after V) were expressed and purified following methods for WT protein. The 
polymerase activities and MTase activities were accessed.  
Interestingly, four mutant NS5 proteins displayed dramatic differences in the 
coupled de novo initiation/elongation activity, but with comparable elongation activity 
(Figure 3.2.13A and B, table 3.2.7). When Val we replaced with Gly (V264G) or Pro 
(V264P), only 25% or 15% de novo polymerase activities were retained respectively. 
Mutant with one Gly insertion after Val (VGN) showed similar de novo activity as 
WT. And mutant with one Pro insertion (VPN) had higher de novo polymerase 
activity. These data suggest that the four mutations influence de novo polymerase 
activity through affecting: (1) RNA (UTR or mainly SLA) recruitment or binding to 
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the NS5 for RdRp function; (2) the stability of the pre-initiation complex NS5-RNA-
NTP; or (3) the transition of NS5 conformations from initiation to elongation.  
We also carried out assays to assess both N7 methyltransferase and 2’O 
methyltransferase activities of the mutants (Figure 3.2.13A and B, Table 3.2.7). Both 
WT and four mutants displayed comparable N7MTase activities as WT protein, while 
the 2’OMTase activities were different. V264G mutation creates a super active 
2’OMTase enzyme with two-fold more activity than WT, while VPN mutant retains 
only about 70% activity of the WT. These data suggested that (1) the linker mutants 
are able to recognize and bind to SLA, and transfer methyl group to the N7 position 
with similar efficiency. (2) Replacement of Val with Gly makes NS5 a more active 
enzyme in 2’Omethylation, which might attribute to the favoured conformation in the 
assay. (3) Different conformations of NS5 are responsible for these two MTase 
activities. 
Table 3.2.7 Enzymatic activities and thermo-stabilities of DENV3 WT and 










time 1 hr 2 hr 3 hr 1 hr 2 hr 3 hr N7 2’-O Tm (°C) 
WT 100 100 100 100 100 100 100 100 37 
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Polymerase activities of DENV3 WT and mutant NS5 proteins were measured in de 
novo initiation and elongation FAPA assays. Results shown are the average 
percentage activity compared against DENV3 FL WT NS5 protein derived from 
average relative fluorescence units (RFU) obtained for each protein from one 
experiment. All data points were performed in triplicate wells. N7 and 2’-O MTase 
of the DENV3 FL WT and mutant NS5 proteins measured in SPA assays. Results 
shown are the average percentage activity compared against DENV3 FL WT NS5 
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protein derived from average corrected counts per minute (CCPM) obtained for each 
protein. Thermo-stability was assessed using the thermo-denaturation assay. 
 
Figure 3.2.13 In vitro enzymatic activities of DENV3 NS5 and its mutants. (A) De 
novo initiation/elongation activities and (B) Elongation activities of DENV3 WT and 
mutant NS5 proteins. (C) N7 MTase and (D) 2’-O MTase of DENV3 WT and mutant 
NS5 proteins. 
 
3.2.5.2 Effect of the linker mutants on virus replication 
To further examine the role of the conserved residue V/I in the linker, we 
introduced same mutations into DENV2 infectious clone (GeneBank 
accession EU081177.1) by reverse genetics following previously published protocol 
(Tay et al., 2015). Their phenotypes in viral RNA synthesis and infectious virus 
production were examined over the course of 5-days post transfection. Besides, the 
presence of viruses inside the cells was confirmed by IFA staining of dsRNA and NS5 
protein with their perspective antibodies (Figure 3.2.14).  
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When the highly conserved Ile (in DENV2, Val in DENV3) was replaced with 
Gly (I265G), or a Gly (IGG) or Pro (IPG) was inserted after the Ile residue, virus 
replications were slightly slower than that of the WT. The detected vRNAs from both 
intracellular and extracellular were about 0.5-1 log10 lower from 24 hour to 72 hour 
post-electroporation, however, the I265G mutant virus caught up the WT on day 4, 
with more extracellular vRNA detected and more infectious virus produced. On the 
other hand, when Ile was replaced with Pro (I265P), the mutant virus was highly 
attenuated, exhibiting defect in replication, as well as a significant lower of infectivity 
(<5%) as compared with WT (50-60%) on day 3, indicated by the IFA staining of 
dsRNA and NS5.  
Overall, it appeared that there was no firm correlation between the relative 
effects of the mutants in the in vitro biochemical and in vivo viral growth analysis, 
however, it suggested that (1) virus viability required a threshold level of polymerase 
activity (25%). V264G retains 25% polymerase activity, and mutant viruses replicated 
similarly as WT, while V264P only retains 15% polymerase activities, and merely 
infectious virus recovered.(2) the I265G mutant with a superior 2’O methylation 
activities rescued the viruses replication, despite the low polymerase activity. This 
suggests the genetic interactions among flaviviral methyltransferase, RdRp. 
From structural perspective, replace V/I with G, and insert one G or P could 
increase the flexibility of the linker region, this could affect the conformational 
transition as well as cross-talking efficiency between MTase and RdRp domain, thus 
resulting in attenuated viruses. In contrast, replacing V or I with P restricts the linker 
flexibility. NS5 could not transform its conformation to accommodate special 
functional requirements during virus replication cycle, such that mutant virus is 
infection and replication defective. 
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Figure 3.2.14 Replication profiles of NS5 interface mutants. (A) 10µg in vitro 
transcribed infectious clone RNA was electroporated into BHK-21 cells and viral 
replication was monitored over a course of 5 days. Intracellular viral RNA replication 
as detected by qRT-PCR. The grey dotted line represents the background detection of 
uninfected cells. (B) Extracellular viral RNA in the supernatants detected by qRT-
PCR. The grey dotted line denotes background signal of uninfected supernatant. (C) 
Infectious virus titer measured by standard BHK-21 plaque assay. (D) IFA images 






3.2.6 Solution structure of NS5 probed by HDX-LCMS 
Full length NS5 from DENV3 was reported to adopt multiple conformations 
in solution with Small angle X-ray scattering technique (Bussetta and Choi, 2012), 
from extended conformation, where two domains do not interact with each other, to 
more compact conformation, where two domains cross talk. In our study, we captured 
NS5 in a compact conformation showing two domains cross-talking through a unique 
polar interface (Figure 3.2.8). To better understand the dynamics of NS5 in solution, 
we performed Hydrogen/Deuterium Exchange Mass Spectrometry (HDX-MS) 
experiments. Among these three types of Hydrogen atoms within a protein: O-H, N-H, 
and C-H, the backbone amide hydrogen (N-H) is the only one that is exchangeable to 
deuterium with an exchange rate accessible for liquid chromatography mass 
spectrometry (LC-MS) analysis (Figure 3.2.15). The kinetics of amide H/D in protein 
structure characterization is dependent on many factors, including secondary structure, 
local fluctuations or protein stabilities, etc. Therefore, the deuterium labelling induced 
mass shift and H/D exchange rate could reflect the protein conformational dynamics 
and hydrogen bonding activities of protein secondary structures (Konermann et al., 





Figure 3.2.15 Amide hydrogens for HDX-MS. Three types of hydrogen atoms that 
exist in a peptide sequence (NDSCK). Hydrogens (red) at the backbone amide 
positions exchange at a rates that can be measured by LC-MS; hydrogens (green) 
covalently bonded to carbon essentially are not exchangeable; hydrogens (blue) on the 
side chains exchange very fast and typically cannot be detected by LC-MS. 
 
 
In this experiment, we performed HDX-MS experiments for purified DENV3 
NS5, MTase domain (1-296) and RdRp domain (273-900) proteins. The HDX-MS 
heat maps (Figure 3.2.16A,C,E) for three proteins were overlaid onto their respective 
crystal structures, and structures were coloured as the different extents of deuterium 
exchange rate measured for protein backbone amide hydrogen atoms (Figure 
3.2.16BDF). Then the differences in deuterium exchange rate between full length 
NS5 and domains were compared (Figure 3.2.16). The missing residues 406-417, 
455-468, and 884-891 in DENV3 NS5 were modelled based on the homology to JEV 
NS5 structure. Regions that were lack of deuterium uptake information were coloured 
gray.  
Overall, MTase domain in the context of NS5 displays similar level of 
deuterium exchange rate as the isolated MTase domain proteins (Figure 3.2.16B and 
D). For both proteins, the region aa120-140 was shown to be relatively more solvent 
exposed (green in colour) than the rest (blue or cyan in colour) with the exception of 
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two ends, suggesting that the dynamics of MTase domain do not affected by the 
presence of RdRp domain.  
In contrast, the overall deuterium exchange rate RdRp domain protein (mostly 
blue) is much lower than that for the RdRp domain in the context of full length NS5 
(cyan or green in general), for example, peptides from thumb subdomain (I735-L748, 
S781-M809, V812-L850, and L853-S895) and the middle finger (K311-M340) 
(Figure 3.2.16B and F). This indicates that that RdRp domain becomes more 
dynamic when it is linked to MTase domain. 
Next we examined the deuterium uptake at the interface region. Surprisingly, 
peptides located at the domain interface from MTase (residues 65-77 and 96-118) and 
RdRp (291-301 and 581-587) domains of NS5 exhibit comparable deuterium 
exchange rate compared to those regions in the isolated domain proteins (Boxed ared 
in Figure 3.2.16B and D, F). Notably, these peptides (about 20-30%) display a 
relatively higher extent of deuterium uptake than the core regions of the domain 
(about 10%, blue). In Figure 3.2.16G, HDX extent for interface peptides aa65-77, aa 
95-118 and aa243-273 were compared and the same patterns of MS isotopic 
distributions explained the observed comparable HDX behaviour in solutions for NS5 
and domain proteins (Figure 3.2.16H). All these results suggest that the interface 
between MTase domain and RdRp domain is solvent accessible, which well correlates 
with our NS5 crystal structure that reveals a polar nature interface.   
Interestingly, the local protein dynamics of NS5 is also revealed by HDX-MS. 
The thumb subdomain displays higher extent of deuterium uptake than Fingers and 
Palm subdomains, in the context of NS5 as well as RdRp domains (Figure 3.2.16B 
and F). This also correlates with the distribution of crystallographic temperature 
factors (B-factor) observed for the RdRp domain of NS5: the B-factor for thumb 
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subdomain is higher than that for Fingers and Palm subdomains (Figure 3.2.16I). In 
our NS5 structure, residues constituting motif G are disordered, and similarly, they 
are shown to have a higher degree of amide hydrogen exchanges in HDX-MS (Figure 
3.2.16AB). (Lim et al., 2013a; Yap et al., 2007). Overall, the HDX-MS experiment 
indicates that the interface observed in DENV3 NS5 in the crystal structure is also 
accessible in solution. Meanwhile the existences of other conformations for NS5 are 
possible, which fits the multi-conformations of NS5 in solution probed by SAXS 





























Figure 3.2.16 HDX-MS results. Deuterium uptake data shown in the heat map 
format where peptides are represented using rectangular strips below the portion of 
the protein sequence they map back to and colors are used to categorize average 
deuterium incorporation for each peptide. The key shows colors assigned to % 
deuterium ranges.(A) DENV3 NS5 (full length), (B) Heat map data overlaid onto a 
crystal structure for the DENV3 NS5 (6-895). (C) DENV3 NS5-MTase (1-296), (D) 
Heat map data overlaid onto a crystal structure for the DENV3 MTase (1-296). (E) 
DENV3 NS5-RdRp (273-900). The colour key indicates the extent of the deuterium 
uptake (%), in which blue means the lowest deuterium uptake. Peptides that colored 
gray are regions that information of deuterium uptake is missing. F: motif F; G: motif 
G. (D) Comparison of HDX extent of the peptides at the inter-domain interface. 
Peptide F65-77, which positions as one interface region in MTase, exhibited similar 
deuterium uptake activities in both MTase protein (12%) and full-length NS5 protein 
(12%). Another interface region, residues K95-118, displayed 18% and 20% average 
deuterium uptakes for all HDX time points. (E) These two peptides displayed 
comparable HDX behaviour in solutions as indicated by the same patterns of MS 
isotopic distributions. The C terminal region of MTase (peptide T243-273) also 
showed high hydrogen bonding activities in both MTase domain and NS5 samples.   
(F) Putty cartoon view of temperature factor variation on the crystal structure of 
DENV3 NS5, coloured from low to high values (20~180 Å
2





3.2.7 Comparison with crystal structure for NS5 from Japanese Encephalitis 
virus (JEV) 
Same as DENV, JEV belongs to Flavivirus genus of Flaviviridae family. NS5 
proteins from these two closely related flaviviruses share about 70% sequence identity. 
The crystal structure for JEV NS5 (4K6M) was solved to 2.6 Å recently (Lu and 
Gong, 2013). To better understand NS5, we compared these two available structures 
for full length NS5 proteins in depth.  
3.2.7.1 Overall structures 
Both NS5 proteins share similar molecular shape, with MTase domain 
residing at the backside of the RdRp domain. However, the relative orientations 
between MTase domain and RdRp domain are different. Superposition of RdRp 
domains, two MTase domains are misaligned by a 105° rotation (Figure 3.2.17A). 
Besides, the physical linkers connecting MTase domain and RdRp domain are also 
different. In JEV NS5, half of the linker (residues A266-G270) is in an extended 
conformation and the other half (residues E271-V272-H273) are disordered and 
missed from the electron density map. While in DENV3 NS5, residues H263-N272 
are well ordered and they form a compact 310-helix followed by a loop that connected 
to RdRp domain. Because of the compacted structured of linker, DENV3 NS5 adopts 
a relatively more compact shape than JEV NS5. The maximum molecular dimensions 
for DENV3 NS5 is approximately 87 Å, and it is 13 Å shorter than that for JEV NS5 
(100 Å) (Figure 3.2.17A).  
3.2.7.2 Two unique but conserved interfaces 
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The total buried inter-domain surface areas were calculated for both NS5 
structures with PISA (http://www.ebi.ac.uk/pdbe/pisa/). We defined residues 6-262 in 
DENV3 and 6-265 in JEV as the MTase domains, and the RdRp domains were 
designated as residues 273-883 in DENV3 NS5 and 276-896 in JEV NS5.  DENV3 
NS5 has a slightly larger area (1502 Å
2
) than that for JEV NS5 (1464 Å
2
) (Table 
3.2.9). This is consistent with the rather compact shape for DENV3 NS5 shown in 
Figure 3.2.17A. 
Interestingly, the nature of these two inter-domain interfaces differs 
remarkably. In DENV3 NS5, two areas of cross-talk through a polar interface, 
occurring between charged residues through direct side chain interactions or water-
mediated contacts (Figure 3.2.17B, and Table 3.2.5) is observed. In contrast, the 
interface for JEV NS5 constitutes predominantly hydrophobic residues, including 
P113, L115, W121 from MTase and F467*, F351* and P585* from the RdRp domain 
(Figure 3.2.17B). Despite the significant differences in the crystallised conformation, 
the residues in both interfaces were highly conserved among flaviviruses during 
evolution (Figure 3.2.17C). Superposition of MTase domains of the two NS5 
structures, two RdRp domains interact with their respective MTase domain from 
different sides using the finger subdomains, thus establishing their unique interfaces 
(Figure 3.2.17D). 
To further rationalize the observed unique interface for DENV3 NS5, we 
performed homology modelling using HHpred server 
(http://toolkit.tuebingen.mpg.de/hhpred). Both crystal structures of DENV3 NS5 and 
JEV NS5 were used to generate homology models for NS5 from other flavivirual NS5, 
including WNV, YFV, TBEV (Figure 3.2.17E and F). Structure alignment of 
residues at both interfaces revealed both interfaces are likely interface for NS5 from 
 149 
 
all flaviviruses, since residues surround the interface are highly conserved. The result 
here suggests that NS5 from flaviviruses may adopt both open and closed 
conformations and the interdomain interface formed in the closed conformation may 







Figure 3.2.17 Comparison of NS5 structure between DENV3 and JEV. (A) Side-
by-side view of the DENV3 NS5 and the JEV NS5 structures in thin ribbon style. 
Same color scheme as in Figure 1: MTase is in yellow, RdRp fingers in green, palm in 
blue, thumb in salmon. The linker regions (260-271 in DENV3 NS5; 263-274 in JEV 
NS5) are shown as cartoon in red. Missing residues (407-417 and 455-468 in DENV3 
NS5; 271-273 in JEV NS5) are indicated as dots. The rotation axis that relates both 
MTase domains is indicated with the corresponding angle. (B) Analysis of the 
electrostatic properties of the domain interfaces of the two NS5 structures. Positive 
surface charge is highlighted in red, negative charge in blue. (C) Analysis of the 
evolutionary conservation of the domain interfaces of the two NS5 structures. The 
colour key indicates the degree of conservation, with cyan means highly variable and 
purple means highly conserved. RdRp domains of the two structures have been 
displayed in the same orientation and the buried surfaces (indicated by the labelled 
interface residues) from the RdRp domains are relatively overlapping between the two 
NS5 structures. (D) The relative orientations of the RdRp domain relative to the 
MTase domain in two structures in thin ribbon style.  DENV3 NS5 is in blue, JEV 
NS5 is in green. “KDKE” highlights the MTase active site shown as mesh in purple 
and “GDD” for the RdRp active site shown as mesh. Residues at interface are 
highlighted and shown as dots. Linker (262-272) in DENV3 NS5 is shown as cartoon. 
(E) Structure alignment of the homology models of NS5 from JEV, WNV, YFV, and 
TBEV based on DENV3 NS5 crystal structure (this work), at the interface area. 
Similarly, the key polar residues that are labeled based on DENV3 NS5. These 
residues are also within the close proximity, suggesting a likely interface, possible for 
NS5 from all flaviviruses. (F) Homology modelling of DENV3, WNV, YFV, and 
TBEV NS5 to JEV NS5 was performed using HHpred server 
(http://toolkit.tuebingen.mpg.de/hhpred). The figure below is the structure alignment 
at the JEV interface. The hydrophobic residues at the interface are labelled based on 
DENV3 NS5. These residues are within the close proximity, suggesting a likely 






Table 3.2.8 Summary of the MTase-RdRP interdomain interface analysis of NS5 
from DENV3 and JEV.  
  DENV3 NS5 JEV NS5 
  MTase RdRp MTase RdRp 
Residues 6-262 273-883 5-265 276-895 
i
Nres 26 23 21 19 
Interface area, Å² 726. 3 775. 9 713. 0 751. 0 
Total Buried Area, Å² 1502.2 1464 
gain on complex formation, ΔiG, kcal/mol  2.4 -6.9 
average gain, kcal/mol -3.1 -1.4 
P-value 0. 845 0. 780 0. 151 0. 162 
NHB / NSB 9 / 8 10 / 3 
NvdW 5 4 7 6 
Comparative analysis of MTase-RdRP in DENV3 NS5 and JEV NS5. The MTase 
domain and RdRP domain were defined as regions listed in the table. 
i
Nres: number 
of residues involved in MTase-RdRP interactions. Total buried area: calculated as the 
difference between total accessible surface areas of isolated and interfacing structures, 
divided by two, using PISA. ΔiG: Indicates the solvation free energy gain upon 
formation of the interface. The value is calculated as difference in total solvation 
energies of isolated and interfacing structures, using PISA. NHB/NSB/NvdW: number 
of putative hydrogen bonds, salt bridges and additional van der Waals interactions 







In this study, we tried to crystallize full length NS5 from DENV3 with the aid 
of NS5 specific antibody 5M3. We studied the solution structure of full length NS5 by 
Small Angel X-ray Scattering (SAXS), which suggested MTase domain and RdRp 
domain interact through residues 94-99 (LKKVTE) and 294-297 (DDEN). Based on 
available NS5 structures, we designed a truncated constructs for NS5, NS56-895, which 
got successfully crystallized and structure solved. In this first crystal structures for 
NS56-895 from DENV3 complexed with SAH and GTP at 2.3 Å resolution, we 
observed a unique electrostatic-rich interface between domains. Interface mutants 
played essential role in regulating virus replication, although the analogous mutations 
mostly do not abolish the in vitro enzymatic activities of the recombinant proteins. Of 
them, two key polar contacts at the interface (K95 and R352) severely impared virus 
replication and infectivity. Also the DENV3 NS5 structure revealed well ordered 
physical linker (263-272) between two domains, which defines the boundaries for 
MTase domain (1-262) and RdRp domain (267-900) of DENV NS5. Mutagenesis 
studies of the conserved Val/Ile residue within the least conserved linker region 
suggest the linker flexibility plays essential role in virus replication. Furthermore, the 
solution HDX-MS experiment of NS5 is consistent with our DENV3 structure that (1) 
the interface is rich in polar residues and solvent accessible, (2) thumb subdomain is 
more flexible with a higher average B factor and higher degree of deuterium exchange. 
We made a comprehensive comparison of DENV3 NS5 structure with JEV NS5 
structure. The two NS5 structures have their own unique interfaces for cross-talking 




3.3 Crystal structure of NS5 complex with RNA 
3.3.1 Structure determination 
NS5 N-terminal MTase domain catalyzes two methyltransfering events for the 
formation of Type I capped structure at 5’end of flaviviral genome, and C-terminal 
RdRp domain is required for RNA replication. To decipher the molecular basis 
underlying the multiple functions of the DNEV3 NS5, we tried to obtain the crystal 
structure of NS5 with different RNA substrates. We successfully determined the 
complex structure of NS5 with cap 0 RNA fragment (5’-N7meG0pppA1G2U3U4G5U6U7-
3’) and co-factor SAH by soaking of NS5crystal into solution containing 15% 
PEG8000, 0.2M Magnisum acetate, 0.1 M sodium cacodylate pH 6.4 that was 
supplemented with 0.5mM RNA for overnight before freezing. A summary of the 
crystallographic data collection and refinement statistics is shown in Table 3.3.1. The 
structural information of NS5with 7-mer capped RNA provides a structural basis for 
sequence-dependent RNA recognition and giving insight at atomic resolution into the 
mechanism behind the 2’O methylation  event required to form the type I capped 










Table 3.3.1 Data collection and Refinement statistics for NS5-RNA-SAH. 
 NS5- Capped RNA7-SAH 
Resolution range (Å) 47.33 - 2.70 (2.85 - 2.70)* 
Space group P 21 21 2 
Unit cell 94.66 151.394 69.432 90 
Total reflections 114,953 (17,172) 
Unique reflections 28,027 (4,018) 
Multiplicity 4.1 (4.3) 
Completeness (%) 99.7 (99.6) 
Mean I/sigma(I) 9.6 (2.1) 
R-merge 0.126 (0.625) 
R-work 0.2027 (0.2925) 
R-free 0.2510 (0.3496) 
Number of non-hydrogen atoms 7,102 
  macromolecules 6,889 
  ligands 45 
  water 168 
Protein residues 851 
RMS(bonds) 0.004 
RMS(angles) 0.85 
Ramachandran favoured (%) 95.45 
Ramachandran allowed (%) 4.31 
Ramachandran outliers (%) 0.24 
Clashscore 6.37 
Average B-factor 38.90 
  macromolecules 49.00 
  ligands 53.10 
  solvent 28.60 





3.3.2 Overall structure of NS5-RNA-SAH ternary complex  
This ternary complex structure of NS5- Capped RNA7-SAH was refined to 
R=0.2027, Rfree=0.251 at a resolution of 2.70 Å (Figure 3.3.1 and Table 3.3.1). 
Superposition with apo NS5 structure (NS5-SAH: 40VQ) yields r.m.s.devation of 
0.295 Å for 755 Cα atoms (Figure 3.3.1C), indicating the absence of large 
conformational change upon capped RNA binding and the relative orientation 
between MTase and RdRp domains is preserved compared to the apo-NS5 protein. 
Notably, crystal for the ternary complex structure was obtained by soaking of apo 
NS5 crystal in precipitation buffer supplemented with capped RNA. It suggests that 
the RNA binding groove appears largely preformed. 
 
Figure 3.3.1 Crystal structure for ternary complex of NS56-896-RNA-SAH. (A) 
Crystal structure of NS56-896 bound to RNA (5’-
7me
GpppAGUUGUU-3’, magenta 
sticks) and SAH (yellow sticks). NS5 protein is represented as cartoon, and MTase 
domain is coloured in cyan and RdRp domain is coloured in green. RNA and SAH 
binding sites are boxed. (B) Superposition of NS5-capped RNA7-SAH ternary 





3.3.3 Specific recognition of flaviviral RNA by NS5 
Within this ternary complex, the RNA moiety (5’-N7meG0pppA1G2U3U4) is well-
ordered into an L-shape and is located at RNA basic binding groove, which extends 
between F25 at one end and the SAH binding pocket at the other end, spanning a 
distance of approximately 17 Å. Little electron density is visible for G5U6U7 that 
extend out of the MTase binding groove (Figure 3.3.2). The observation that the 
MTase RNA binding groove can accommodate four well-ordered bases A1G2U3U4 in 
addition to 
N7me
G0 and the three connecting phosphate groups is consistent with earlier 
RNA foot-printing results showing that a total of four nucleotides become protected 
by the flavivirus MTase, during 2’O methylation (Dong et al., 2007).  
The N7-methylated Guanine (
N7me
G0) is stabilized by residues in the GTP-
binding pocket as observed in GTP or cap analogues-bound MTase domains 
structures (Figure 3.3.3) (Egloff et al., 2002; Egloff et al., 2007): (1) the guanine base 
ring hydrophobic stacks with F25 phenyl ring, add the addition of a methyl group at 
position N7 of the base is likely to enhance its stacking interactions with the phenyl 
ring; (2) its N2 atom establishes hydrogen bonds with carbonyl oxygen atoms from 
L17 and L20; and (3) its ribose 2’OH forms hydrogen bond with the side chain of 
N18, which was shown by mutagenesis to be crucial for interaction with GTP (Dong 
et al., 2008b). The vaccinia virus VP39 was reported to preferentially bind methylated 
guanine (Dong et al., 2008a) and enhanced π-π interactions derived from sandwiching 
between two aromatic residues favours methylated over non-methylated guanine 
(Quiocho et al., 2000).  
In contrast to all cap analogues-MTase structures determined so far (Egloff et 
al., 2007; Yap et al., 2010), however, the first two bases of nucleotides at the 5’ end of 
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the RNA substrate 
N7me
G0 and A1 do not stack against each other but adopt an 
extended conformation that places A1 into a pocket next to the methyl donor 
(SAM/SAH) binding site (Figure 3.3.3). The negative charges of the triphosphate 
moiety that connects 
N7me
G0 and A1 are neutralized by a Mg
2+
 ion and also by 
hydrogen bonding with S213. The remainder of the RNA adopts an A-helical 
conformation along an axis that runs approximately at right angle with the 
N7me
G0ppp 
moiety (Figure 3.3.3), giving an L-shape to the RNA with A1 at the bend. While 
bases A1G2U3U4 are stacked, only poor density is visible for bases at the RNA 3’ end 
and G5U6U7 that extend out of the MTase binding groove are disordered.  
 
Figure 3.3.2: Stereo views of the electron density maps of the RNA and SAH. The 
simulated annealing mFobs – DFcalc omit maps for the RNA and SAH ligands are in 
green, contoured at 3σ. RNA ligands and SAH are shown in sticks. The magnified 





Figure 3.3.3 RNA binding within ternary complex. (A) Surface representation of 
NS5 (positive surface charge is highlighted in red, negative charge in blue). Capped 
RNA (magenta) and SAH (yellow) are shown in stick representation. (B) Close-up 
view of the RNA and SAH binding sites as in B. NS5 is displayed in surface 
representation. Protein residues involved in RNA and SAH binding are represented by 
sticks, coloured by cyan carbons and labelled accordingly. Capped RNA is shown in 
sticks and coloured by magenta carbons, nucleotides are labelled. SAH is shown in 
sticks and coloured by yellow carbons. The interaction networks are shown by dash 
lines. Mg
2+




The first nucleotide of the flaviviral genome, which is always adenosine, 
resides ~ 8 Å away from and nearly perpendicular to the 
N7me
G0 via the triphosphate 
linkage. The adenine base stacks to a hydrophobic wall formed by the backbone and 
the side chain carbons of I147-G148-E149-S150 and leans against the ribose of SAH 
(Figure 3.3.4A). The hydroxyl side chain of S150 forms a weak hydrogen bond with 
the N7 of the adenine base. The replacement of adenine with Guanine would result in 
potential clashes between N2 amine group of G and the ribose ring of the SAH (~1 Å) 
(Figure 3.3.4A) Conversely, replacing adenine with a pyrimidine base (either C or U) 
would leave a large empty space in the pocket and are energetically less favourable 
than adenine (Figure 3.3.4A). Taken together, there is perfect shape complementarity 
between adenine base of the first nucleotide from the viral genome and NS5 MTase. 
The second nucleotide of the flaviviral genome, guanosine (G2) stacks with the A1 
base. One hydrogen bond is established between the carboxylic group of E111 and the 
N2 amine group of G2 (Figure 3.3.4B). Similarly, we modelled X2 (7meG0pppAX2-
RNA) in place of G2, no other bases is able to form any polar contacts with NS5 
MTase but instead there could be unfavourable charge-charge repulsion (Figure 
3.3.4B). Thus specificity is a consequence of optimum shape complementarity and 
specific hydrogen bonds between the protein, the SAM methyl donor and the viral 
RNA. The 5’ consensus sequence (G0pppA1G2) is strictly conserved across the 
genomes of all flaviviruses (Figure 3.3.4CD) (Paranjape and Harris, 2009), so are the 
residues from NS5 (Figure 3.3.3B, Table 3.3.3) that form the binding pocket and 





Figure 3.3.4 Local environment selects adenine as the first base and guanine as 
the second base. (A) Modelling of X1 (
7me
G0pppX1-RNA) in place of A1: N2 amine 
group from G1 base potentially clashes with the ribose ring of the SAH (~ 1 Å) while 
a pyrimidine base would leave a large empty space in the pocket and are energetically 
less favourable than adenine. (B) Modelling of X2 (
7me
G0pppAX2-RNA) in place of G2: 
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other bases are unable to form any polar contacts with NS5 MTase E111, and there 
could be unfavourable charge-charge repulsion.(C) Multiple sequence alignment of 
the first 12-nucleotides from flaviviral genomes (D) Sequence conservation of the 
first 12-nucleotides from flaviviral genomes. Figure is generated with WebLogo. 
 
3.3.4 Enzymatic mechanism of 2’O Methylation 
The geometry of the DENV MTase catalytic site suggests that the present 
complex represents a snapshot along the 2’-O methylation pathway and predicts the 
enzymatic mechanism of 2’-O methylation: (1) the side chain of K180 activates the 
2’OH of the adenosine ribose either by proton abstraction or destabilization of the 
hydroxyl oxygen orbital (Li et al., 2004), (ii) the activated ribose 2’O makes a 
nucleophilic attack on the methyl group of the positively charged sulphur centre via 
an in-line SN2 reaction (Figure 3.3.5AB). At pH=8.5, a value close to the pKa of the 
lysine ε- amino-group side-chain, where the 2’-O MTase reaction is maximal (Dong 
et al., 2010a; Zhou et al., 2007), the side-chain of K180 can be easily deprotonated. 
Moreover, because K180 is sandwiched between the acidic side-chains of D146 and 
E216, its side chain could alternate between a charged and uncharged species, at 
various stages of the 2’-O methylation cycle.  
The stereochemical parameters derived from the present ternary complex 
illustrate the effective and specific in-line SN2 mechanism for methyl transfer, where 
the lone pair of the acceptor group (2’O of ribose) attacks the positively charged 
methyl group (Sδ-CεH3). We modelled Sδ-CεH3 methyl group of the SAM methyl 
donor using the bound SAH (Figure 3.3.5C). The Sδ-CεH3 points towards the target 
2’-O of the adenosine-ribose (with a Cε-O distance of 2.3 Å). This distance is 
intermediate between theoretical values of 2.96 Å and 1.97 Å calculated for the 
reactant and transition complex respectively (Li et al., 2004). The Sδ-Cε bond of SAM 
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and the O2’ of the ribose subtends an angle (179.5 o) close to the expected 180o for an 
in-line attack (Li et al., 2004). In addition, the angle subtended by the ribose C2’-O2’ 
bond with the putative Cε hydrogen bond (108.6°) is appropriate for nucleophilic 
attack by the 2’-oxygen, (this angle would be 109o for a perfect tetrahedron (Li et al., 
2004)). By correctly arranging the 2’hydroxyl group of A1 ribose (the attacking 
nucleophile) and methyl group of SAM in close proximity and thereby increasing the 
effective concentration of the reaction partners; Activation of the attacking 
nucleophile by abstraction of a proton by the proper orientated and protonated K180. 
This has been also nicely illustrated by the complex structures of the human mRNA 
cap-specific 2’O-ribose MTase CMTr1 and Vaccinia virus VP39 proteins (Hodel et 
al., 1998; Smietanski et al., 2014). Given the conservation of the active site, the 
mechanism proposed for 2’O methyl transfer is expected to be commonly used by 
other 2’O MTases with the second K from the KDKE motif (K180 in DENV3, K404 
in CMTr1, and K175 in VP39 among the enzymes. (Structural comparison will be 
presented in section 3.3.5).  
A requirement for Mg
2+
 ion was reported for COMT as well as for FtsJ 2’O 
methylation activities (Hager et al., 2002; Vidgren et al., 1994). Lim et al., 2008 also 
showed that Mg
2+
 has stimulatory effect on DENV 2’O MTase activity (Lim et al., 
2008b). The structure of COMT suggests that the role of Mg
2+
 is important for RNA 
stabilization but not for catalysis. It was also proposed that since both VP39 and FtsJ 
superimpose well at the active site, the mechanism of 2’O methylation does not 
require Mg
2+
 (Hager et al., 2002). This agrees with the observation that the presence 
of Mg
2+
 enhances 2’O methylation which is consistent with the observation of bound 
Mg
2+ 







Figure 3.3.5 The catalytic site and the proposed enzymatic mechanism for 2’O 
methylation. (A) K61-D146-K180-E216 catalytic tetrad is shown as yellow sticks 
and labelled. RNA and SAH are shown as sticks. G0 is coloured by green carbons, A1 
is coloured by cyan carbons, and G2U3U4 are in gray. SAH is coloured by magenta 
carbons. The distance between 2’O of adenine and amino group of the K180, is shown 
as dash line and labelled, as well as the distance between 2’O of adenine and sulphur 
group of SAH. (B) Proposed enzymatic mechanism for 2’O methylation. (1) K180 
acts as a general base, abstracting or steering a proton from the 2’OH adenosine. (2) 
Subsequently, the activated nucleophilic oxygen attacks the methyl group at the 
positive sulphur centre using a SN2 nucleophilic addition reaction. (3) Pentacovalent 
transition state. (4) The methyl group is transferred to the 2’O of the ribose generating 
the reaction by-product SAH. D146 receives a proton from K180, regenerating the 
base. (C) The stereochemistry of the active site is represented. The Sδ-CH3 methyl 
bond of the SAM methyl donor was modelled using the bound SAH). Distances and 
angles for the proposed general base K180 and the 2’O of the adenosine are indicated. 
The conformation adopted by brings the 2’O atom of its A1 adenosine ribose next to 
the sulphur of SAH (distance 3.4 Å), points towards the target 2’O of the adenosine-
ribose (with a Cε-O distance of 2.3 Å). This distance is intermediate between 
theoretical values of 2.96 Å and 1.97 Å calculated for the reactant and transition 
complex respectively(Schmidt et al., 2014). The Sδ-Cε bond of SAM and the O2’ of 
the ribose subtends an angle close to the expected 180
o









3.3.5 Comparison with other 2’OMTase proteins 
To gain structural insights into the evolutionary aspects of NS5 MTase, we 
performed a DALI search against the NS5 MTase domain (Holm and Rosenstrom, 
2010). Flavivirus NS5 belongs to a family of SAM-dependent RNA MTases, which 
are responsible for methylation of diverse species of RNA (mRNA, rRNA, tRNA and 
siRNA) at the bases and the 2’hydroxyl group of the specific nucleosides. Within the 
flavivirus genus, both the primary sequence and the 3D structures of MTase domain 
are highly conserved (sequence identity 51-100% and Z score 32.2-43.8). Surprisingly, 
the highest scoring non-flavivirus-NS5 match is the human mRNA cap-specific 2’-O-
ribose MTase CMTr1 (PDB code 4N48, with 2.9 Å rmsd over 222 of the 406 CMTr1 
amino acids, 14% sequence identity, Z score of 15.8). The 2nd to the 8th hits are also 
non-viral but ribosomal 2’-O-ribose RNA MTases from cellular organisms and two 
putative bacterial hemolysins (low sequence identity 14-20% and Z score 12.4-14.4). 
Following are the viral mRNA cap-specific 2’-O-ribose MTases: 9th - VP1 and 10th - 
λ2 proteins from Reoviruses - dsRNA viruses. NSP10/16 from SARS coronavirus - 
positive sense RNA virus - ranks at 19
th
 and VP39 from Vaccinia virus - dsDNA virus 
- 42
nd
 only (Figure 3.3.6, Table 3.3.4). On one hand, these structure hits share the 
general  Rossmann-fold core domain that forms the SAM binding pocket and 
the highly conserved K-D-K-E catalysis tetrad (Figure 3.3.6), immediately pointed to 
the shared mechanism of catalysis - SN2 methyl transfer reaction. On the other hand, 
the structural divergence beyond the Rossmann-fold core domain may reflect the 
RNA substrate preference (2’-O-Ribose of capped RNA or ribosomal RNA) and 
differences in the pre-mRNA capping as well as ribosomal RNA modification 





                                                           61                                               111 
01 DVNS5   HAVSRGSAKLQWFVERNMVIPEGRVIDLGCGRGGWSYYCAGLKKVTEVRGYTKGGPGHEEPVPMSTYGWNIVKLMSGKDVFYLPPE 
02 4n48B   FFLNRAAMKMANMDFVF-MFTNLYFADVCAGPGGFSEYVLWRK--AKGFGMTLKG--PNDFKLEDYSASELFEPYYDGDITRISAF 
03 1eizA   LRS-RAWFKLDEIQQS-DKLFKMTVVDLGAAPGGWSQYVVTQIG-GRIIACDLL-----PMDP-----IVGVDFLQ-GDFRDMKAL 
04 2nyuB   SYRSRSAFKLLEVNERH-QILRLRVLDCGAAPGAWSQVAVQKVNAGFVLGVDLL-----HIFP-----LEGATFLCPADVTDTSQR 
05 3hp7A   RYVSRGGLKLEKALAVFNLSVEXITIDIGASTGGFTDVXLQN-GAKLVYAVDVGT---NQLVWK----DDRVRSXEQYNFRYAEP- 
06 3douA   QLRSRAAFKLEFLLDRYRVVRGDAVIEIGSSPGGWTQVLNSL--ARKIISIDLQ-----EXEE-----IAGVRFIR-CDIFKIFDD 
07 2plwA   -YRSRAAYKLIELDNK-YLFLKKIILDIGCYPGSWCQVILERT--NKIIGIDKK-----IMDP-----IPNVYFIQ-GEIGKDN—- 
08 3opnA   RYVSRGGLKLEKALKEFHLEINKTCLDIGSSTGGFTDVXLQN-GAKLVYALDVG---TNQLAWK----DERVVVXEQFNFRNAVL- 
09 4b17A   DAPSRSTLKLEEAFHVFI----MWAVDLGACPGGWTYQLVKR--NMWVYSVDNG-----PMAQS----TGQVTWLR-EDGFKFRPT 
10 3k1qA   ---DRSAIKDRAVFDFL-----FSMAYLGASSPVILADIRSGPIPRRIVQFGY-----DVVH------------GSLLDLRAVPTG 
11 1ej6A   ---DRSLVKDTAVL--KHAY--QSVAYFGASQPLVIEPWIQVPPPSSVRQFGY----DVAR-------------GAIVDLRPFPSG 
12 3r24A   ---MMNVAKYTQLCQYL-----MRVIHFGAGVAPGTAVLRQLPTGTLLVDSDLN-----DFVS--------DSTLI-GDCATVHTN 
13 1p39A   ----KLLLGELFFLSKL-----ATVVYIGSAPGTHIRYLRDHFVIIKWMLIDGR-----HHDPI----LRDVTLVT-RFVDELRSI 
 
01 DVNS5   LLLLLHHHHHHHHHHHLLLLLLLEEEEEELLLLLHHHHHHLLLLLEEEEEEELLLLLLLLLLLLLLLLLHHHEEEELLLLHHHLLL 
02 4n48B   -LLLLLHHHHHHHHHHHL-LLLLEEEEEELLLLLHHHHHHHHHH--EEEEEELLLL--LLLLLHHHLLLLLLEEELLLLLLLLHHH 
03 1eizA   LLLL-HHHHHHHHHHHH-HLLLLLEEEEELLLLLHHHHHHHHHHL-LEEEEEELL-----LLLL-----LLLEEEEE-LLLLLHHH 
04 2nyuB   -LLLLLHHHHHHHHHHHH-LLLLLEEEEELLLLLHHHHHHHHHHLLLEEEEELLL-----LLLL-----LLLEEEELLLLLLLHHH 
05 3hp7A   -LLLLLLHHHHHHHHHHLLLLLLLEEEEELLLLLHHHHHHHHL-LLLEEEEELLLL---LLLLHH----LLLEEEELLLLHHHLLH 
06 3douA   -LLLLHHHHHHHHHHHHHLLLLLLEEEEELLLLLHHHHHHLLL--LLEEEEEELL-----LLLL-----LLLLEEEE-LLLLLHHH 
07 2plwA   --LLLLLHHHHHHHHHH-HLLLLEEEEEELLLLLHHHHHHHHHL--EEEEEEELL-----LLLL-----LLLLEEEE-LLLLLLL- 
08 3opnA   LLLLLLLHHHHHHHHHHLLLLLLLEEEEELLLLLHHHHHHHHL-LLLEEEEELLL---LLLLLHH----LLLEEEELLLLHHHLLH 
09 4b17A   LLLLLLLHHHHHHHHHHHL----LEEEEELLLLLHHHHHHHHL--LLEEEEELLL-----LLLHH----LLLEEEEL-LLLLLLLL 
10 3k1qA   ----LHHHHHHHHHHHHH-----EEEEEEEEELLHHHHHHHHLLLEEEEEEEEE-----ELLL------------LEELLLLLLLL 
11 1ej6A   ----LHHHHHHHHHH--HHHL--LEEEEELLLLLLLHHHHHHLLLLLEEEEELL----LLLL-------------LLLLLLLLLLL 
12 3r24A   ----LHHHHHHHHHHHHH-----LEEEEELLLLLHHHHHHHHLLLLLEEEEEELL-----LLLL--------LEEEE-LLHHHEEE 
13 1p39A   -----HHHHHHHHHHHHH-----LEEEEELLLLLHHHHHHHHHHLLLEEEEEELL-----LLLHH----LLLEEEEE-LLLLHHHH 
              146                               180                                 216 
01 DVNS5   KCDTLLCDIGESSPSPTVEESRTIRVLKMVEPWLKNNQFCIKVLNPYMPTVIEHLERLQRKHGGMLVRNPLSRNSTHEMYWISN 
02 4n48B   GVHFLMADGGFSVQENL-QEILSKQLLLCQFLMALGGHFICKTFDLFTPFSVGLVYLLYCCFRVCLFKPITSRPANSERYVVCK 
03 1eizA   KVQVVMSDMAPMSGTPAVDIPRAMYLVELALEMCRGGSFVVKV-FQGE-GFDEYLREIRSLFKVKVRKPDSSRARSREVYIVAT 
04 2nyuB   RADVILSDMAPATGFRDLDHDRLISLCLTLLSVTPGGTFLCKT-WAGS-QSRRLQRRLTEEFNVRIIK-------SSEVYFLAT 
05 3hp7A   LPSFASIDVSF-------------ISLNLILALAKGGQVVALVKP-HEKVLETVTAFAVDGFSVGLDFSPIQG-GNIEFLAHL- 
06 3douA   KVDDVVSDAXAVSGIPSRDHAVSYQIGQRVXEIAVGGNVLLKQ-FQGD-XTNDFIAIWRKNFSYKISKP------SSEIYIXFF 
07 2plwA   KIDIILSDAAVPCGNKIDDHLNSCELTLSITFMEQGGTYIVKM-YLGS-QTNNLKTYLKGMFLVHTTKPK-----SREIYLVCK 
08 3opnA   RPSFTSIDVSF-------------ISLDLILPLYENGEVAALIKP-VHQXTIEKVLKTATGFSVGLTFSPIKGAGNVEFLVHL- 
09 4b17A   NISWMVCDMVE----------KPAKVAALMAQWLV-RETIFNLKL-RYEEVSHNLAYIQAQAQIQARQLYHD---REEVTVHVR 
10 3k1qA   TFGLVYADLDQVGTDMPAANRAAIAMLGTALQMTTGGVSVLKVNFP-TRAFWTQVFNYATHATLHLVKPT-IVNS-SEVFLVFG 
11 1ej6A   DYQFVYSDVDQVVDDLSISSGLVESLLSSCMHATPGGSFVVKINFP-TRPVWHYIEKILPNISYMLIKPF-VTNN-VELFFVAF 
12 3r24A   KWDLIISDMYDPTKHVT-----KEGFFTYLCGFILGGSIAVKITEH----WNADLYKLMGHFWWTAFVTNVNAS-SSEAFLIGA 
13 1p39A   K-IILISDVRS------PSTADLLSNYALQNVMINPVASSLKWR-CPFP------FYIP---HGNKMLQPFAPSYSAEMRLLSI 
 
01 DVNS5   LLLLEEEELLLLLLLLHHHHHHHHHHHHHHHHHHLLLLEEEEEELLLLLHHHHHHHHHHHHHHLLEEELLLLLLLLLLLEEEEL 
02 4n48B   HLEEEEEELLLLLLLHHH-HHHHLHHHHHHHHHHHHEEEEEEEELLLLLHHHHHHHHHHHHHEEEEEELLLLLLLLLLLEEEEE 
03 1eizA   HLEEEEEELLLLLLLLHHHHHHHHHHHHHHHHHHHHEEEEEEEE-ELLL-LHHHHHHHHHHHEEEEEELLLLLLLLLLEEEEEE 
04 2nyuB   HLEEEEEELLLLLLLLHHHHHHHHHHHHHHHHHLHHEEEEEEEE-ELLL-LHHHHHHHHHHHEEEEEEL-------LLEEEEEE 
05 3hp7A   -LLLEEEELLLL-------------LLHHHLHHHHHLLEEEEEELH-HHHHHHHHHHHHHHLEEEEEEELLLLL-HLLLEEEEE 
06 3douA   HLEEEEEELLLLLLLLHHHHHHHHHHHHHHHHHHHHEEEEEEEE-ELLL-HHHHHHHHHHHHEEEEEELL------LLEEEEEE 
07 2plwA   -LEEEEEELLLLLLLLHHHHHHHHHHHHHHHHHHHHEEEEEEEE-ELLL-LHHHHHHHHHLLEEEEELLLL-----LLEEEEEE 
08 3opnA   -LLLEEEELLLL-------------LLHHHLHHHHHLLEEEEEELH-HHHHHHHHHHHHHHLEEEEEEELLLLLLLLLLEEEEE 
09 4b17A   LLLLEEEELLLL----------LHHHHHHHHHHHHH-LEEEEEEEL-HHHHHHHHHHHHHHHEEEEEELLLLL---LLEEEEEE 
10 3k1qA   LLEEEEEEELLLLLLLHHHHHHHHHHHHHHHHHHEEEEEEEEEELLL-LHHHHHHHHHHHHHEEEEEEEEL-LLLL-LLEEEEE 
11 1ej6A   LLEEEEEELLLLLLLLHHHHHHHHHHHHHHHHHHEEEEEEEEEELLL-LHHHHHHHHHLHHHEEEEEEEEE-LLLL-LLEEEEE 
12 3r24A   LLEEEEEELLLLLLLLLL-----LLLHHHHHHHHHEEEEEEEEELLL----LLHHHHHHHLLEEEEEEEEHHHLL-LLLEEEEE 




Figure 3.3.6 Structural based alignment of NS5 with non-flaviviral MTase using 
Dali server. (A) Amino acid sequences alignment of the top 10 non-flaviviral hits 
with NS5 and the secondary structure assignments by DSSP. The most frequent 
amino acid type is coloured in each column. The KDKE catalytic tetrad is highlighted 
in yellow. (B) Close-up view of the MTase active sites from the above listed hits. 
Proteins are shown in cartoon representative with the KDKE catalytic tetrad is shown 
in sticks. Ligands (RNA or SAH) are shown in sticks and coloured by yellow carbons. 
 
We also took a closer examination of the electrostatic potential surfaces of the 
four structurally well-characterized mRNA cap 2’-O-ribose MTases (DENV3 NS5 
MTase, human CMTr1, vaccinia virus MTase VP39, and SARS coronavirus MTase 
nsp16). Figure 3.3.7 highlights the similarities and differences in shape 
complementation and surface charge distributions between the enzyme, cofactor and 
the RNA substrate. The pocket for G0 from VP39 is deepest and is more apart from 
the RNA binding groove than NS5 and CMTr1. As a result, G0 base is deeply buried 
inside the pocket while the ribose facing out of VP39. In contrast, there is no apparent 
G0 binding pocket in nsp16. Triphosphates are relatively flexible and display different 
conformations: extended in VP39 and CMTr1 and bent in NS5. In all three complex 
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structures, four bases of RNA occupy the positively charged groove largely through 
backbone sugars and phosphates. The RNA binding groove in nsp16, on the other 
hand, is shallow and is less positively charged. In the ternary complexes for both 
CMTr1-RNA and VP39-RNA, the 2’OMTase interacts with the rest nucleotides 
substrate (besides G0) by forming several hydrogen bonds and salt bridges with the 
phosphodiester backbone, suggesting that capped RNA binding and methylation in a 
sequence-independent manner, while NS5 MTase specifically recognizes the 5’end of 
flaviviral RNA through shape and charge complementarity (elaborated in section 
3.3.3, Figure 3.3.4). 
SAM/SAH binding pockets are relatively conserved among the four enzymes 
except at the adenine base binding site: In NS5, a positively charged small pocket is 
found next to N7 of adenine base of SAH; in CMTr1, the corresponding pocket is 
much deeper and larger; in VP39, the corresponding pocket is open and is negatively 
charged; In nsp16, there is no apparent pocket next to the adenine base of SAH.  As 
cap methylation is essential for viral replication, specific inhibitors interfering with 
this enzymatic activity have potential therapeutic value against flaviviruses. In this 
respect, the snapshot of cap 0 RNA bound in the MTase gleaned from the present 
crystal structures can assist in the design of specific inhibitors. Lim et al designed 
SAM analogues with substitutions in the adenine ring that specifically inhibited the 
flavivirus MTase and not the human enzyme homologues (Lim et al., 2011). 
Targeting the SAM binding pocket and the A1 RNA binding site, for example by 
extending SAM analogue towards the RNA binding groove, may further distinguish 




Table 3.3.2 Non-flaviviral NS5 MTase hits in PDB. 
 
 
NO PDB-chain Z score RMSD LALI NRES %ID Species Description 
1 4N48-B 16.2 2.9 222 406 14 HUMAN CMTR1, CAP-SPECIFIC MRNA 2'-O-RIBOSE-
METHYLTRANSFERASE  
2 1EIZ-A 14.4 2.4 155 180 19 ESCHERICHIA COLI FTSJ, 23S RIBOSOMAL RNA METHYLTRANSFERASE 
3 3HP7-A 13.8 3.6 181 275 15 STREPTOCOCCUS 
THERMOPHILUS 
STU1215, PUTATIVE HEMOLYSIN 
4 2NYU-B 13.8 2.3 150 183 20 HUMAN PUTATIVE RIBOSOMAL RNA METHYLTRANSFERASE  
5 3DOU-A 13.6 2.2 148 176 18 THERMOPLASMA 
VOLCANIUM 
RLME, RIBOSOMAL RNA LARGE SUBUNIT 
METHYLTRANSFERASE J 
6 2PLW-A 13.2 2.2 146 183 14 PLASMODIUM FALCIPARUM PF12_0052, PUTATIVE RIBOSOMAL RNA METHYLTRANSFERASE 
7 3OPN-A 13.0 3.1 161 208 16 LACTOCOCCUS LACTIS YIIB, PUTATIVE HEMOLYSIN 
8 4B17-A 12.4 4.2 162 358 20 ESCHERICHIA COLI RLMM, 23S RIBOSOMAL RNA 2'-O-RIBOSE-
METHYLTRANSFERASE 
9 3K1Q-A 12.2 3.3 189 1299 20 AQUAREOVIRUS VP1, MRNA-CAPPING OUTER CAPSID PROTEIN  
10 1EJ6-A 11.2 3.4 199 1283 11 REOVIRUS LAMBDA2, MRNA-CAPPING OUTER CAPSID PROTEIN  
19 3R24-A 10.3 3.2 170 293 12 SARS CORONAVIRUS NSP10/16, MRNA 2'-O-RIBOSE-METHYLTRANSFERASE 




Figure 3.3.7 Comparison of DENV3 NS5 MTase with human and other viral 2’O 
MTases: VP39 from vaccinia virus MTase, CMTr1 from human and nsp16 from 
SARS coronavirus MTase. Proteins are shown in surface representation (positive 
surface charge is highlighted in red, negative charge in blue), RNA is shown in sticks 




3.3.6 Functional significance of the ternary complex structure 
In the present NS5-RNA-SAH ternary complex, an RNA binding groove 
specific for flaviviral RNAs was identified. The interaction network and functional 
implications of those residues involved in capped RNA7 binding were summarized in 
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Table 3.3.3 based on previous mutagenesis studies of the effect of alanine mutants on 
both N7- and 2’O- MTase activities of NS5 MTase from DENV and WNV (Dong et 
al., 2010b; Dong et al., 2008b).  
Notably, mutants targeting the K61-D146-K180-E216 catalytic tetrad motif 
completely abolished 2’O methylation activity. Of them, D146 plays a key role in the 
methyl transfer reaction: its carboxylic side-chain is at the right distance to stabilize 
the electrophilic sulphur group of SAM as well as K180, following activation of the 
2’-OH adenosine ribose. D146 also interacts with the methyl donor by anchoring the 
amino group of its carboxylic tail (Figure. 3.3.5A) (Dong et al., 2008b). The D146A 
single mutant is completely devoid of 2’-O methylation activity, but also completely 
inactive in N7 methylation activity. Residue K61 interacts with α-phosphate from A1, 
residue K180 established direct interaction with 2’OH of the ribose from A1 to make 
it nucleophilic, and residue E216 forms hydrogen bonds with K61 and K180. 
Mutation of D146 abolished both MTase activities in DENV and WNV. Mutations of 
these residues only exhibited defect in 2’O MTase activity, while retained about 16-
76% activities in N7-MTase assay.   
Alanine mutations targeting residues K14, F25, K29, R57, R211 S213, and 
Y218 also significantly reduced 2’O MTase activities to 2%, 4%, 15%, 6%, 7%, 22% 
and 8% of the WT MTase respectively. K14, F25, R57 and S213 make direct 
interactions with 
Nm7
GPPPA; R211 interacts with U3 through water- mediated 
hydrogen bonds; while the side chain of S218 forms two hydrogen bonds with side 
chains of K61 and D146, stabilize the active site. In contrast, several mutations, 
targeting residues L17, N18, K42, and S150, only affect 2’O MTase activity modestly 
(about 40-90% activities retained), even though they establish several direct 
interactions with RNA.  
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In general, all alanine mutations reported displayed more disruptive effect on 
2’O MTase activity than N7 MTase activity, with the exception of residue R84 and 
T214: Residue R84 specifically interacts with 2’hydroxyl group from the U3 ribose, 
alanine mutation of R84 completely abolished N7 MTase activity and retained about 
60-100% 2’O MTase activity; and residue T214 forms hydrogen bond with γ-
phosphate group, mutation of T214 was shown to have little or no effect on both 
MTase activities in WNV NS5 MTase. 
 
3.3.7 Summary 
In this study, the structures of ternary complex of DENV3 NS5 with an authentic cap 
0 viral RNA substrate (5’-N7mGpppAGUU-3’) and SAH was determined. In this 
structure, RNA folds into an L-shape in the RNA binding groove, and forms extensive 
interactions with residues from MTase domain. Charge and shape complementarity 
between viral RNA and its binding site in NS5 explains the sequence dependent 
recognition and the highly conserved 5’A1G2 dinucleotide sequence present in all 
falviviral genomes. Also the ternary complex structure representing the MTase caught 
in the act of transferring a methyl group helps explains the specificity for adenosine 
2’O ribose methylation, thus rationalizes the mutagenesis studies targeting the strictly 
conserved enzymatic motif K61-D146-K180-E216 as well as residues lying in the 
RNA binding groove and provides mechanistic and evolutionary insights into cap 1 





Table 3.3.3 Residues involved in RNA binding and effect alanine mutants on MTase activities of NS5 MTase from DENV4 and WNV。 
Residues in 
DENV3 NS5 
Interactions Distance N7 MTase activities 
 










WT   100 100 100 100 
K14 NZ/G0-2’O 2.4 67 77 2 7 
L17 O/G0-N2 3.1 nd 111 nd 41 
N18 OD1/G0-2’O 3.0 100 100 70 52 
L20 O/G0-N2 2.8 nd* nd* nd* nd* 
F25 GMP Hydrophobic stacking 15 15 4 33 





nd* 91 nd* 90 
R57 NH2/G2-OP1 2.2 nd 13 Nd 6 
K61 NZ/A1-OP1 2.9 34 70 0 0 
R84 NH1/U3-2’O 4.6 5 4 62 100 
E111 OE1/G2-N2; N3 3.0; 2.8 nd* nd* nd* nd* 
D146 OD1/K180-NZ; OD2/A1-2’O 3.0; 4.1 0 0 0 0 
S150 N/A1-N7 3.3 100 80 55 62 
K180 NZ/A1-2’O 2.3 16 42 6 0 
R211 NH1/H2O/U3-OP2 3.4-2.2 nd* 31 nd* 7 
S213 OG/G0-O2B 2.6 111 nd 22 nd* 
T214 OG1/G0-O2C 3.4 nd* 100 nd* 104 





nd* 31 nd* 8 
a
Data from Dong et al., 2010 (Dong et al., 2010); 
b
Data from Dong et al., 2008 (Dong et al., 2008). *nd: not determined. 
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Chapter 4: Discussion and Future Directions 
4.1 Preface 
Dengue is an emerging infectious disease caused by mosquito-transmission of 
any of the four serotypes of dengue virus (DENV). It threatens almost half of the 
world’s population. Currently, no effective vaccine or therapeutic antiviral is available 
for prevention or treatment of dengue infection. Dengue virus replication takes place 
in membrane associated replication complex (RC), which constitutes seven 
nonstructural proteins (NS1-NS5), viral RNA and unknown host factors. Among them, 
the non-structural protein 5 (NS5) is the largest and the most conserved flaviviral 
protein.  
NS5 performs enzymatic reactions essential for viral replication. The N-
terminal domain of NS5 is the S-adenosyl-L-methionine (SAM)-dependent 
methyltransferases, which is responsible for formation of the type I capped structure 
at 5’end of the flaviviral genome by transferring methyl group from cofactor SAM to 
N7 position of the capped Guanine (G0) and 2’O position of the ribose of the first 
adenosine. The type I cap is essential for efficient viral genome translation into 
polyprotein using the host ribosome by mimicking of mRNA, also it protects viral 
genome against degradation and evades from host immune response. The C-terminal 
domain of NS5 is the RNA-dependent RNA polymerase domain (RdRp) that 
catalyzes RNA synthesis during viral replication. Additionally NS5 interacts with 
several viral and host proteins to modulate viral RNA replication and the host’s innate 
immune response, thus making NS5 a good target for designing anti-viral compounds. 
High resolution structures were available for either domain separately but the 
molecular view of full length NS5 was still lacking. Thus, to study the overall 
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architecture of NS5 and the molecular basis for these essential enzymatic activities of 
NS5, we employed various technologies and methods to explore the structural and 
functional characterization of NS5 protein from dengue. 
 
4.2 NS5 specific monoclonal antibodies as a toolbox for dengue research 
In the first result chapter (Chapter 3.1), we performed panning of NS5 against 
a naïve human phage library, and identified in total eight monoclonal antibodies that 
are specific for dengue NS5 protein: three targeting MTase domain (5M1, 5M2 and 
5M3), and five targeting RdRp domain (5R1, 5R2, 5R3, 5R4, and 5R5). Of them, two 
antibodies (5M1 and 5R3) are cross-reactive for NS5 from all four serotypes of 
dengue. Epitope binding site of 5M1 was mapped by peptide-phage display and 
peptide competitive ELISA methods to highly conserved residues 6-20 of NS5; and 
conformational epitope for 5R3 was also mapped to highly conserved residues 786-
800 by peptide competitive ELISA method. The epitope for the third antibody 5M3, 
which forms stable complex with NS5 or NS5MTase (in chapter 3.2) was also 
mapped by combination of peptide-phage display and western blot methods to 
residues 19-29, which is specific for NS5 from DENV3. These well-characterized 
antibodies provide useful toolbox for dengue research, especially studies of NS5 
functions and interactions within replication complex, as well as the dengue 
pathogenesis associated with NS5 differential subcellular localization. 
4.3 First 3D structure of full length NS5 from dengue virus revealed domain 
crosstalk and conformational flexibility is regulated by a polar interface and 
physical linker, which are important for flavivirus replication. 
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In the second result chapter (Chapter 3.2), we explored different strategies to 
obtain structure information for full length NS5: co-crystallization with Fab, solution 
studies of NS5 by SAXS and truncation of NS5 to remove flexible termini for 
crystallization. We successfully obtained NS5 crystal with the truncated construct 
NS56-895 and determined 3D structure for NS5-SAH (SAH, co-purified with NS5 from 
bacteria) and NS5-SAH-GTP complex. The full length NS5 adopts overall globular 
shape with size of 87 Å × 72 Å × 55 Å. In DENV3 NS5, the MTase domain resides on 
top of the fingers subdomain and attached to the backside of RdRp domain, near the 
NTP entry site, with all functional sites from two domains are not blocked. Two 
domains crosstalk through a highly charged interface with residues 63-69, 95-96 and 
252-256 from MTase domain, residues from fingers subdomain of RdRp domain and 
residues 267-269 from the 10aa-linker. Besides, the physical linker (aa 263-272) 
between MTase and RdRp domains was fully resolved for the first time. Mutagenesis 
and reverse genetic studies were carried out to evaluate the functional implication of 
residues from the interface and linker. The highly charged interface and structural 
transition of the linker residues 263-266 (HVNA) are believed to be responsible for 
the conformational flexibility of NS5 for accommodating its various enzymatic 
activities, as well as its dynamic properties within the replication complex for viral 
replication.  
Based on our studies on DENV3 NS5, and in combination with comparable 
studies on NS5 from JEV and other flaviviruses, we proposed the divergent 
evolutionary model for flaviviral NS5 proteins (Figure 4.1).  In this model, the 
MTase domain and RdRp domain originally existing as two separate proteins. They 
became linked together to form the NS5 protein from an ancestral Flavivirus, possibly 
through gene fusion. This fusion promoted colocalization of both enzymatic activities 
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and effectively increased the effective concentration of the proteins with respect to 
each other. Following further evolution under different selection pressure, NS5 
acquired different adaptive mutations and gave rise to the NS5 proteins now observed 
for various viruses, including DENV, JEV and possibly other flaviviruses). Thus NS5 
proteins from DENV and JEV may have different conformations and different 
allosteric mechanisms, in which the MTase and RdRp domain cross-talk to each other 
through unique interfaces specific to either DENV or JEV (Selisko et al., 2014).  
However, it is also possible that a series of NS5 conformations are shared 
among flaviviruses, but different conformations for JEV NS5 and DENV3 NS5 were 
captured by X-ray crystallography (Figure 4.2). During virus replication, NS5 may 
adopt various conformations: from extended to compact (JEV-like) or more compact 
(DENV3-like) upon recruitment of and interaction with NS3, viral RNA and other 
viral and host cofactors. The question of which molecular conformation(s) 
participates in the various stage(s) of the virus replication cycle remains elusive. The 
structure transition at the short linker of NS5 is likely to dictate the conformational 
flexibility of NS5. Also the sequence heterogeneity of the linker residues suggests the 
suggests that other flaviviral NS5 proteins may display comparable (or even higher) 
degrees of freedom, possibly reflecting the need to accommodate additional host 
factors that must be recruited to the RC for replication. This hypothesis is also 
indirectly supported by the disordered linker sequence of JEV NS5. Interestingly, 
another multifunctional protein for flavivirruses, NS3 protease-helicase, also contains 
an inter-domain linker. The linker is flexible and variable in sequence as well, and it 
is able to adopt multiple conformations at different stages of the virus life cycle 
(Assenberg et al., 2009; Li et al., 2014a; Luo et al., 2012; Luo et al., 2010; Luo et al., 
2008a). Notably, NS3 and NS5 have almost all essential enzymatic activities required 
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for virus replication, besides the inter-domain linkers observed in them might have 
evolved to play a structural role for the assembly of the RC. Further studies exploring 
possible connections between virus pathogenesis and the dynamics of viral replicative 
enzymes in various flaviviruses are now needed, which are likely to be of interest to 





Figure 4.1 A schematic model for the divergent evolution of flaviviral NS5 
proteins. The same color scheme as in Figure 1 is used: MTase is in yellow, RdRp 
fingers in green, palm in blue, thumb in salmon. The linker region 310
 
helix (residues 
263-266) between the two domains is in orange. Active sites for MTase and RdRp are 
labelled with dotted tetragon and pentagon respectively. Linker residues and interface 
residues are labeled. A possible evolutionary pathway is presented: the MTase domain 
and RdRp domain originally existing as two separate proteins (left) became linked 
together to form the NS5 protein from an ancestral Flavivirus, possibly through gene 
fusion. This fusion promoted colocalization of both enzymatic activities and 
effectively increased the effective concentration of the proteins with respect to each 
other (middle panel). Following further (divergent) evolution, NS5 acquired different 
adaptive mutations and gave rise to the NS5 proteins now observed for various 
viruses, including DENV, JEV and possibly other flaviviruses) (right panel). Thus 
NS5 proteins from DENV and JEV may have different conformations and different 
allosteric mechanisms, in which the MTase and RdRp domain cross-talk to each other 




Figure 4.2 Schematic model of possible conformations of NS5FL. The NS5FL 
from DENV3 adopts a compact conformation with MTase domain cross-talking with 
RdRp domain through multiple inter-domain interactions. Key residues at the 
interface are labelled. Potential transformation of NS5FL conformations – extended 
form and JEV NS5FL like form - is also included for comparison. Note the flexibility 
of the linker region in order to accommodate these different conformations. Dynamic 
transition between the closed and open conformations may well exist to meet the 
versatile functions of NS5 protein and to regulate the access of other host/viral 
components during virus replication cycle.  
 
4.4 A ternary complex for NS5 with authentic cap 0 viral RNA reveals the 
mechanistic for 2’OMTase activity and molecular basis for sequence 
conservation at 5’end of flaviviral genome. 
In the third result chapter (Chapter 3.3), the dengue NS5 was captured in 
complex with an authentic cap 0 viral RNA substrate (5’-N7mGpppAGUUGUU-3’) and 
SAH. In this ternary complex, RNA adopts an L-shaped conformation in the RNA-
binding site of MTase domain and is stabilized by shape and charge complementarity 
with NS5. Especially, interactions between the G0, A1, and G2 with NS5 explain the 
specific recognition of the flaviviral RNA 5’cap structure and the highly conserved 
5’-A1G2 dinucleotide sequence present in all flaviviral genomes. Furthermore, this 
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structure represents a snapshot along the 2’-O methylation reaction pathway, which is 
for the first time that a catalytic-relevant conformation of flaviviral NS5 captured in 
complex with RNA. Thus it provides the molecular basis for basis for specific 2’O 
methylation at ribose of adenosine, and rationalizes mutagenesis studies targeting the 
K61-D146-K180-E216 enzymatic tetrad as well as residues in the RNA binding 
groove and offers novel mechanistic insight in cap 1 formation, which underlies 
innate immunity evasion by flaviviruses. For developing anti-dengue therapeutics, 
one possible strategy would consist in extending SAM analogues towards the RNA 
binding groove - for instance by linking the A1 moiety to nucleoside analogues (eg: 
ribavirin) that bind at the GTP binding site, next to residue F25. This strategy may 
lead to larger but more specific and potent flavivirus MTase inhibitors. 
4.5 Coupling of RNA capping with RNA replication. 
The single molecular NS5 is a multifunctional protein, which is capable of carrying 
out both MTase activity for RNA capping and RdRp activity for RNA replication. In 
the full length NS5 structure, the MTase domain is positioned to the backside of the 
RdRp domain, which is away from the exit tunnel for the newly synthesized RNAs 
(Figure 4.3A). We proposed three possible ways to couple RNA capping and RNA 
replication (Figure 4.3B):  (1) the newly synthesized RNA reaches certain length so 
that it can approach the KDKE active site of the MTase domain for capping; (2) NS5 
could adopt various conformations, regulated by the interface and physical linker 
between two domains, and possibly MTase could swing to the front of RdRp domain 
so that the newly synthesized RNA can be readily capped, this hypothesis of MTase 
domain repositioning is also postulated by another group (Selisko et al., 2014); (3) 
another NS5 within the replication complex can perform the capping function (Figure 
4.3C). The n
th
 (+) strand RNA was synthesized by RdRp domain of the first NS5 and 
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exited from RdRp domain together with the (-) template strand. Then capping of the 
n
th
 (+) strand at 5’end by MTase domain of the second NS5, bring its RdRp close to 
3’end of the (-) template strand, which could initiate new round of RNA synthesis of 
the (n+1)
th




Figure 4.3 Model for coupled RNA capping and RNA replication. (A) NS5 in 
complex with RNA substrate for 2’O methylation (crystal structure of NS5-RNA) and 
RNA replication (modelled). NS5 is in surface representation with positive charges in 
blue and negative charges in red. Template RNA for replication is coloured yellow 
and newly synthesized RNA is coloured purple. The RNA substrate for 2’O 
methylation is coloured in red. (B) Three possible ways for NS5 to cap at 5’end of the 
newly synthesized RNA. (C) Proposed model for the third hypothesis. 
 
4.6 Outlook 
Future directions to understand the molecular details of flavivirus replication 
machinery centering on the multifunctional NS5 methyltrasferase and polymerase are: 
1. To reveal the mechanism for N7-methyltransferase activity of NS5: Stem loop A 
(SLA) is required for the N7MTase activity, thus new structures of NS5 or NS5 
MTase domain in complex with SLA are of great interest, alternatively 
crosslinking coupled mass spectrometry can be employed to mapping the binding 
between NS5 protein and viral RNA to facilitate the substrate selection for 
crystallization.   
2. To decipher the molecular basis for NS5 de novo initiation and elongation 
activities: currently no structure for RdRp-RNA complex is available for 
flaviviruses, which have a narrow RNA template tunnel and priming loop for de 
novo initiation of RNA replication. Thus an intelligent design of RdRp constructs 
and RNA substrate is very important for cocrystallization of RdRp-RNA complex. 
And crosslinking coupled mass spectrometry can be employed to mapping the 
binding between NS5 protein and viral RNA to facilitate the substrate selection. 
3. To further explore the conformational flexibility and dynamic properties of NS5: 
NS5 could adapt multiple conformations in solution, techniques like SAXS, NMR 
etc can be employed to study the dynamics of NS5 and thus better understanding 
of the multifunctional roles of NS5.  
 184 
 
4. To characterize the roles of NS5 in viral replication through interactions with 
either viral protein, or genomic RNA and other factors within the replication 
complex, this could facilitate uncovering of the mystery of dengue replication 
complex. 
All in all, structural and functional studies of NS5 could advance the development of 
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